0001493152-24-014774.txt : 20240416 0001493152-24-014774.hdr.sgml : 20240416 20240416124321 ACCESSION NUMBER: 0001493152-24-014774 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240416 DATE AS OF CHANGE: 20240416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NP Life Sciences Health Industry Group Inc. CENTRAL INDEX KEY: 0001781726 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-EDUCATIONAL SERVICES [8200] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 832912878 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56140 FILM NUMBER: 24846799 BUSINESS ADDRESS: STREET 1: 4125 BLACKHAWK PLAZA CIRCLE STREET 2: SUITE 166 CITY: DANVILLE STATE: CA ZIP: 94506 BUSINESS PHONE: (925)-362-3169 MAIL ADDRESS: STREET 1: 4125 BLACKHAWK PLAZA CIRCLE STREET 2: SUITE 166 CITY: DANVILLE STATE: CA ZIP: 94506 FORMER COMPANY: FORMER CONFORMED NAME: GJ Culture Group US, Inc. DATE OF NAME CHANGE: 20190705 10-K 1 form10-k.htm
false FY 0001781726 0001781726 2023-01-01 2023-12-31 0001781726 2023-06-30 0001781726 2024-04-15 0001781726 2023-12-31 0001781726 2022-12-31 0001781726 us-gaap:RelatedPartyMember 2023-12-31 0001781726 us-gaap:RelatedPartyMember 2022-12-31 0001781726 2022-01-01 2022-12-31 0001781726 us-gaap:PreferredStockMember 2021-12-31 0001781726 us-gaap:CommonStockMember 2021-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001781726 us-gaap:RetainedEarningsMember 2021-12-31 0001781726 2021-12-31 0001781726 us-gaap:PreferredStockMember 2022-12-31 0001781726 us-gaap:CommonStockMember 2022-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001781726 us-gaap:RetainedEarningsMember 2022-12-31 0001781726 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001781726 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001781726 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001781726 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001781726 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001781726 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001781726 us-gaap:PreferredStockMember 2023-12-31 0001781726 us-gaap:CommonStockMember 2023-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001781726 us-gaap:RetainedEarningsMember 2023-12-31 0001781726 NPLS:NPLifeSciencesHealthSingaporePteLtdMember 2023-08-16 0001781726 NPLS:IndividualHolderMember 2023-08-16 0001781726 NPLS:GWHealthConsultingManagementIncMember 2023-12-31 0001781726 NPLS:NLPLHealthIndustryGroupCoLimitedMember 2023-12-31 0001781726 NPLS:NPLifeSciencesHealthSingaporePteLtdMember 2023-12-31 0001781726 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001781726 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001781726 NPLS:TraditionalCultureAndEducationMember 2023-01-01 2023-12-31 0001781726 NPLS:TraditionalCultureAndEducationMember 2022-01-01 2022-12-31 0001781726 NPLS:CareerPlanningExperienceSharingAndGuidanceMember 2023-01-01 2023-12-31 0001781726 NPLS:CareerPlanningExperienceSharingAndGuidanceMember 2022-01-01 2022-12-31 0001781726 NPLS:TwoCustomerMember 2022-12-31 0001781726 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001781726 us-gaap:RelatedPartyMember NPLS:LoanAgreementMember 2023-12-31 0001781726 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NPLS:FourCustomersMember 2023-01-01 2023-12-31 0001781726 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NPLS:FourCustomersMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerAMember 2023-01-01 2023-12-31 0001781726 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NPLS:CustomerAMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerBMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerCMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerDMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerEMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerFMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerFMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerGMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerGMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerHMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerHMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NPLS:CustomersMember 2023-01-01 2023-12-31 0001781726 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NPLS:CustomersMember 2022-01-01 2022-12-31 0001781726 us-gaap:SubsequentEventMember NPLS:LoanAgreementMember 2024-04-05 0001781726 2023-10-01 2023-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended: December 31, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________  to ___________

 

Commission file number: 000-56140

 

NP Life Sciences Health Industry Group Inc.
(Exact name of registrant as specified in its charter)

 

Nevada   83-2912878

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

4125 Blackhawk Plaza Circle, Suite 166

Danville, CA 94506

 

(Address of principal executive offices)

 

(925) 362-3169

 

(Registrant’s telephone number, including area code)

 

Securities registered under Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value   NPLS   N/A

 

Securities registered under Section 12(g) of the Exchange Act:

 

Common Stock

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

 

Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Yes ☒ No ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes ☐ No

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. No market value can be provided as no trading was done during the period referenced.

 

The number of shares outstanding of the registrant’s common stock as of April 15, 2024 was 42,959,574 shares, $0.0001 par value.

 

 

 

 

 

 

NP Life Sciences Health Industry Group Inc.

 

FORM 10-K

 

Table of Contents

 

    Page No.
PART I
Item 1. Business. 4
Item 1A. Risk Factors. 23
Item 1B. Unresolved Staff Comments. 23
Item 2. Properties. 23
Item 3. Legal Proceedings 24
Item 4. Mine Safety Disclosures. 24
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 24
Item 6. Selected Financial Data. 24
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 25
Item 7A. Quantitative and Qualitative Disclosures About Market Risk. 29
Item 8. Financial Statements and Supplementary Data. 30
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. 31
Item 9A. Controls and Procedures. 31
Item 9B. Other Information. 32
PART III
Item 10. Directors, Executive Officers and Corporate Governance. 33
Item 11. Executive Compensation. 36
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 37
Item 13. Certain Relationships and Related Transactions, and Director Independence. 38
Item 14. Principal Accounting Fees and Services. 39
PART IV
Item 15. Exhibits, Financial Statement Schedules. 39

 

2

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve substantial risks and uncertainties. All statements, other than statements of historical fact, included in this annual report regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management are forward-looking statements. The words “anticipates,” “believes,” “continue,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would,” the negative of these terms and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

 

We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that the expectations underlying our forward-looking statements are reasonable, these expectations may prove to be incorrect, and all of these statements are subject to risks and uncertainties. Therefore, you should not place undue reliance on our forward-looking statements. We have included important risks and uncertainties in the cautionary statements included in this annual report. We believe these risks and uncertainties could cause actual results or events to differ materially from the forward-looking statements that we make. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections or expectations prove incorrect, actual results, performance or financial condition may vary materially and adversely from those anticipated, estimated or expected. Our forward-looking statements do not reflect the potential impact of future acquisitions, mergers, dispositions, joint ventures or investments that we may make. We do not assume any obligation to update any of the forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law. In the light of these risks and uncertainties, the forward-looking events and circumstances discussed in this annual report may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.

 

3

 

 

PART I

 

ITEM 1. BUSINESS.

 

OUR COMPANY

 

NP Life Sciences Health Industry Group Inc. (“NP Life Sciences”, “NPLS”, the “Company”, “we”, “us” or “our”), formerly GJ Culture Group US, Inc, was formed as a Nevada corporation on December 20, 2018 for the purpose of providing educational and other related services based on classical Chinese studies and culture. We aim to serve as a cultural and educational meeting point between China and the U.S. We are an emerging company and is qualified and authorized to transact intestate business in California. We are dedicated to providing educational services based on classical Chinese studies and culture. We aim to serve as a cultural and educational meeting point between China and the U.S. Our business is providing education and training courses based on classical Chinese studies both in Chinese and English, organizing China-U.S. international study tour activities for participants of all ages, and organizing and promoting China-U.S. cultural events, art fairs, and exhibitions and other relevant activities related to educating the public about Chinese culture.

 

On November 8, 2022, we formed our wholly-owned subsidiary GW Health Consulting Management Inc. ( “GW”), a California corporation.. GW’s business has been limited to providing online career planning experience sharing and guidance consulting services, and mainly through introductions among friends to obtain customer resources. GW’s business operations are at a very early stage and did not generate revenue in the fiscal year ended December 31, 2022 and generated $99,599 in revenue in the fiscal year ended December 31, 2023 from two customers.

 

GW plans to provide offline and online mental health consulting services for families, individuals, and company employees. GW plans to expand offline market especially to focus on the Southeast Asian market, including but not limited to South Korea, Singapore, and China. By providing mental health consulting services, in the future, GW plans to extend its business to health care projects, health monitoring, psychological hospitals, aesthetic and medicine.

 

On March 8, 2023, GW established a wholly owned subsidiary, NLPL Health Industry Group Co., Limited, a Hong Kong based company, which had no business transaction in the reporting period.

 

On August 16, 2023, the Company established a subsidiary named NP Life Sciences Health (Singapore) Pte. Ltd., a Singapore based company, in which the Company holds 90% of the shares and an individual holds 10% of the shares. The subsidiary had no business transaction in the reporting period.

 

Our executive office is located in Danville, California. Additionally; we have cooperative agencies in California and China. We have established a cooperative relationship with Shaanxi Guojiang Cultural Industry Group Co. Ltd (“Guojiang China”), which is an affiliated company of us based in Shaanxi, China and also engages in business related to Chinese classical education. We intend through our cooperative partners to enter into contracts for cooperation with experts in various fields of traditional Chinese culture and art; to offer a diverse and systematic array of services related to Chinese classical studies, that cover the demand of the American market. We will focus on education and the cultural exchange between China and the U.S. relying on our experience in the field of Chinese classical culture and art. We intend to capitalize on the growing interest in China and on its increasing global influence. We will do this by offering a curated and systematized curriculum of classical Chinese studies, and contribute to the exchange and development of cultural education and art between China and the U.S.

 

We are committed to becoming a professional service institution of education, specifically in classical Chinese studies, culture and art. Classical studies and art are at the core of our services. We will offer international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. All of these will enrich, elevate and complement each other, forming a vertically integrated set of products and services with growth potential.

 

There is a growing global interest in China, and an increasing demand to learn more about the Chinese culture and language. We believe it is because the market for classical Chinese studies education and training in the U.S. exists, but it is still in an early stage of development. Based on the market search results by Zero Power Intelligence Research Institute as described in previous chapter, we estimate that this industry presents large training needs, many business opportunities and potential profit margins.

 

We plan to generate most of the revenue through provision of classical studies lectures, international study tour services, classical studies education and training, and organizing cultural and artistic events. All of these services will be paid for by our students or participants in advance.

 

We are qualified to trade on the OTC Markets Group Inc.’s OTCQB® Venture Market under the symbol “NPLS.”

 

4

 

 

Industry Background

 

Increasing Demand for Classical Chinese Studies Education in the U.S.

 

Since initiating market reforms in 1978, China’s economy has been transitioning from a planned economy to a more market-oriented economy. The economy in China has grown significantly over the past few decades. China’s overall economy and the average wage in China have increased in recent years and are expected to grow, which inspired a growing global interest in China, and a growing demand to learn more about the Chinese culture and language. Even Mark Zuckerberg, Facebook’s CEO, offered RMB 840,000 (approximately USD 125,000) to hire a Chinese speaking nanny for his daughter. Currently, there is a demand of Chinese education, both culturally and language-wise, of about 6 million people in the U. S.

 

The market for classical Chinese studies education and training in the U.S. exists, but is still in an early stage of development.

 

Targeting Market for Classical Chinese Studies Education in the U.S. – The Chinese-American Demographic

 

According to the U.S. Census Bureau, there were 4.52 million Chinese people living in the U.S. in 2018. This makes Chinese people the largest Asia-Pacific ethnic group in the U.S., and the second largest ethnic group after the Mexicans, when considering all ethnic minorities as a whole. The US Department of Homeland Security lists Chinese immigrants as the third-largest immigrant group in the United States. There are 21 million Asia-Pacific Americans in the U.S., accounting for 6.7% of the total population. It is expected that by 2050 Asia-Pacific Americans will account for 10% of the total U.S. population.

 

Chinese people gather in certain parts of the U.S., mainly in California, New York, and other metropolitan cities. Half of all Chinese Americans live in the western part of the U.S. One fifth live in the northeast and south. In the west of the U.S. they concentrate in Seattle, Washington, Los Angeles, San Francisco, and other cities located in California; and in the south in cities located in Texas, such as Houston and Dallas. In the Northeast they concentrate in New York and Boston. New York City, with 570,000 Chinese, is a metropolis with a large Chinese population.

 

Most Chinese Americans are concentrated in California, with 36.9% of the total Chinese population, followed by New York, with 16.9%; New Jersey, with 4.4%; Texas, with 4.2%; and Florida, with 4.1%.

 

These 4.52 million Chinese-Americans, with a prior affinity to the Chinese identity and culture, will be our initial target audience. They are the driving force behind the American educational enterprises offering traditional Chinese culture immersion courses and services related to Chinese language and classical Chinese studies.

 

Challenges Faced by Institutions Offering Classical Chinese Studies Education in the U.S.

 

The classical Chinese studies education offered in the current U.S. market is in a state of chaotic development. This is mainly reflected by two key factors: (i) the design and planning of course content is disorganized; and (ii) teachers are poorly selected and trained. The combination of these two elements results in the fact that the concept of classical Chinese studies is not clearly defined.

 

  i. Course setting. Due to the lack of carefully planned course and content design, there is no consensus on the subject of what constitutes classical Chinese studies in the U.S. This causes institutions and universities to develop their own policies and their own interpretation when selecting the curriculum and content for their classical Chinese studies courses. There is no unified curriculum for classical Chinese studies in the U.S. today. Each learning center and university uses the resources available to them when structuring a course, some prioritize art over history and literature, while others do the opposite. They all emphasize their perceived strong subjects or where they have more available resources.
     
  ii. Teacher selection. The present market lacks teachers who are specialized or have the required skills, experience, and qualifications to teach a classical Chinese studies course. Some teachers who are not qualified to teach subjects related to classical Chinese studies are somehow teaching those courses. This lack of specialization and professionalism among the teachers themselves makes delivering a real classical Chinese studies course very difficult. Students, not knowing any better, blindly obey.

 

5

 

 

Market Opportunity Analysis of Classical Chinese Studies Education in the U.S.

 

There are not many education service providers who offer classical Chinese studies in the U.S., and long-term operating experience in this field is non-existent. This may be because most of the educational institutions operating in the market pursue revenue and tend to ignore the needs of clients. Many Internet educators focus on profitability rather than education itself, and their lack of competitive teaching methods and content renders them unable to enter into an overseas market with a full-fledged array of different education offers like they can in the U.S.

 

Service providers offering classical Chinese studies education have two major functions: To teach American students Chinese and provide services so that some of those American students can study abroad in China, and to promote the excellence of Chinese culture as a whole. Some companies use their platform to provide American students with English-language versions of classical Chinese studies courses and Chinese language learning courses. They also invite experts in Chinese language and professors, scholars, and academics of classical Chinese studies to give lectures.

 

 

 

Data source: Zero Power Intelligence Research Institute. The data supporting the two tables appearing in the Registration Statement on pages 15 and 18 was calculated based on statistics from National Bureau of Statistics of China, or NBSC, and relevant associations. To be more specific, Zero Power used the population data of the United States in 2015 from National Bureau of Statistics (http://data.stats.gov.cn/easyquery.htm?cn=G0104) and the historical population data from 1968 to 2018 of the United States from World Bank (https://data.worldbank.org.cn/indicator/SP.POP.TOTL?locations=US). Zero Power then estimated the number of people participating in Chinese education studies through its own theoretical deduction and data model based upon its industry research. Zero Power also estimated that the annual spending on the such education is approximately $1,000 per person; and The number of people participating in classical Chinese studies education in the U.S. mainly includes the number of enrollments of Confucius Institutes and classical Chinese studies education and training institutions in the U.S.

 

The numbers represent billions in USD.

 

6

 

 

COMPANY OVERVIEW

 

NPLS was formed as a Nevada corporation on December 20, 2018 for the purpose of providing educational and other related services based on classical Chinese studies and culture. We aim to serve as a cultural and educational meeting point between China and the U.S.. We are an emerging company and is qualified and authorized to transact intestate business in California. We are dedicated to providing educational services based on classical Chinese studies and culture. We aim to serve as a cultural and educational meeting point between China and the U.S. Our business is providing education and training courses based on classical Chinese studies both in Chinese and English, organizing China-U.S. international study tour activities for participants of all ages, and organizing and promoting China-U.S. cultural events, art fairs, and exhibitions and other relevant activities related to educating the public about Chinese culture. On September 8, 2022, we filed a Certificate of Amendment to its Articles of Incorporation with the State of Nevada to reflect its corporate name change from “GJ Culture Group US, Inc.” to “NP Life Sciences Health Industry Group Inc.”.

 

On November 8, 2022, we formed our wholly-owned subsidiary GW, a California Corporation, for the purpose of providing mental health consulting and other related services. GW plans to provide offline and online mental health consulting services for families, individuals, and company employees. GW plans to expand offline market especially focus on the Southeast Asian market, including but not limited to South Korea, Singapore, China, etc. By providing mental health consulting services, GW plans to extend its business to health care projects, health monitoring, psychological hospitals, aesthetic medicine, etc. GW’s business operations are at a very early stage and GW did not generate any revenue in 2022, GW’s business has been limited to providing online career planning experience sharing and guidance consulting services, and mainly through introductions among friends to obtain customer resources.

 

OUR MISSION AND VISION

 

Committed to quality education service based on classical Chinese studies and culture

 

Generally speaking, classical Chinese studies mainly refer to an academic system which utilizes the study of Chinese classics to illustrate and convey the ethos, philosophy, character, and moral and social code of the Chinese nation. Classical Chinese studies are applied to guarantee the quality of education. It contributes to the development of intelligence in children, which requires the constant acquisition of knowledge, the enhancement of language through reading and speaking, and the cultivation of memory abilities. All of these qualities can be developed through Di Zi Gui, which offers the standards for being a good pupil and child, and the San Zi Jing (Three Character Classic) used to teach children Confucian values.

 

Adolescents have entered the stage of understanding the world and establishing their personalities, and need to be guided in words and deeds, as in this stage they have begun to learn through imitation. Therefore, in addition to words and deeds, they need to be given the proper resources to enable them to fully digest and understand their pre-memory knowledge. Adolescents learn to develop critical thinking and perception skills through classical Chinese poetry, painting, calligraphy, chess, and the Chinese Game of Go.

 

Adults have the richness of life experience behind them. Their life, work, and emotional spheres are more complex, so education at this stage of life is dedicated to reflection, experience, and contemplation. Studying the rich ideological and theoretical works of the Chinese classics will help adults think and act wisely and face with ease all difficulties that may present themselves in their life.

 

Committed to the dissemination of ancient Chinese philosophical ideas.

 

The development of a country cannot be separated from the proliferation of culture, which in turn cannot be separated from the inheritance and dissemination of the cultural traditions existing in the area. In fact, Chinese culture is both ancient and complex, in and of itself is an evidence of the continuing accumulation of knowledge through civilization. Chinese classical studies contain abundant ancient Chinese philosophy. It is not only the essence of classical Chinese culture, but also an important factor to maintain the sustainable development of contemporary China. We believe that Chinese culture and Chinese classical studies contribute not only to the sustained development and expansion of the Chinese people, but to the sustained development of the world as a whole. Our long-term objective is to introduce ancient Chinese philosophical ideas into collective consciousness.

 

Committed to become a bond between Chinese and western cultures and art.

 

NPLS intends to gradually expand its international study tour services, classical Chinese studies education services, seminars, cultural events, and art fairs by integrating and managing the valuable resources we have accumulated in the field of Chinese classical studies, culture, and art. Over the years we have gained knowledge, experience, and expertise in the fields of both Chinese and western culture and art. We anticipate that this knowledge will position us not only as an education service provider, but also as a platform for the exchange of culture and art between China and the U.S. We intend to serve as a melting pot for the continuous amalgamation of Chinese and American cultures.

 

7

 

 

OUR COMPETITIVE STRENGTHS

 

The contents of our seminars and teaching materials will be written and composed specifically for classical Chinese educational purposes.

 

The contents of our classical Chinese studies education curriculum will be designed based on the traditional Chinese classics. To develop the contents and systematize our course curriculum we have incorporated both Chinese and western education models, applying a directional development approach. Our system is different from other institutions in this industry that simply read the traditional classics and design courses according to the objective needs of classes and lectures. We will adapt Chinese classical cultural principles to storytelling to meet the dynamic needs of classroom lectures and will also use pictorial impressions to help students memorize and understand complex text descriptions.

We will divide our students according to their developmental stage and design each course accordingly. This will allow us to offer the rich and diverse content of classical Chinese studies and education services effectively and systematically. We have also planned to develop special teaching programs and assessment materials for teachers and tutors of classical Chinese studies.

 

Sophisticated classical Chinese studies education system and one-stop training system

 

Our classical Chinese studies education services include curriculum education, lectures, international study tours, and cultural and art exchanges. We believe our education services cover all aspects of classical Chinese culture. We have planned to specially develop phase-linked courses and teaching methods that correspond to the different stages of classical Chinese studies. These phase-linked courses and teaching methods guarantee that students learn classical Chinese studies systematically within a structured framework of education, which in turn encourages students to further their education by taking the advanced courses. Systematic learning and the possibility to advance their education increases student engagement. The variety of services we provide, such as classes, public lectures, international study tours, cultural events and art exhibitions, will provide our students with a first-hand, hands-on integral learning experience.

 

Scientific Theoretical System of Classical Studies Education

 

We have combined western psychology, neuroscience and Chinese classical studies to create a scientific theory of classical Chinese studies. Using the analogy of how a tree grows, we have taken classical studies as the soil, moral behavior as the root, thoughts as the stem, and the arts as the branches, emphasizing the idea of “infiltrating the soul and enlightening wisdom.” This idea is the basis of our approach. We aim to provide a systematic classical studies education process for our students of different ages. We have developed diversified services and products horizontally, these include lectures, classroom education, international study tour services and cultural and artistic events. All of our students can participate in these activities because vertically we have adopted the concept of multi-level and phased product development, so each product created horizontally is vertically adapted to cater to different needs according to different developmental stages.

 

Resources for Classical Studies Education

 

Education is a subject that requires professionalism, and classical Chinese studies education requires professional teachers who can convey its contents through a systematized and scientific approach. NPLS plans to collaborate with well-known masters in the field of Chinese culture and art and plans to establish solid cooperation relationships with some institutions of classical Chinese culture and art in China.

 

Our team and contributors provide professional classical studies education, culture and art courses to numerous Chinese-Americans, scholars and people interested in Chinese culture in general. We plan and co-ordinate our resources, and the resources of our contributors, to offer a diverse and systematic array of services related to Chinese classical studies, to cover the demand of the American market.

 

8

 

 

OUR GROWTH STRATEGIES

 

NPLS is committed to becoming a professional service institution in the field of education, specifically in classical Chinese studies, culture, and art. Classical studies and art are at the core of our services. We will offer international study tours, classical Chinese studies seminars and lectures, and cultural and artistic events, all of which will enrich, elevate and complement each other, forming a vertically integrated offer of products and services with great potential for growth.

 

We aspire to become a pre-eminent education service provider for classical Chinese culture study and intend to pursue the following strategies to further grow our business:

 

Enhance education quality and academic results

 

We place great emphasis on enhancing our education quality. We offer one of the most comprehensive classical Chinese culture studies, and plan to further enhance the breadth and depth of our course offerings to enrich our students’ learning experience. We will also continue to devote resources to recruit experienced teachers, enhance ongoing teachers’ training programs through collaboration with other education institutions, and develop proprietary teaching materials.

 

Promote brand awareness

 

We believe that our education quality speaks volumes for our brand. Word-of-mouth referrals by former and current students and their families have been an important source of student enrollment. We will continue to drive word-of-mouth marketing by focusing on improving our education quality and students’ academic achievements while leveraging social media to improve the efficiency of our brand building and marketing initiatives.

 

In addition, we plan to organize more event-driven marketing campaigns to further increase our influence in the industry and among parents, such as seminars for prospective students, international education conferences and formation of strategic partnerships with international education institutions.

 

Expand into new markets across the U.S.

 

We will continue to expand our course network into other regions in the United States to capture nationwide demand for quality classical Chinese culture education. We intend to continue to replicate our success and apply our experience and know-how from the operation of our mature facilities to new facilities and promote the sharing of teaching and administrative resources within our network.

 

Increase utilization rate and improve operating efficiency

 

We seek to increase our student enrollment and program utilization rate, especially for our programs that are at the ramp-up stage, through marketing efforts and dedicated student recruiting teams. A larger student base allows more efficient utilization of our infrastructure and resources and improves our operating efficiency and profitability. We will continue to standardize operation of our programs in areas such as curriculum design, teaching resource allocation, cost control, auxiliary facilities, and service management. This will also allow for better resource sharing within our network to achieve greater economies of scale. We will also provide training to our management and administrative staff to ensure proper implementation of our standardized best practices.

 

Pursue strategic alliances and selective acquisition opportunities

 

We intend to continue to form strategic partnerships with reputable education institutions and make selective strategic alliances with and acquisitions of complementary businesses to further improve our education quality, expand our student base and network, and diversify our service offerings.

 

We are actively exploring potential joint venture opportunities with reputable overseas operators of classical Chinese culture institutes to further expand our program network. We seek to invest in or acquire companies that are complementary to our business, including institutions providing education and trading courses based on classical Chinese studies. We seek to increase our cooperation with organizations, especially those specializing in organizing China-U.S. international study tour activities for participants of all ages and organizing and promoting China-U.S. cultural events and art fairs and exhibitions, to further enhance and enrich our students’ learning experience and results.

 

9

 

 

CURRICULUM DEVELOPMENT

 

Definition of Chinese Classical Studies Education

 

Chinese classical studies refer to the chief educational institutions established and operated by the imperial courts of ancient China, such as the imperial colleges of “Guo Zi Jian” or “Tai Xue.” In the early 20th century, the terms classical studies and Chinese classical academy became synonymous. Classical studies are a universe of content that revolve around the teachings of the Chinese classical and ancient culture. It studies and interprets Chinese classical culture and academia with Confucianism as basis. There are two levels of classical studies. In the broad sense, classical studies are what Hu Shi calls “all the past cultural history of China”, including literature, history, religion, art, mathematics, etc. In a narrow sense, classical studies refer to the classical Chinese ideology and culture. In short, classical studies education is the education of Chinese classical culture. It has two goals: (i) to enrich the training system and quality of modern education by infusing it with the excellence of ancient Chinese culture; and (ii) to absorb a deep understanding of the philosophical ideas that permeate ancient Chinese culture.

 

Classification of Classical Studies

 

One classification method of classical studies is the classification method of “Siku Quanshu,” which classifies classical studies into four sections: Jing, Shi, Zi and Ji.

 

“Jing” (Classics) refers to ancient books, such as the Classic of Changes, the Classic of Poetry, the Classic of Filial Piety, the Analects of Confucius, the Mencius, etc. Some works on language exegetics, such as the Erya, were included later.

 

“Shi” (Histories) refers to historical works, including general history, such as Sima Qian’s Records of the Grand Historian and Zheng Qiao’s Tongzhi; dynastic history in Ban Gu’s Book of Han, Chen Shou’s Records of the Three Kingdoms, and Ouyang Xiu’s New History of the Five Dynasties; political history, in the Sima Guang’s Zizhi Tongjian, and Li Tao’s Xu Zizhi Tongjian Changbian; and a detailed history of institutions and cultural relics, classics, and texts, in Du You’s Tongdian andMa Duanlin’s Wenxian Tongkao and other chronicles of the region.

 

“Zi” (Masters) refers to the collection of works of people who created a theory or school during the course of Chinese history, which incluedes Xunzi of Confucianism, Han Feizi and the Book of Lord Shang of Legalists, Sun Tzu of Military Strategists, Lao Tzu and Zhuangzi of Taoists, as well as books on Buddhism, the life of peasants, manuals for doctors, astronomical algorithms, mathematics, arts, genealogy, miscellaneous writers, and novelists, all of which belong to the section of Zi.

 

“Ji” (Collections) include a collection of intellectuals and scholars and individual collections in history. Collections of individuals are called “Bie Ji”, these include Li Taibai Ji, Du Gongbu Ji, Wang Jinggong Ji, etc. General collections include Zhaoming Wenxuan, Wenyuan Yinghua, Yutai Xinyong, etc. Some ancient opera works, not included in Siku, such as Changshengdian, Xixiangji and Peony Pavilion, are part of Ji.

 

The other method classifies classical studies according to their content attributes in three categories: the study of Neo-Confucianism, the study of textual research and the study of poetry and prose.

 

The purpose of the study of Neo-Confucianism is to discover the underlying truth of all things, its essence is philosophical. The study of textual research is to engage in historical research, that is, historiography. The study of poetry and prose is literature, and its purpose is to engage in the creation of practical literary styles such as poetry, prose, reports, memorials to emperors and judgments. Later, the study of country management, i.e. politics, economics, law and other social sciences for governance were included; as well as the study of science and technology, i.e. acoustics, optics, chemistry, electrics and other natural sciences.

 

RESEARCH AND DEVELOPMENT OF OUR SERVICES AND PRODUCTS

 

The research and development our services and products mainly include: (i) project development of our international study tours; (ii) the content design of our lectures on classical Chinese studies; (iii) the curriculum development of our classical Chinese studies courses; and (iv) the organizations and promotion of cultural events and art exhibitions.

 

10

 

 

The research and development of the international study tours we will provide include the design of the tour routes, content modules, travel activities, safety plans, etc. The research and development of our classical Chinese studies lectures, and classical Chinese studies courses includes the curriculum of contents, teaching materials, audio and audio-visual resources, teaching plans and references, courseware tools, teaching methods, assessment standards, etc. The planning content of cultural events and art exhibitions mainly includes the design of themes, activity scenarios, activity flows, activity promotion schemes, etc.

 

The Company plans to cooperate with experts or scholars who are interested in and have a thorough study of classical Chinese culture, or form the Chinese culture or study center of major Chinese and American universities, or from some Chinese and American non-government institutions which engage in classical Chinese culture and studies, for the research and development of educational products. By combining education and research, we intend to improve the level and efficiency of our research and development process and lay a solid foundation for the sustainable development of the educational services we offer. Our R&D will use market research and competitive analysis to determine which product and/or service to develop, it will complete a description of such product and/or service, deconstruct the project design structure, implement the sub-module product or service according to the results of the deconstruction, and then integrate the sub-module, to finally integrate the products and services. After the initial market validation, such products and services will be revised based on the feedback received from students and participants, and then the comprehensive marketing work to promote such products and services will begin.

 

 

 

OUR PRODUCTS AND SERVICES

 

International Study Tour Services

 

Our international study tour services mainly serve people in China and the U.S. who have an interest in Chinese classical culture and art. By participating in our study tours based on classical Chinese studies, people will be able to mingle and network, improve their level of classical Chinese culture and experience life in China. The tour will be cared for by specially-assigned staff selected to ensure the participants safety. We currently offer three different types of international study tours: (i) the youth study tour series; (ii) the adult study tour series; and (iii) themed study tour series of culture and art.

 

11

 

 

We intend to organize cultural exchange education tours targeting U.S. students, scholars, families, Chinese culture and art enthusiasts, and others who wish to participate. The destinations in China will include ancient capitals such as Xi’an, Beijing and Hangzhou. Classical Chinese education seminars and workshops will be provided during the course of the trip. Participants will be able to learn about Chinese history, culture, art and classical studies in an interactive, fun, and hands-on way.

 

We entered into a Business Cooperation Agreement (the “China Travel Agreement”) with Xi’an China Travel Service Co., Ltd. (“China Travel”) on March 5, 2019. China Travel is the organizer of the traditional education related tour camp from the U.S. to China. Pursuant to the China Travel Agreement, China Travel engages our Company to provide promotion and marketing services to recruit participants to the Chinese classical culture related tour camp organized by China Travel from July to August, starting 2019, and agreed to pay us $20,000 in promotional and marketing expenses. China Travel further agreed to pay us 15% of tour tuition we collected from the participants we recruit and share 50/50 of any exceeding amount that we collect above base sales price of the tour tuition which is $5,000 per participant. On June 3, 2019, we entered into a Supplementary Agreement to Business Cooperation Agreement (the “China Travel Supplementary Agreement”) with China Travel whereby the China Travel Agreement was amended to postpone the organizing period of Chinese classical culture related tour camp from July to August, starting 2019, to January to February, 2020 or July to August, every year since 2020. Due to the coronavirus outbreak, we further postponed the tour camp related to Chinese classical culture we plan to organize for China Travel to the end of 2022 or 2023.

 

  Youth Study Tour Series

 

The youth study tour series will guide students while visiting major historical and cultural cities in China. The aim of the tour is for the participants to experience classical Chinese culture at first hand. During the tour, we will teach participants classical Chinese cultural entertainment skills such as chess, Luban lock, etc. Our youth study tour series will provide its participants a rich and varied experience of classical Chinese culture, games and entertainment. We will create a happy and positive learning environment for our students, enabling them to have a profound and intuitive understanding of the essence of classical studies, and to truly appreciate the charm of Chinese culture.

 

Basic Tour Information

 

Tour Theme: Classical Chinese Studies Education.

 

Target Audience: Youths, ages 13 to 17.

 

Tour Length: 1-2 weeks (during summer and winter holidays).

 

Destinations: Single city or multiple cities.

 

Departure City: San Francisco, California.

 

Group Size: Around 20 participants.

 

Tour Content: Visits to historical and cultural sites; visits to museums; learn the basics of Chinese language; first-hand experience of classroom curriculum.

 

  Adult Study Tour Series

 

The adult tour series will guide its participants while visiting major historical and cultural cities in China, to explore and experience Chinese culture and customs, and to interact and network with other classical Chinese studies enthusiasts from all over the world. Our adult tour series provides first-class classical studies tutors and excellent courses integrating leisure and entertainment with tourism. Its participants will benefit from a comfortable learning environment, which will allow them to experience first-hand the beauty of classical studies and to truly appreciate its essence.

 

12

 

 

Basic Tour Information

 

Tour Theme: Classical Chinese Studies

 

Target Audience: College students, young professionals, families, Chinese history, art and culture enthusiasts.

 

Tour Length: 1-2 weeks

 

Destinations: Single city or multiple cities.

 

Departure City: San Francisco, California

 

Group Size: Around 20 participants.

 

Tour Content: Visits to historical and cultural sites; visits to museums; first-hand experience of Chinese chess, the Chinese Game of Go and calligraphy, and etc.

 

  Themed Study Tour Series

 

The themed study tour series will guide participants while exploring Chinese culture, art and art collections, visiting major historical and cultural cities in China. Participants will learn about Chinese classical culture and art, and network with other Chinese culture and art enthusiasts from all over the world. The themed study tour series is based on aesthetics, integrating art and tourism. These themed art tours will allow art enthusiasts to gather together, exchange and learn from each other. Providing a unique first-hand experience of the charm of Chinese classical culture and art.

 

Basic Tour Information

 

Tour Theme: Chinese art.

 

Target Audience: Culture and art enthusiasts, art collectors, etc.

 

Tour Length: 1-2 weeks.

 

Destinations: Single city or multiple cities.

 

Departure City: San Francisco, California

 

Group Size: Around 20 participants

 

Tour Content: Visits to historical and cultural sites; visits to art museums; first-hand experience of calligraphy, Chinese tea ceremony, classical Chinese painting, etc.

 

Lectures on Classical Studies

 

Classical Chinese studies involve the classical Chinese academy, which includes philosophy, Confucian classics, literature, history, politics, military science, natural science, theology, art, etc. All of these contents taken as a whole constitute the essence of classical Chinese studies. Classical studies are based on the Chinese classics of the pre-Qin Dynasty, around 2000 years ago, and on the theories of various masters. Classical Chinese studies cover a complete set of unique cultural and academic systems, such as Confucianism of the Han Dynasty, Metaphysics of the Wei and Jin Dynasties, Neo-Confucianism of the Song and Ming Dynasties, Poetry of the Han Dynasty, Parallel prose of the Six Dynasties, Poetry of the Tang and Song Dynasties, Operas of the Yuan Dynasty, novels of the Ming and Qing Dynasty, and etc. Classical Chinese studies represent the richness of Chinese culture covering thousands of years and contain the wisdom and essence of China’s 5,000-year history. Nowadays, China’s growth and development have caused a surge of interest in all things Chinese. More people are interested in studying and understanding China’s history, culture, and ethos. We will capitalize on this growing interest by offering “Lectures on Chinese Classical Studies” bringing the core values of Chinese culture to those who have an interest in learning.

 

13

 

 

Basic Information

 

Target Audience: Ethnic Chinese people, people interested in Chinese culture, scholars and academics, etc.

 

Form of Lecture: Face to face lectures at regular intervals and online video courses.

 

Content of Lecture: (i) Classical Studies Series on Neo-Confucianism, philosophy series; (ii) Classical Studies Series on Country Management, social sciences series; (iii) Classical Studies Series on Poetry and Prose; (iv) Classical Studies Series on Textual Research, series on history and historical research.

 

Meditation Courses

 

These courses, through the enlightenment of meditation instructors, are aimed at achieving mental clarity, calmed emotions, and awakening the healing power of awareness through channeling the meridian energy of the body. Meditation restores tranquility and awareness, opening up the treasures of wisdom.

 

Basic Information

 

Teaching Method: Face to face lessons.

 

Target Audience: People who want to improve their physical health; people who want to achieve harmony in their career, family and relationships; people who want to enhance their awareness and insight in daily life; people who want to improve their sense of happiness, joy and abundance; people who seek the truth and essence of life.

 

Contents: (i) Teaching the basic knowledge of meditation. (ii) Understanding the principles of meditation and experiencing various meditation techniques. (iii) Understanding, learning and mastering various meditation techniques. (iv) Analyzing the principles of meditation, revealing the key knowledge of meditation, and teaching techniques for “constant awareness.” (v) Integrating the body and mind into the natural landscape for self-building and participating in a spiritual sublimation journey.

 

Education and Training

 

As the name implies, classical Chinese studies are the study of Chinese history and tradition, which has been around for 5,000 years. In the wave of economic globalization, classical Chinese studies have attracted the attention of people around the world, gradually becoming a popular trend of intercultural studies. We believe there is a good business opportunity in offering classical Chinese studies courses and education. We believe its contents will help enrich people’s spiritual life. There is a global interest in learning about Chinese culture, and a growing desire to take classes on the subject. However, the institutions offering classic Chinese studies in the U.S. at the moment offer neither a systematic concept of classical studies education nor a professional approach to teaching. With this in mind, and in order to structure different programs according to the different stages of cognitive development, we have developed junior or beginner classes of classical studies for young people, a middle-level version course for classical Chinese culture enthusiasts, and premium classes for professionals and corporate executives.

 

  Beginner Classes

 

Course Content: Di Zi Gui (Standards for being a Good Pupil and Child), Tao Te Ching, Analects of Confucius, etc.

 

Target Audience: Children and teenagers.

 

Purpose of the Course: to provide children with the fundamental teachings of classical Chinese culture, to improve literacy and moral standards, and to lay a good foundation for their academic formation and life.

 

Meaning of Classes: Di Zi Gui (means standards for being a good student and child), originally named “Xun Meng Wen”, is the reading material used to encourage and uphold integrity, educating students in the importance of fulfilling their duties and responsibilities, protecting them against evil and preserving their innocence, and fostering loyalty and honesty. Tao Te Ching is the philosophy of good people. The study of Tao Te Ching, as well as the Analects of Confucius can edify our wisdom and enhance our ability to deal with the world. Therefore, when using these classics to educate children and teenagers, teachers quote the spirit therein and can guide their behavior correctly, which is an extremely effective way to strengthen their development and training and promote the development of their personality.

 

14

 

 

  Mid-level Classes

 

Course Content: Shiji (Records of the Grand Historian), Wenxin Diaolong (the Literary Mind and the Carving of Dragons), Legends, calligraphy, Chinese Painting, chess, art, etc.

 

Target audience: Children, youths, adults and seniors

 

Purpose of the Course: to comprehend the ancient philosophy behind doing things from ancient legends and historical classics.

 

Meaning of Classes: The class contents contain the stories of monarchs and seigniors, interpreting “the truth of life in the world.” Taking this course may help students to get inspired by ancient legends and to cultivate their minds with the introduction of new ideas. The course also includes calligraphy, Chinese painting, and chess to include active tutoring and to experience the charm of classical Chinese culture in a relaxed learning atmosphere.

 

  Premium Classes

 

Courses Content: Sun Zi Bing Fa (The Art of War), the Records of the Three Kingdoms, Zizhi Tongjian (Comprehensive Mirror in Aid of Governance), calligraphy, Chinese painting, chess art, etc.

 

Target Audience: professionals, corporate executives and classical culture learners.

 

Purpose of the Course: to apply ancient classics to the world of business and to improve the understanding of classical Chinese culture.

 

Course objective: Many strategies in Sun Tzu’s Sun Zi Bing Fa can be applied in modern society, especially to the world of business. The Records of the Three Kingdoms and Zizhi Tongjian can help people understand how ancient emperors managed their country successfully; and to get management inspiration and insight. Calligraphy, Chinese painting, and chess art can contribute to the general improvement of the person as a whole, regardless of their industry.

 

Cultural Events and Art Exhibition Activities

 

The Company regularly hosts various exhibitions on the subject of Chinese culture and art. Our exhibitions are based on the concepts of being “international, professional, market-oriented and high-quality.” They demonstrate the fruitful achievements of the development of the Chinese and western culture and art. They also serve as a melting pot of the latest theories and views on the development of culture and art, and establish a trading platform for cultural and artistic products and services. We believe that they contribute to further the development of culture and art and to the exchange of culture and art between China and the U.S.

 

We intend to organize cultural and art exhibitions in the U.S., starting in California, as a way to promote our other business activities. The exhibitions will be held in major art venues in San Francisco and the Bay Area, targeting the general public and Chinese culture and art enthusiasts. The exhibitions will encompass important Chinese cultural artifacts, such as traditional paintings, craftsmanship, calligraphy, and ancient literature. The events will be interactive and act as a form of cultural and business promotion for us.

 

The subject of activities includes:

 

  China-U.S. Cultural Events and Art Exhibitions
     
  Chinese Classical Painting Art Exhibitions
     
  Chinese Porcelain Art Exhibitions
     
  Chinese Classical Chess Exchange

 

15

 

 

Consulting Services Relating to Classical Chinese Culture

 

The Company provides consulting service for those clients who are interested in doing business related to the classical Chinese studies and culture. Our services include research and analysis services related to classical Chinese studies and culture for the business activities proposed by our clients, online consulting and planning services for the development of client’s business related to classical Chinese studies and culture, training services for business staffs of our client, and also w will be responsible for arranging the transportation and accommodations if our client organize its business staffs for field trips to the U.S. as well.

 

We entered into a Consulting Services Agreement with Shanaxi Qinming Culture Communication Co., Ltd., a limited company incorporated in Shaanxi, China (“Shananxi Qinming”) on April 20, 2019. Shaanxi Qinming provides exhibition services, organizes cultural and artistic activities, and engages in public relations activity planning. Pursuant to the Consulting Services Agreement, we will provide research and analysis services related to the classical Chinese study and culture for the business activated proposed by Shaanxi Qinming, provide online consulting and planning services regarding the development of their potential business related to classical Chinese studies and culture, be responsible for the training of business staff of Shaanxi Qinming (“Business Staff”) and arrange transportation and accommodations for the Business Staff if Shaanxi Qinming organize its Business Staff for field trips to the U.S. Shaanxi Qinming agreed to pay us a preliminary fee for group training for the Business Staff and fees regarding the services provided by us.

 

We also entered into a Consulting Services Agreement with Hangzhou Zhuoya Cultural Planning Co., Ltd., a limited company incorporated in Hangzhou, China (“Hangzhou Zhuoya”) on January 1st, 2020. Hangzhou Zhuoya engages in organizing culture art exchange activities, exhibitions, and corporate brand and image promotion and planning services. Pursuant to the Consulting Services Agreement, we will provide research and analysis services related to the classical Chinese study and culture for the business activated proposed by Hangzhou Zhuoya, including but not limited to providing data and information related to market size, customer preference, development trend of classical Chinese culture study, and provide online consulting and planning services regarding the development of their potential business involving classical Chinese culture, especially for organizing and planning traditional Chinese cultural activities. Hangzhou Zhuoya agreed to pay us $15,000 service fee upon completion of the services provided by us. We have received the payment of $15,000 from Hangzhou Zhuoya on March 12, 2020.

 

On October 25, 2021, the Company also entered into a Services Agreement with Wenting Chen (“Chen”), an individual. Pursuant to the Services Agreement, the Company will provide high-level customized study tour, including accommodation, catering, transportation, scenic, and learning services etc. for Chen. The Company will utilize its excellent education information of classical Chinese study and culture, advanced concept as well as local resources in the States to provide customized consulting services to Chen. Chen paid the Company $20,000 service fee upon entering into the Services Agreement with the Company. The Company and Chen were not related parties as of the effective date of the Consulting Services Agreement.

 

On October 30, 2021, the Company also entered into a Supplementary Agreement to Services Agreement dated October 25, 2021 with Wenting Chen (“Chen”), an individual. Pursuant to the Supplementary Agreement, and due to objective factors such as the Covid-19 epidemic and the circuit breaker arrangement for Sino-US flights, Chen and Company amended the services to be provided under the Services Agreement. Pursuant to the Supplementary Agreement, the Company will provide (1) research and analysis services to Chen related to classical Chinese study and culture for the business activities proposed by Chen, including but not limited to providing data and information related to market size, customer preferences, development trend of classical Chinese study and culture, etc. and; (2) online (including but not limited to telephone, email) consulting and planning services for the development of Chen’s business related to classical Chinese study and culture, including but not limited to providing solutions to problems encountered in Chen’s business involving classical Chinese culture. Chen paid the Company $20,000 service fee under the terms of the Supplementary Agreement with the Company. The Company and Chen were not related parties as of the effective date of the Consulting Services Agreement.

 

16

 

 

On November 24, 2021, the Company also entered into a Consulting Services Agreement with Xin Zeng (“Zeng”), an individual. Pursuant to the Consulting Services Agreement, the Company will provide research and analysis services related to the classical Chinese study and culture for the business activities proposed by Zeng, including but not limited to providing data and information related to market size, customer preference, development trend of classical Chinese culture study, and provide online consulting and planning services regarding the development of their potential business involving classical Chinese culture, especially for organizing and planning traditional Chinese cultural activities. The Company will utilize its excellent education information of classical Chinese study and culture, advanced concept as well as local resources in the United States to provide customized consulting services to Zeng. Zeng paid the Company $15,000 service fee upon entering into the Services Agreement with the Company. The Company and Zeng were not related parties as of the effective date of the Consulting Services Agreement.

 

In 2022, the Company also entered into four Consulting Services Agreements with four individual customers respectively. Pursuant to those Consulting Services Agreements, the Company provided research and analysis services related to the classical Chinese study and culture for the business activities proposed by individual customers, including but not limited to providing data and information related to market size, customer preference, development trend of classical Chinese culture study, and provide online consulting and planning services regarding the development of their potential business involving classical Chinese culture, especially for organizing and planning traditional Chinese cultural activities. The Company utilizes its excellent education information of classical Chinese study and culture, advanced concept as well as local resources in the United States to provide customized consulting services to them. The four individual customers paid the Company $102,020 service fee under the terms of Services Agreement. The Company and those four individual customers were not related parties as of the effective date of the Consulting Services Agreements.

 

OUR REVENUE

 

Regular Business Income

 

We expect to generate most of our revenues from the international study tours we will offer, from the classical Chinese studies education course and from our meditation training courses. All of these services will be paid for by our students or participants in advance. As of today, all of our revenue is generated from providing consulting services to our contracted Chinese partners, including telephone or online consultation regarding market and research analysis of classical Chinese culture study in U.S. for the business activities or international tour proposed by our Chinese partners. We also provide online trainings to the staff of our Chinese business partners.

 

17

 

 

Sales of incidental materials required for our course training.

 

To participate in some of our courses, students will sometimes need to purchase certain supplies, such as the four stationery treasures of study, Hanfu clothing, classical musical instruments, sets of chess and Chinese Go, classical books, etc. As the number of students increases, the demand for these supplies will increase. The company will customize some of these supplies through novel design concepts. We expect these supplies to generate revenue for the company.

 

Sales Income from Cultural Events and Art Exhibitions

 

We expect to generate revenues from our activities organizing, hosting, and promoting cultural events and art exhibitions through participation fees, ticket sales, commissions on sales, sponsorships, etc.

 

Health Consulting Services and Career Planning Experience Sharing Consulting Services

 

GW intends to generate revenue from offline and online mental health consulting services for families, individuals, and company employees; and currently generates revenue from online career planning experience sharing consulting services.

 

OUR SALES

 

Our Service Target Market

 

We will mainly provide our educational services in the field of classical Chinese studies, art, and culture to Chinese-Americans, American youths, scholars, art collectors, and professional and corporate executives interested in learning more about Chinese culture.

 

 

 

Sales Management Model

 

The Company’s sales model combines front-end promotion, mid-end contract, and back-end services to form a complete chain. Sales services are initiated by the sales department, based on its current plan, scope, objectives, and methods. Promotion will be made through advertising, customer referral, network publicity, and word-of-mouth. After engaging customers, the sales department will extend a telephone invitation and carry out on-site visits and post-sale services. After formally hiring our services, the corresponding business department will provide customers with the products and services they purchased. The R&D department will supervise the products and services delivered to our customers. Our general manager will supervise the whole process and revise it according to the feedback we receive. The general manager will also provide guidance to the sales department according to the scope, goals and methods of the sales department.

 

18

 

 

 

 

OUR DEVELOPMENT PLAN

 

Product Plan To establish user-centered product service strategy
       
    To continuously improve the professional level of our products and services.
       
    To gradually enrich our products and services.
       
    To establish a process for product and service development
       
Market Plan To establish a market strategy implemented step-by-step and emphasizing development
       
    Phase I: Key Development – San Francisco
       
    Phase II: Regional Market Development – California
       
    Phase III: Overall Development - US
   
Talent Plan To establish talent recruitment strategy
   
    To establish a talent recruitment system
       
    To establish an efficient talent training system
       
    To establish a scientific talent assessment system

 

OUR BRANDING AND MARKETING

 

We have established a clear target audience and market objectives and have structured on marketing plan and determined a detailed marketing strategy with the objective of achieving reaching our target audience.

 

  Market Agent

 

Our goal is to become the leading service provider of classical Chinese education, with emphasis in the field of art and culture. In the next five years, we will focus our business in the U.S. and China. Our chief executive office is currently located in Danville, California. From there we intend to expand our business ventures, initially within the state of California and then to the rest of America.

 

19

 

 

  Product Distribution

 

Our product and service distribution strategies will emphasize our achievements with respect to the professionalization and the systematization of knowledge and content of classical Chinese cultural and artistic studies. Because the content of classical Chinese education and culture are rather complex, they present multiple possibilities when combining content in the process of product development. Students of different age groups and backgrounds have different preferences. In order to satisfy the diverse demands of our customers, we intend to adjust and optimize our products and services from time to time, and to provide tailored services to meet the requirements of our customers. We will develop products and services based on Chinese education, culture, and art in accordance with the needs of our customers. We will prioritize the systematization of content, the creation of different product categories, and the professionalization of our teaching methods when designing our product and service distribution strategy.

 

  Marketing Geographic Area

 

We will initially operate in San Francisco Bay Area, and expand our business throughout the state of California and into the rest of America in stages as follows:

 

Stage 1: Central Market - San Francisco and the Bay Area

 

Our executive office is located in Danville, San Francisco Bay Area, California. Around 20% of the 800,000 people residing in San Francisco Bay Area are Chinese or of Chinese descent. San Francisco is one of the cities with the highest density of residents with Chinese heritage. San Francisco has a large district called “Chinatown” which has played a significant role in the political, economic, and social aspects of life in the California region. Therefore, we believe that the San Francisco Bay Area will provide us with a natural market advantage in the field of Chinese education, justifying our choice of San Francisco Bay Area as an entry point for the exploration of the U.S. market.

 

Stage 2: Regional Market – California

 

Expanding from the market in San Francisco, we will focus on the rest of the state of California. As the market area grows, team-building and marketing efforts will be strengthened. The state of California presents a strong market due to its large Sino-Asian population base. The state also has the largest number of Chinese students studying abroad in the U.S. The total number of international students in California is about 135,130, with 33.6% being Chinese.

 

Stage 3: Comprehensive Market - the United States

 

When the Company obtains strong operational capabilities and enters the stage of rapid development, it will gradually expand its target market to cover to the whole U.S. With the continuous improvement of our service capabilities and the continuous development of our business, we will strive to establish branches in key markets and metropolitan areas in the U.S.

 

  Marketing Strategies

 

In terms of marketing strategies, the company will focus on cultural activities and supplement those with advertising and promotion. Marketing will be carried out in three stages.

 

Stage 1: Market penetration.

 

To penetrate the market we will advertise in paper publications, such as local newspapers and magazines. We will strive to convey the Company’s name, products, and brand to our target audience through the media and radio. Specific concepts and images will be incorporated into these communication strategies.

 

In addition, promotional materials such as leaflets, posters, and gifts will be delivered on a regular basis to our target audience. Marketing personnel will distribute these materials in crowded places to achieve the desired market outreach. Additionally, we will set up fixed help desks near schools and in places where our target audience concentrates. We will seek to connect with museums and cultural venues in general to discuss mutual cooperation and brand promotion.

 

20

 

 

Stage 2: Media Marketing

 

Once we start generating profits we will consider including advertising through television, the internet, and other media. In addition to strong a media presence, we also intend to organize conferences, classical cultural exchange meetings, cultural and artistic exchanges, and three-dimensional art exhibitions, all of which will help to represent and promote our brand. With this approach to marketing we intend to establish an attractive corporate image and increase the Company’s visibility. We plan to conduct regular exchanges with local schools, offering free course trials to students to encourage them to experience classical Chinese studies. We expect to build a good reputation and corporate image through the word-of-mouth.

 

Stage 3: Seminar Marketing

 

When the company’s development becomes stable and has a certain influence in the industry, we plan to host classical Chinese culture seminars regularly, inviting Chinese scholars, Chinese cultural enthusiasts or other Chinese education institutions to send representatives to conduct classical studies exchanges. These seminars will be held on a regular basis. We intend to scale and expand these events to become the most influential Chinese school exchange event in the United States.

 

COMPETITION

 

Competition Analysis of Classical Studies Education Market in the U.S.

 

American colleges and universities, for the purpose of cooperation, connect Chinese and American educational enterprises. The collaboration between the two includes exchanging classrooms, language training, high-end applications for studying abroad, homework counseling and career guidance services. After cooperating, the parties mainly provide services to Chinese students studying in America. American enterprises provide various services for students interested in studying abroad through the integration of regional platforms.

 

On the one hand, Chinese classical studies education enterprises provide language training and preparation for the entrance exams required for foreign students interested in studying in the U.S. On the other hand, they also provide an English version of the preparation of entrance exams and an English version of classical Chinese culture courses for native American students in the U.S. In addition to basic learning courses, Chinese classical studies education enterprises have also launched internships and employment guidance courses for foreign students and pre-employment guidance services for graduates returning home.

 

Trend of Classical Studies Education in the U.S.

 

The American education industry operates in a large market. The major classical studies education enterprises in the U.S. are just recently starting to pay attention to the application of scientific and technological methods to teaching, barely grasping the industry trends and level of competition. Many major classical studies education enterprises in the U.S. prefer to develop their business through distance-learning and through cooperation with Chinese classical studies education companies, having their content developed by Chinese companies, and a sales and promotion department in America.

 

Analysis of Information Trend Development of Classical Studies Education

 

In the social media era, the dissemination of new media through computers and mobile phones has proved convenient for the development of classical Chinese studies education. Firstly, American classical studies enterprises can now set up a column for “Classical Studies” on their platforms and select several teachers with profound knowledge of classical Chinese culture to teach and manage course online. Fast, open and interactive online communication channels between teachers and students contribute to learning. Secondly, the opening of online courses is an effective way of promotion. We will engage experienced and successful online course designers to design and operate online courses related to classical studies. Thirdly, we may take advantage of the opportunity to organize online classical Chinese culture competitions for promotional purposes.

 

21

 

 

Chart: Value Chain of Educational Informatization

 

 

 

EMPLOYEES

 

At the date hereof, we do not have any full-time employees but we plan to hire employees in the foreseeable future as our business grows.

 

We have entered into a Business Collaboration Agreement with BEEC Inc, a Nevada corporation, whereby they will serve as our agents for the purpose of selling and promoting our products and services. As such, they will assist us in the process of obtaining the appropriate qualification to do business in California, to enroll students and recruit teachers, and use BEEC employees to help us with arranging meals, accommodation, transportation and sightseeing during our international study tours. The term of the Business Collaboration Agreement is two years, which shall automatically renew for an additional two-year period, unless earlier terminated by both parties. For their agency services, BEEC, Inc. will receive a commission equivalent to 25% of the sales price invoiced to our customers. According to the Business Collaboration Agreement, BEEC, Inc. shall act as our agent in the U.S.

 

REGULATIONS

 

Effect of Existing or Probable U.S. Government Regulations on the Business

 

Generally, we intend to provide non-certified educational services without the issuance of a degree. Providers of such educational services are generally not required to be licensed under applicable state laws. For example, the New York Education Law exempts from its licensing provisions schools that provide instruction in only the following subjects: religion, dancing, 38 music, painting, drawing, sculpture, poetry, dramatic art, languages, reading comprehension, mathematics, recreation, yoga, martial arts, pilates and athletics. In California, another state we intend to provide services, the California Education Code and the California Code of Regulations, Title 5, Education apply uniquely to K-12 public schools, special education services and ancillary topics concerning the former, including teacher credentialing. We believe that the other states in which we intend to operate provide similar exemptions from licensure.

 

We are subject to laws, rules or regulations of general applicability, including laws respecting labor, work safety and health. To date, these laws have not had a material adverse effect on our operations. While our business operations have not been materially adversely affected by regulation, we cannot assure you that we will not be adversely affected in the future nor can we predict the effect of any future legislation or regulation.

 

Existing or Probable PRC Government Regulations on the Business

 

The Standing Committee of the National People’s Congress promulgated Tourism Law of the PRC on 25 April 2013 and amended it on 7 November 2016 and 26 October 2018. Tourism Law of the PRC applies to tours, vacations, recreations and other forms of tourism activities within the territory of the PRC and including outbound tours but organized within the territory of the PRC and the incidental services provided. Pursuant to Tourism Law of the People’s Republic of China, approval from the tourism authorities shall be obtained and industrial and commercial registration shall be made in accordance with the relevant PRC law in order to establish a travel agency, attract, organize and receive tourists, and provide tourism services, the following requirements shall be met: (i) have a fixed business site; (ii) equipped with the necessary business facilities; (iii) have registered capital that conforms to the regulations; (iv) have necessary management staff and tour guides; and (v) any other condition stipulated by the laws and administrative regulations.

 

Travel agencies may engage in the following businesses: (i) domestic tourism; (ii) outbound tourism; (iii) border tourism; (iv) inbound tourism; and (v) other tourism businesses. To engage in businesses (ii) and (iii) above, a travel agency must obtain the required business license. Specific requirements shall be set by the State Council of the PRC.

 

22

 

 

The Regulations on Travel Agencies was promulgated by the State Council of the PRC on 20 February 2009, and amended on 6 February 2016 and 1 March 2017 (the “Regulations on Travel Agencies”). The term “travel agencies” as mentioned in the Regulations on Travel Agencies shall refer to enterprise legal persons that engage in such activities as soliciting, organizing and receiving tourists, provide tourists with relevant tourism services, and conduct domestic tourism business, inbound tourism business, or outbound tourism business. A travel agency operating different tourism businesses shall deposit different quality assurance funds. A travel agency operating the domestic tourism business and inbound tourism business shall deposit the quality assurance fund of RMB200,000. Where, in violation of this Regulation on Travel Agencies, and if the travel agency refuses to correct, its business permit for travel agencies shall be revoked.

 

In order to strengthen the administration of tourism safety, Administrative Measures for Tourism Safety was promulgated by the China National Tourism Administration of the PRC (which entity has been revoked, changed to Ministry of Culture and Tourism of the PRC on 27 September 2016 (the Administrative Measures”). Pursuant to the Administrative Measures, tourism operators shall observe the following requirements: (i) their service places, service items, facilities and equipment meet the requirements of the relevant safety laws, regulations and mandatory standards; (ii) recruiting the necessary safety and rescue personnel and installing relevant facilities and equipment; (iii) establishing a safety management and responsibility system; and (iv) guaranteeing capital investment in work safety.

 

We collaborate with travel agencies inside China to provide international study tour services from U.S. to China or from China to U.S. According to the Business Cooperation Agreement (the “China Travel Agreement”) we entered into with Xi’an China Travel Service Co., Ltd. (“China Travel”) on March 5, 2019, China Travel shall be the organizer of the classical Chinese culture related tour camp from the U.S. to China. We only cooperate and engage with qualified PRC travel agencies, such as above mentioned China Travel, with required business license to organize Chinese classical culture related tour program inbound or outbound China. Because we are not engaged in travel agency business in China, the Tourism Law of the PRC, the Regulations on Travel Agencies, and Administrative Measures for Tourism Safety promulgated by relevant Chinese governments and authorities are not applicable to us.

 

INTELLECTUAL PROPERTY

 

We have completed our three trademark applications in the States and have obtained approval from the USPTO. We have registered our domain name WWW.GJCC.US and completed building our website.

 

INSURANCE

 

We currently do not maintain any insurance policies, such as personal injury protection insurance, business interruption insurance, product liability insurance or key-man life insurance.

 

PRINCIPAL ADDRESS

 

Our principal address is located at 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506. Our telephone number is (925) 362-3169.

 

ITEM 1A. RISK FACTORS.

 

We are a smaller reporting company as defined in Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

Not applicable.

 

ITEM 1C. CYBERSECURITY.

 

We ae not conducting significant operations, so cybersecurity threats have not affected our business strategy or results of operations and the Board of Directors will assess the potential threat to future operations as such operations develop. The Board of Directors oversees management’s processes for identifying and mitigating risks, including cybersecurity risks, to facilitate mitigating our risks involved with cybersecurity. help align our risk exposure with our strategic objectives. The Board relies on its executive officers to identify cybersecurity risks and retains oversight of cybersecurity. In the event of an incident, we intend to take appropriate steps from incident detection to mitigation, recovery and notification of appropriate parties. Management is responsible for day-to-day monitoring of cybersecurity, including detection and response and to report risks and incidents to the Board of Directors. We rely on computer software provided by third parties to protect our computer systems against cybersecurity threats.

 

ITEM 2. PROPERTIES.

 

Our company does not own any real property.

 

We have leased a section of the office space rented by BEEC, Inc. located at 4125 Blackhawk Plaza Circle Suite 166, Danville, California. The term of the sublease is one year, beginning on December 15th, 2018 and ending on December 31, 2019 subject to automatic annual renewal unless terminated by either party upon advance written notice. Our monthly rent amounts to $800, payable on the first day of each calendar quarter. In addition to rent we will pay BEEC, Inc. $2,050 a year for bookkeeping charges; $135 for setting up our separate phone line and $425 for our door sign and directory. BEEC, Inc. may end our sublease by giving us a minimum of two months prior notice.

 

23

 

 

ITEM 3. LEGAL PROCEEDINGS.

 

Our company is not a party to any legal proceedings.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Mine safety disclosures are not applicable.

 

PART II

 

ITEM 5. MARKET FOR REGISTRANTS’ COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASE OF EQUITY SECURITIES.

 

Market Information

 

Our common stock is quoted on the OTCQB Market system under the symbol “NPLS.” The following table sets forth the high and low quotations of our common stock reported by the OTC Market system for the periods indicated. Over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down, or commissions, and may not necessarily represent actual transactions.

 

(Expressed in U.S. Dollars based on Yahoo Finance)

 

   2023      2022 
   High   Low      High   Low 
First quarter  $0.51   $0.51   First quarter  $0.75   $0.75 
Second quarter  $0.55   $0.55   Second quarter  $0.75   $0.35 
Third quarter  $0.51   $0.51   Third quarter  $0.75   $0.525 
Fourth quarter  $0.55   $0.55   Fourth quarter  $0.95   $0.15 

 

Number of Holders

 

As of April 15, 2024, 42,959,574 shares of our common stock were outstanding and held of record by approximately 59 stockholders of record.

 

Dividends

 

We cannot provide any assurance that we will declare or pay cash dividends on our common stock. Any future determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our board of directors may deem relevant. Our board of directors may determine it to be necessary to retain future earnings (if any) to finance our growth. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

Recent Sales of Unregistered Securities

 

None.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

We have not adopted an Equity Compensation Plan.

 

ITEM 6. SELECTED FINANCIAL DATA.

 

Not applicable.

 

24

 

 

ITEM 7. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

This discussion contains forward-looking statements about our business and operations. Our actual results may differ materially from those we currently anticipate as a result of many factors, including those we described under “Risk Factors” and elsewhere in this prospectus. Certain statements contained in this discussion, including, without limitation, statements containing the words “believes,” “anticipates,” “expects” and the like, constitute “forward-looking statements.” However, as we will issue “penny stock,” as such term is defined in Rule 3a51-1 promulgated under the Exchange Act, we are ineligible to rely on these safe harbor provisions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any of the future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any of such factors or to announce publicly the results of revision of any of the forward-looking statements contained herein to reflect future events or developments. For information regarding risk factors that could have a material adverse effect on our business, refer to the “Risk Factors” section of this prospectus beginning on page 3.

 

Overview

 

The Company, formerly GJ Culture Group US, Inc, is an emerging company incorporated in Nevada and is qualified and authorized to transact interstate business in California. Our executive office is located in Danville, California.

 

Online Career Consulting On November 8, 2022, we formed our wholly owned subsidiary GW, a California corporation, GW’s business operations are at very early stage. GW’s business has been limited to providing online career planning experience sharing and guidance consulting services, and mainly to customers obtained through introductions among friends.

 

Mental Health Consulting GW plans to provide offline and online mental health consulting services for families, individuals, and company employees. GW plans to expand the offline market, focusing on the Southeast Asian market, including but not limited to South Korea, Singapore, China, etc. By providing mental health consulting services, GW plans to extend its business to health care projects, health monitoring, psychological hospitals, and aesthetic medicine.

 

In order to facilitate such expansion in Southeast Asia, GW established one subsidiary in Hong Kong and the Company established one subsidiary in Singapore.

 

On March 8, 2023, GW established a wholly owned subsidiary, NLPL Health Industry Group Co., Limited, a Hong Kong based company, which had no business transaction in the reporting period. On August 16, 2023, the Company established a subsidiary named NP Life Sciences Health (Singapore) Pte. Ltd., a Singapore based company, in which the Company holds 90% of the shares and an individual holds 10% of the shares. The subsidiary had no business transaction in the reporting period.

 

Classical Chinese Studies We are dedicated to providing educational services based on classical Chinese studies and culture. We aim to serve as a cultural and educational meeting point between China and the U.S. Our business is providing education and training courses based on classical Chinese studies both in Chinese and English, organizing China-U.S. international study tour activities for participants of all ages, and organizing and promoting China-U.S. cultural events, art fairs, and exhibitions and other relevant activities related to educating the public about Chinese culture.

 

We intend to offer a diverse and systematic array of services related to Chinese classical studies, that cover the demand of the American market. We will focus on education and the cultural exchange between China and the U.S. relying on our experience in the field of Chinese classical culture and art. We intend to capitalize on the growing interest in China and on its increasing global influence. We intend to do this by offering a curated and systematized curriculum of classical Chinese studies, and contribute to the exchange and development of cultural education and art between China and the U.S.

 

25

 

 

At present, the Company intends to offer international study tours, online and offline, in classical Chinese studies through classes, lectures, cultural, and artistic events. All of these will enrich, elevate and complement each other, forming a vertically integrated set of products and services with growth potential.

 

There is a growing global interest in China, and an increasing demand to learn about the Chinese culture and language. We believe it is because the market for classical Chinese studies education and training in the U.S. exists, but it is still in an early stage of development. Based on the market search results by Zero Power Intelligence Research Institute, we estimate that this industry presents large training needs, many business opportunities and potential profit.

 

We plan to generate revenue through providing classical studies lectures, international study tour services, classical studies education and training, and organizing cultural and artistic events. We intend that these services will be paid for by our students or participants in advance.

 

General

 

Revenues are comprised of providing promotions and consulting services to our partner who gives international study tour services and, commission to be received from partner enrollment services, and career planning experience sharing and guidance consulting services.

 

Our general and administrative expenses consist of costs related to marketing, selling, personnel cost, and professional fee to law firm and accounting firm, etc.

 

Results of Operations

 

Comparison of the Year Ended December 31, 2023, and 2022

 

The following table sets forth key components of our results of operations for the periods indicated:

 

   For the year ended 
   December 31, 
   2023   2022 
Revenues  $164,621   $102,002 
Cost of revenues   -    - 
Gross profit   164,621    102,002 
Selling, general and administrative expense   165,311    120,857 
Interest (income)/expense, net   645    1 
Income/(loss) before income taxes   (1,335)  $(18,856)
Income tax expense   1,600    - 
Net loss  $(2,935)  $(18,856)

 

Revenues

 

Our revenue in 2023 was $164,621, compared to revenue of $102,002 in 2022, an increase of 61%. The increase was mainly due to the revenue of $99,599 generated by GW.

 

Revenues are comprised of promotion and consulting services rendered to our partner who provides international study tour services, and online career planning experience sharing and guidance consulting services.

 

Cost of Revenues

 

There was no cost of revenue during the reporting periods ended December 31, 2023, and 2022.

 

 26 
 

 

Selling, general and administrative expenses

 

We recorded $165,311 in selling, general and administrative expenses in the reporting period, and it mainly consists of professional service from our law firm, auditor and accountant.

 

Our selling, general and administrative expenses increased by $44,454 or 37% from $120,857 for 2022 to $165,311 for 2023. The increase was primarily attributable to the increase of professional service fees.

 

Liquidity and Capital Resources

 

We plan to fund operations of the Company through the proceeds from public offerings, private placements of restricted securities, or the issuance of stock in lieu of cash for payment of services until profitable operations are achieved. If we do not raise all of the money we need from public offerings or through private placements, we will have to find alternative sources, such as loans or advances from our officers, directors or others. Such additional financing may not become available on acceptable terms and there can be no assurance that any additional financing that the Company obtains will be sufficient to meet its needs in the long term. There are no written agreements in place for such funding or issuance of securities and there can be no assurance that such will be available in the future. We believe that this plan provides an opportunity for the Company to continue as a going concern.

 

The failure to achieve the necessary levels of profitability or obtain additional funding would be detrimental to the Company.

 

Cash Flows

 

The following table presents the major components of net cash flows used in and provided by operating, investing and financing activities for the periods presented:

 

   For the year ended 
   December 31, 
   2023   2022 
Net cash provided by (used in):          
Operating activities  $(73,607)  $93,873 
Investing activities   -    - 
Financing activities   22,362    - 
Net increase in cash and cash equivalents  $(51,245)  $93,873 

 

Operating Activities

 

Operating activities consisted primarily of net income/(loss) adjusted for certain non-cash items. In addition, operating cash flows included the effect of changes in operating assets and liabilities.

 

The cash used by operating activities in 2023 was $73,607 which decreased by $167,480 from $93,873 cash provided for 2022. The increase in cash used in operating activities was mainly due to the decrease of net loss of $15,921 and the decrease of net cash flows from operating assets and liabilities of $70,672.

 

Investing Activities

 

There was no investing activity in the reporting period.

 

Financing Activities

 

In 2023, the Company had a long-term loan of $22,362 from a shareholder. The Company is required to repay the loan before April 11, 2025, subject to an automatic extension for one year if not repaid on the maturity date, with an annual interest rate of 4%. The loan has a term of 12 months with no collateral.

 

 27 
 

 

Significant Accounting Policies

 

Use of Estimates and Assumptions

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

 

Due to the limited level of operations, the Company has not needed to make material assumptions or estimates other than the assumption that the Company is a going concern.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has two bank accounts in Bank of America. Since the balance of each bank account is less than $250,000, thus the amount is insured by Federal Deposit Insurance Corporation

 

Fair Value of Financial Instruments

 

ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management at the time of this report. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

 

Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.

 

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts and other payable, accrued liabilities, and related party payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value.

 

Revenue Recognition

 

The Company will recognize revenue in accordance with Accounting Standards Codification No. 606, “Revenue from Contracts with Customers” (“ASC-606”). ASC-606 requires that the criteria must be met before revenue can be recognized:

 

executed contract(s) with customers that the Company believes is legally enforceable;
identification of performance obligation in the respective contract;
determination of the transaction price for each performance obligation in the respective contract;
allocation of the transaction price to each performance obligation;
recognition of revenue only when the Company satisfies each performance obligation.

 

The Company provides consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. The Company enters a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year, and all of the Company’s contracts are short-term. The Company typically satisfies its performance obligations in contracts with customers upon completion of service rendered. Generally, payment is advance payment from customers. The Company recognizes the revenue at a single point in time after every service rendered and the transaction price is stated in the contract. Historically, there was no sales returns.

 

When above criteria were met, the Company will recognize revenue accordingly.

 

 28 
 

 

Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.

 

Basic and Diluted Net Loss Per Share

 

Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. There were no adjustments to net loss required for purposes of computing diluted earnings per share.

 

The Company has no potentially dilutive securities, such as options or warrants, currently issued and outstanding.

 

Comprehensive income (loss)

 

The Company follows the provisions of the Financial Accounting Standards Board (the “FASB”) ASC 220 Reporting Comprehensive Income and establishes standards for the reporting and display of comprehensive income, its components and accumulated balances in a full set of general purpose financial statements. The Company’s comprehensive loss consists of net loss.

 

Recently Issued Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses”, which will require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Further, the FASB issued ASU No. 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-02 to provide additional guidance on the credit losses standard. The amendments for ASU 2016-13 are effective for fiscal years beginning after December 15, 2022. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is in the process of evaluating the effect of the adoption of this ASU.

 

In February 2018, the FASB issued Accounting Standards Update No. 2018-02 Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (ASU 2018-02). The standard provides financial statement preparers with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income (AOCI) to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (or portion thereof) is recorded. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. We adopted this ASU in the 2019 and it did not have a material impact on our consolidated financial statements.

 

In December 2018, the FASB issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (ASU 2018-05). The ASU adds various Securities and Exchange Commission (“SEC”) paragraphs pursuant to the issuance of the December 2017 SEC Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which was effective immediately. The SEC issued SAB 118 to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Cuts and Jobs Act in the period of enactment. SAB 118 allows disclosure that timely determination of some or all of the income tax effects from the Tax Cuts and Jobs Act are incomplete by the due date of the financial statements and if possible, to provide a reasonable estimate. We adopted this ASU in the 2019 and it did not have a material impact on our consolidated financial statements.

 

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.

 

As of December 31, 2023, except for the above, there are no recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable.

 

 29 
 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

NP Life Sciences Health Industry Group Inc.

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Report of Independent Registered Public Accounting Firm F-1
   
Consolidated Balance Sheets as of December 31, 2023, and 2022 F-2
   
Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2023, and 2022 F-3
   
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2023, and 2022 F-4
   
Consolidated Statements of Cash Flows for the years ended December 31, 2023, and 2022 F-5
   
Notes to Consolidated Financial Statements F-6

 

 30 
 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To: The Board of Directors and Stockholders of

 

NP Life Sciences Health Industry Group Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of NP Life Sciences Health Industry Group Inc. and its subsidiaries (collectively the “Company”) as of December 31, 2023 and 2022, and the related consolidated statement of operations and comprehensive loss, consolidated statements of stockholders’ equity, and consolidated statements of cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the company incurred a net loss and the accumulated deficit for the years ended December 31, 2023 and 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plan in regards to these matters are described in Note 2. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

WWC, P.C.

Certified Public Accountants

(PCAOB ID: 1171)

 

We have served as the Company’s auditor since 2019.

 

San Mateo, CA

 

April 16, 2024

 

 

 F-1 
 

 

NP Life Sciences Health Industry Group Inc.

Consolidated Balance Sheets

As of December 31, 2023 and 2022

(Audited)

 

         
   As of 
   December 31,   December 31, 
   2023   2022 
         
ASSETS          
           
Current assets          
Cash and cash equivalents  $70,614   $121,859 
Prepaid expenses   6,250    5,925 
Total assets  $76,864   $127,784 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities          
Accounts payables  $6,130   $6,130 
Other payables   6,894    239 
Accrued liabilities   25,097    2,500 
Deferred income - contract liabilities   -    99,599 
Total current liabilities  $38,121  

$

108,468 
           

Non-current liabilities

          
Long-term loan- related party   $22,362   $- 
Total non-current liabilities  $

22,362

   $- 
           
Total liabilities  $60,483   $108,468 
           
Commitments and Contingencies   -    - 
           
Stockholders’ Equity          
Preferred stock, $0.0001 par value, 30,000,000 shares authorized, no shares issued and outstanding as of December 31, 2023, and 2022  $-   $-
Common stock, $0.0001 par value, 320,000,000 shares authorized, 42,959,574 shares issued and outstanding as of December 31, 2023, and 2022   4,296    4,296 
Additional paid in capital   360,330    360,330 
Accumulated deficit   (348,245)   (345,310)
Non-controlling interest   

-

    

-

 
Total stockholders’ equity  $16,381   $19,316 
           
Total liabilities and stockholders’ equity  $76,864   $127,784 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-2 
 

 

NP Life Sciences Health Industry Group Inc.

Consolidated Statements of Operations and Comprehensive Loss

For the years ended December 31, 2023 and 2022

(Audited)

 

         
   For the years ended 
   December 31, 
   2023   2022 
Revenue  $164,621   $102,002 
           
General and administrative expenses   165,311    120,857 
Loss from operations   (690)   (18,855)
           
Interest expense   645    1 
           
Loss before income taxes   (1,335)   (18,856)
           
Income taxes   1,600    - 
           
Net loss  $(2,935)  $(18,856)
           
Less: net loss attributable to the non-controlling interest   $-   $- 
           
Net loss attributed to the Company   (2,935)   (18,856)
          
Total comprehensive loss  $(2,935)  $(18,856)
           
Basic and diluted loss per common share  $-   $- 
           
Weighted average number of common shares used in per share calculations – basic and diluted   42,959,574    42,959,574 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-3 
 

 

NP Life Sciences Health Industry Group Inc.

Consolidated Statements of Stockholders’ Equity

For the years ended December 31, 2023 and 2022

(Audited)

 

                             
   Number of
Shares
   Preferred   Number of
Shares
   Common   Additional
Paid in
   Accumulated   Total
Stockholders’
 
   Outstanding   Stock   Outstanding   Stock   Capital   Deficit   Equity 
                             
Balance – December 31, 2021         -   $      -    42,959,574   $4,296   $360,330   $(326,454)  $38,172 
                                    
Net loss   -   $-    -   $-   $-   $(18,856)  $(18,856)
                                    
Balance – December 31, 2022   -   $-    42,959,574   $4,296   $360,330   $(345,310)  $19,316 
                                    
Net loss   -   $-    -   $-   $-   $(2,935)  $(2,935)
                                    
Balance – December 31, 2023   -   $-    42,959,574   $4,296   $360,330   $(348,245)  $16,381 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-4 
 

 

NP Life Sciences Health Industry Group Inc.

Consolidated Statements of Cash Flows

For the years ended December 31, 2023 and 2022

(Audited)

 

   2023   2022 
   For the years ended
December 31,
 
   2023   2022 
         
Cash flows from operating activities:          
Net loss  $(2,935)  $(18,856)
           
(Increase)/Decrease in Prepaid expenses   (325)   4,500 
Increase/(Decrease) in Other payable   6,655    - 
Increase/(Decrease) in Accounts payable   -    6,130 
Increase/(Decrease) in Accrued liabilities   22,597    2,500 
Increase/(Decrease) in Deferred income – contract liabilities   (99,599)   99,599 
           
Net cash provided by (used in) operating activities  $(73,607)  $93,873 
           
Cash flows from financing activities          
Long-term loan from related parties  $22,362   $- 
Net cash provided by financing activities  $22,362   $- 
           
Net change in cash and cash equivalents  $(51,245)  $93,873 
           
Cash and cash equivalents – Beginning of period   121,859    27,986 
           
Cash and cash equivalents – End of period  $70,614   $121,859 
           
Interest paid  $-   $1 
Income tax paid  $1,600   $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 F-5 
 

 

NP Life Sciences Health Industry Group Inc.

Notes to Consolidated Financial Statements

 

1. NATURE OF OPERATIONS

 

NP Life Sciences Health Industry Group Inc. (the “Company”) is a for profit corporation established under the corporation laws in the State of Nevada, United States on December 20, 2018. The Company was originally incorporated as “Guojiang Cultural Industry US, Inc.” and amended the name to “GJ Culture Group US, Inc.” on February 20, 2019. On September 8, 2022, the Company filed a Certificate of Amendment to its Articles of Incorporation with the State of Nevada to reflect its corporate name change from “GJ Culture Group US, Inc.” to “NP Life Sciences Health Industry Group Inc.”. Unless the context otherwise requires, all references to “NP Life Sciences Health Industry Group Inc.,” “GJ Culture Group US, Inc.,” “we,” “us,” “our” or the “Company” are to NP Life Sciences Health Industry Group Inc.

 

The Company is dedicated to providing educational services based on classical Chinese studies and culture. The Company’s goal is to serve as cultural and educational meeting point between China and the U.S. The Company intends to pursue its business objective by providing education and training courses based on classical Chinese studies, organizing China-U.S. international study tour activities for participants of all ages, as well as organizing and promoting China-U.S. cultural events, art fairs, exhibitions, and other activities promoting Chinese culture.

 

On November 8, 2022, the Company established a wholly owned subsidiary, GW Health Consulting Management Inc. (herein after referred to as “GW”), a California Corporation. GW’s current business is limited to providing online career planning experience sharing and guidance related consulting services.

 

On March 8, 2023, GW established a wholly owned subsidiary, NLPL Health Industry Group Co., Limited, a Hong Kong based company, which had no business transactions in the reporting period.

 

On August 16, 2023, the Company established a subsidiary named NP Life Sciences Health (Singapore) Pte. Ltd., a Singapore based company in which the Company holds 90% of the shares and an individual holds 10% of the shares; there was no business transaction in the reporting period by this subsidiary.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Consolidated Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“GAAP”) and presented in US dollars.

 

Basis of Consolidation

 

The Consolidated Financial Statements includes the accounts of the Company and its current owned subsidiary, GW Health Consulting Management Inc (100%), NLPL Health Industry Group Co., Limited (100%), and NP Life Sciences Health (Singapore) Pte. Ltd. (90% of the shares). All significant intercompany transactions and accounts have been eliminated in consolidation.

 

Going Concern

 

The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern. As of December 31, 2023, there was an accumulated deficit of $348,245 and the net loss of 2023 was $2,935. The circumstances give rise to substantial doubt to the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued, and in order to remain solvent that the Company is dependent upon its ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock.

 

 F-6 
 

 

Management plans to fund operations of the Company through the proceeds from an offering pursuant to a Registration Statement on Form S-1, private placements of restricted securities, or the issuance of stock in lieu of cash for payment of services until such a time as profitable operations are achieved. If the Company do not raise all of the money it needs from public offerings or private placements of equity, the Company will need alternative sources, such as loans or advances from our officers, directors or others. Such additional financing may not become available on acceptable terms and there can be no assurance that any additional financing that the Company does obtain will be sufficient to meet its needs in the long term. There are no written agreements in place for such funding or issuance of securities and there can be no assurance that such will be available in the future. The failure to achieve the necessary levels of profitability or obtain the additional funding would be detrimental to the Company.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides an opportunity for the Company to continue as a going concern.

 

Use of Estimates and Assumptions

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

 

Due to the limited level of operations, the Company has not needed to make material assumptions or estimates other than the assumption that the Company is a going concern.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has two bank accounts in Bank of America. The balance of each bank account is less than $250,000; thus, the amount is insured by Federal Deposit Insurance Corporation.

 

Fair Value of Financial Instruments

 

ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management at the time of this report. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

 

Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.

 

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts and other payable, accrued liabilities, and related party payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value.

 

Revenue Recognition

 

The Company will recognize revenue in accordance with Accounting Standards Codification No. 606, “Revenue from Contracts with Customers” (“ASC-606”). ASC-606 requires that the criteria must be met before revenue can be recognized:

 

  executed contract(s) with customers that the Company believes is legally enforceable;
  identification of performance obligation in the respective contract;

 

 F-7 
 

 

  determination of the transaction price for each performance obligation in the respective contract;
  allocation of the transaction price to each performance obligation;
  recognition of revenue only when the Company satisfies each performance obligation.

 

The Company provides consulting services to clients through our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. The Company enters into a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year, and all of the Company’s contracts are short-term. The Company typically satisfies its performance obligations in contracts with customers upon completion of service rendered. Generally, payment is advance payment from customers. The Company recognizes the revenue at a single point in time after every service rendered and the transaction price is stated in the contract. Historically, there was no sales returns.

 

When above criteria were met, the Company will recognize revenue accordingly.

 

Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.

 

   2023   2022 
  

For the years ended

December 31,
 
   2023   2022 
         
Consulting service relating to China traditional culture and education  $65,022   $102,002 
Consulting service on career planning experience sharing and guidance   99,599    - 
           
Total  $164,621   $102,002 

 

General and Administrative Expenses

 

The general and administrative expense mainly consists of service fees occurred by the law firm, auditor, and accountant, etc.

 

Basic and Diluted Net Loss Per Share

 

Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. There were no adjustments to net loss required for purposes of computing diluted earnings per share.

 

 F-8 
 

 

   2023   2022 
  

For the years ended

December 31,

 
   2023   2022 
Loss per share:          
Numerator:          
Net loss used in computing earnings per share  $(2,935)  $(18,856)
           
Denominator:          
Weighted average common shares outstanding   42,959,574    42,959,574 
           
Basic and diluted loss per share  $(0.00)  $(0.00)

 

The Company has no potentially dilutive securities, such as options or warrants, currently issued and outstanding.

 

Comprehensive income (loss)

 

The Company follows the provisions of the Financial Accounting Standards Board (the “FASB”) ASC 220 Reporting Comprehensive Income and establishes standards for the reporting and display of comprehensive income, its components and accumulated balances in a full set of general purpose financial statements. The Company’s comprehensive loss consists of net loss.

 

Recently Issued Accounting Pronouncements

 

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses”, which will require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Further, the FASB issued ASU No. 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-02 to provide additional guidance on the credit losses standard. The amendments for ASU 2016-13 are effective for fiscal years beginning after December 15, 2022. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is in the process of evaluating the effect of the adoption of this ASU.

 

In February 2018, the FASB issued Accounting Standards Update No. 2018-02 Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (ASU 2018-02). The standard provides financial statement preparers with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income (AOCI) to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (or portion thereof) is recorded. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. We adopted this ASU in the 2019 and it did not have a material impact on our consolidated financial statements.

 

In December 2018, the FASB issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (ASU 2018-05). The ASU adds various Securities and Exchange Commission (“SEC”) paragraphs pursuant to the issuance of the December 2017 SEC Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which was effective immediately. The SEC issued SAB 118 to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Cuts and Jobs Act in the period of enactment. SAB 118 allows disclosure that timely determination of some or all of the income tax effects from the Tax Cuts and Jobs Act are incomplete by the due date of the financial statements and if possible, to provide a reasonable estimate. We adopted this ASU in the 2018 and it did not have a material impact on our consolidated financial statements.

 

In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.

 

As of December 31, 2023, except for the above, there are no recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.

 

 F-9 
 

 

3. PREPAID EXPENSES

 

As of December 31, 2023 and 2022, prepaid expenses amounted to $6,250 and $5,925, respectively. Prepaid expenses consists of the following:

 

   December 31,   December 31, 
   2023   2022 
   (Audited)   (Audited) 
         
Prepayment to OTCQB annual fee (unamortized portion)  $6,250   $5,925 
           
Total  $6,250   $5,925 

 

4. DEFERRED INCOME – CONTRACT LIABILITIES

 

In 2022, GW received $99,599 from two customers and recorded such amounts as deferred income - contract liabilities. GW delivered the career planning, experience sharing and guidance services during the year of 2023 and recorded the revenue accordingly.

 

The movement is as follows:

   Deferred income 
   (Audited) 
Balance – January 1, 2022  $- 
Addition   99,599 
Recognize   - 
Balance – December 31, 2022  $99,599 
Addition   - 
Recognize   (99,599)
Balance – December 31, 2023  $- 

 

5. LONG-TERM LOAN – RELATED PARTY

 

As of December 31, 2023, the Company had a long-term loan of $22,362 from one of the shareholders. According to the original loan agreement signed on April 8, 2023, the Company is required to repay the loan before April 7, 2024; after the agreement renewal, the repayment date was extended to April 11, 2025. The renewed loan agreement has a term of 12 months with an annual interest rate of 4% with no collateral is required. Additionally, the loan agreement will be automatically extended to additional one year if the repayment is not completed before due date.

 

As of December 31, 2023, the accrued interest amount to $645.

 

6. CONCENTRATION OF RISK

 

There is a concentration of risk associated with the Company’s services revenue. In 2023, revenue from four customers constituted 88% of the total revenue. In 2022, all revenue came from four customers, comprising 100% of the total. It’s important to note that these customer compositions are not identical.

 

 

  

For the years ended

December 31,

 
   2023   2022 
                 
Customer A   52,059    32%          
Customer B   47,540    29%          
Customer C   30,000    18%          
Customer D   15,000    9%          
Customer E             41,000    40%
Customer F             26,020    25%
Customer G             20,000    20%
Customer H             14,982    15%
Subtotal  $

144,599

    88%   102,002    100%

 

7. INCOME TAX

 

The Company was established in the State of Nevada in United States and is subject to Nevada State and US Federal tax laws. The Company has not recognized an income tax benefit for its operating losses based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the periods presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses and other temporary differences, the realization of which could not be considered more likely than not. Further, the benefit from utilization of NOL (“net operating loss”) carry forwards could be subject to limitations due to material ownership changes that could occur in the Company as it continues to raise additional capital. Based on such limitations, the Company has significant NOLs for which realization of tax benefits is uncertain. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not.

 

 F-10 
 

 

As of December 31, 2023, and 2022, the Company has accumulated deficit of $348,245 and $345,310. In 2023, the Company incurred a net loss of $2,935, as the management is not yet able to reliably estimate when the Company will generate profits that would enable the Company to make use of such potential future tax benefits. Consequently, a valuation allowance has been set up for the entire amount of the net deferred tax asset. Management continually assesses its future earnings potential and related tax impacts. If circumstances change in the future that will enable Management to accurately forecast future profits, the Company may carryover of such tax assets.

 

8. SUBSEQUENT EVENTS

 

On April 5, 2024, the Company and one of the shareholders renewed the loan agreement and extended the repayment date to April 11, 2025, subject to an automatic extension for an additional one year. The annual interest rate is 4% with no collateral.

 

The Company has evaluated subsequent events that have occurred after the date of the balance sheet through April 14, 2024 and determined that no subsequent events require recognition or disclosure to the financial statements other than the above matter.

 

 F-11 
 

 

ITEM 9. CHANGES AND DISAGREEMENTS WITH ACCOUNTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this Annual Report on Form 10-K, the Company’s management evaluated, with the participation of the Company’s principal executive and financial officer, the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act). Disclosure controls and procedures are defined as those controls and other procedures of an issuer that are designed to ensure that the information required to be disclosed by the issuer in the reports it files or submits under the Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, we concluded that the Company’s disclosure controls and procedures are ineffective in gathering, analyzing and disclosing information needed to satisfy the registrant’s disclosure obligations under the Exchange Act. Based upon an evaluation of the effectiveness of disclosure controls and procedures, our Company’s principal executive and principal financial officer has concluded that as of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act) are not effective because of the material weaknesses in our disclosure controls and procedures, which are identified below. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

 

The material weaknesses in our disclosure control procedures are as follows:

 

1. Lack of resources provided to the accounting and reporting function under U.S. GAAP. The Company utilizes a third-party independent contractor for the work required for preparation of its U.S. GAAP consolidated financial statements. There are certain challenges faced in providing sufficient resources in terms of time and access to allow the contractor to properly record all of the adjustments necessary on a timely basis to conform our reporting to U.S. GAAP standards.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Internal control over financial reporting is to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes: maintaining records that in reasonable detail accurately and fairly reflect our transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial statements; providing reasonable assurance that receipts and expenditures of company assets are made in accordance with management authorization; and providing reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on our financial statements would be prevented or detected.

 

 31 
 

 

As of December 31, 2022, management assessed the effectiveness of the Company’s internal control over financial reporting based on the criteria for effective internal control over financial reporting established in SEC guidance on conducting such assessments. Based on this evaluation under the COSO Framework, our management concluded that our internal controls over financial reporting are not effective as of December 31, 2022. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework. Based on that evaluation, they concluded that, as of December 31, 2022, such internal controls and procedures were not effective to detect the inappropriate application of U.S. GAAP rules as more fully described below. This was due to deficiencies that existed in the design or operation of our internal control over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

 

The matters involving internal controls and procedures that the Company’s management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were: (1) lack of a functioning audit committee and lack of a majority of outside directors on the Company’s Board of Directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures; (2) inadequate segregation of duties consistent with control objectives; (3) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of U.S. GAAP and SEC disclosure requirements; and (4) ineffective controls over period end financial disclosure and reporting processes. The aforementioned material weaknesses were identified by the Company’s Chief Financial Officer in connection with the review of our financial statements as of December 31, 2023 and communicated to our management.

 

Management believes that the material weaknesses set forth in items (2), (3) and (4) above did not have an effect on the Company’s financial results. However, management believes that the lack of a functioning audit committee and lack of a majority of outside directors on the Company’s Board of Directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures, can result in the Company’s determination to its financial statements for the future years.

 

We are committed to improving our financial organization. As part of this commitment, we will create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to the Company: i) Appointing one or more outside directors to our Board of Directors who shall be appointed to the audit committee of the Company resulting in a fully functioning audit committee who will undertake the oversight in the establishment and monitoring of required internal controls and procedures; and ii) preparing and implementing sufficient written policies and checklists which will set forth procedures for accounting and financial reporting with respect to the requirements and application of U.S. GAAP and SEC disclosure requirements.

 

Management believes that the appointment of more outside directors, who shall be appointed to a fully functioning audit committee, will remedy the lack of a functioning audit committee and a lack of a majority of outside directors on the Company’s Board. In addition, management believes that preparing and implementing sufficient written policies and checklists will remedy the following material weaknesses: (i) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of U.S. GAAP and SEC disclosure requirements; and (ii) ineffective controls over period end financial close and reporting processes. Further, management believes that the hiring of additional personnel who have the technical expertise and knowledge will result in proper segregation of duties and provide more checks and balances within the department. Additional personnel will also provide the cross training needed to support the Company if personnel turnover issues within the department occur. This coupled with the appointment of additional outside directors will greatly decrease any control and procedure issues the Company may encounter in the future.

 

We will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

 

There have been no changes in our internal controls over financial reporting that occurred during the year ended December 31, 2023 that have materially affected or are reasonably likely to materially affect, our internal controls over financial reporting.

 

This annual report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide management report in the annual report.

 

ITEM 9B. OTHER INFORMATION.

 

During the quarter ended December 31, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 32 
 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 

Executive Officers and Directors

 

The following table sets forth information about our executive officers and directors as of the date of this annual report:

 

Name   Age   Position
Executive Officers:        
Guidong Wang   44   Chief Executive Officer, President, Chief Financial Officer, and Treasurer
Huaying Zhu   44   Secretary

 

Directors:

       
Guidong Wang   44   Chairman
Huaying Zhu   44   Director
Jonathan Ginsberg   30   Director

 

Guidong Wang

 

Mr. Guidong Wang serves as our Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, and as treasurer. He has over eleven years’ experience in business management. Since August 2016, he has been serving as the Chairman of Shanghai Aurora Information Technology Group Co., Ltd., a company based in Shanghai primarily engaged in information technology. He has also been serving as the Dean of Beijing Qihuang Medical Research Institute, where he oversees the direction of academic research and strategic planning. From May 2011 to August 2016, he was the general manger of Yunnan Yijiaren Trading Co., Ltd., where he oversaw the general business strategy. Mr. Wang earned his MBA degree from Central Queensland University, Australia.

 

 33 
 

 

Huaying Zhu

 

Ms. Huaying Zhu serves as our director and Secretary. She has over eleven years’ experience in marketing. Since August 2016, she has been serving as the Vice Chairman of Shanghai Aurora Information Technology Group Co., Ltd., where she oversees the company’s marketing. She has also been serving as the Chairman of Shanghai Mosai Net Technology Co., Ltd, where she oversees the marketing of the company. From May 2011 to August 2016, she was the general manger of Yunnan Yijiaren Trading Co., Ltd., where she oversaw the company’s marketing. Ms. Zhu earned her college degree of Business Administration from Sichuan Agricultural University.

 

Jonathan Ginsberg

 

Jonathan Ginsberg has served as director of our Company since our inception. Mr. Ginsberg has also been the Chief Operating Officer of BEEC Inc. (Beyond Education Consulting) from 2016 until present. He obtained a Bachelor’s Degree in International Relations from the Johns Hopkins University.

 

Significant Employees

 

At the date hereof, we do not have any full time employees but we plan to hire employees in the foreseeable future as our business grows.

 

We have entered into a Business Collaboration Agreement with BEEC Inc, a Nevada corporation, whereby they will serve as our agents for the purpose of selling and promoting our products and services. As such, they will assist us in the process of obtaining the appropriate qualification to do business in California, to enroll students and recruit teachers, and use BEEC employees to help us with arranging meals, accommodation, transportation and sightseeing during our international study tours. The term of the Business Collaboration Agreement is two years, which shall automatically renew for an additional two-year period, unless earlier terminated by both parties. For their agency services, BEEC, Inc. will receive a commission equivalent to 25% of the sales price invoiced to our customers. According to the Business Collaboration Agreement, BEEC, Inc. shall act as our agent in the U.S.

 

Family Relationships

 

There are no family relationships among the directors and executive officers of the Company.

 

Code of Ethics

 

We have adopted a Code of Ethics that applies to our directors, officers, and all employees. It also may be obtained free of charge by writing to NP Life Sciences Health Industry Group Inc ., Attn: President, 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506.

 

Board of Directors

 

Our board of directors currently consists of four members. Our bylaws permit our board of directors to establish by resolution the authorized number of directors, and four directors are currently authorized.

 

Involvement in Certain Legal Proceedings

 

Over the past ten years, none of our directors or executive officers has been: (i) involved in any petition under Federal bankruptcy laws or any state insolvency law; (ii) convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses); (iii) subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from (a) acting as a future’s commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity, (b) engaging in any type of business practice, or (c) engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws; (iv) subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right to engage in any activity described in (iii)(a); (v) found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated; (vi) found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated; (vii) subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of (x) any Federal or State securities or commodities law or regulation, (y) any law or regulation respecting financial institutions or insurance companies, or (z) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or (viii) the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member. Except as set forth in our discussion below in “Certain Relationships and Related Transactions, and Director Independence,” none of our directors, director nominees or executive officers has been involved in any transactions with us or any of our directors, executive officers, affiliates or associates which are required to be disclosed pursuant to the rules and regulations of the SEC.

 

 34 
 

 

Committees of our Board of Directors

 

We presently do not have an audit committee, compensation committee or nominating committee or committee performing similar functions, as our management believes that until this point it has been premature at the early stage of our management and business development to form an audit, compensation or nominating committee. Until these committees are established, these decisions will continue to be made by our Board of Directors. Although our Board of Directors has not established any minimum qualifications for director candidates, when considering potential director candidates, our Board of Directors considers the candidate’s character, judgment, skills and experience in the context of the needs of our Company and our Board of Directors.

 

Nominating Committee. We have not established a Nominating Committee because of our limited operations; we believe that we are able to effectively manage the issues normally considered by a Nominating Committee.

 

Audit Committee. We do not have an Audit Committee. The Company’s Board performs some of the same functions of an Audit Committee, such as: recommending a firm of independent certified public accountants to audit the financial statements; reviewing the auditors’ independence, the financial statements and their audit report; and reviewing management’s administration of the system of internal accounting controls. The Company does not currently have a written audit committee charter or similar document.

 

In the event that our common stock becomes listed on a national stock exchange or an automated quotation system, we will be required to maintain audit, compensation and nominating, and corporate governance committees. We currently have no committees. Rather, the functions typically associated with auditing and other such committees are performed by our board of directors, which currently consists of four members, none of whom is considered independent.

 

 35 
 

 

ITEM 11. EXECUTIVE COMPENSATION.

 

Summary Compensation Table

 

The following Summary Compensation Table provides certain summary information concerning the compensation of our President and our other two highest compensated executive officers.

 

Name and Principal Position  Year   Salary
($)(1)(2)
   Bonus
($)
   Option
Awards
($)
   Stock
Awards
($)
   All Other
Compensation
($)
   Total
Compensation
($)
 
Guidong Wang
Chief Executive Officer, Chief Financial Officer, President, Treasurer and Chairman of the Board
  2023    -0-    -0-    -0-    -0-    -0-    -0- 
   2022    -0-    -0-    -0-    -0-    -0-    -0- 
                                   
Huaying Zhu
Secretary and Director
  2023    -0-    -0-    -0-    -0-    -0-    -0- 
   2022    -0-    -0-    -0-    -0-    -0-    -0- 
                                   
Sanjun Kuang
Former Chief Executive Officer, Former President, Former Treasurer and Former Chairman of the Board
  2023    -0-    -0-    -0-    -0-    -0-    -0- 
   2022    -0-    -0-    -0-    -0-    -0-    -0- 
                                   
Huawei Li
Former Secretary and Director
  2023    -0-    -0-    -0-    -0-    -0-    -0- 
   2022    -0-    -0-    -0-    -0-    -0-    -0- 
                                   
Meisang Hu
Former Director
  2023    -0-    -0-    -0-    -0-    -0-    -0- 
   2022    -0-    -0-    -0-    -0-    -0-    -0- 
                                   
Jonathan Ginsberg
Director
  2023   $12,000    -0-    -0-    -0-    -0-    -0- 
   2022   $12,000    -0-    -0-    -0-    -0-    -0- 

 

(1) We have not paid our executive officers any salary compensation and we have not entered into any written employment agreement with any of our executive officers.
   
(2) In fiscal year 2023, we have agreed to pay the following compensation to one of our director: Jonathan Ginsberg, $12,000 ($1,000 per month).

 

Employment Agreements

 

We currently have no written employment agreements with any of our named executive officers or other employees.

 

Pension Benefits

 

We currently do not maintain any pension plan or arrangement under which our named executive officers are entitled to participate or receive post-retirement benefits.

 

Non-Qualified Deferred Compensation

 

We currently do not maintain any nonqualified, deferred compensation plans or arrangements under which our named executive officers are entitled to participate.

 

Employee Benefit Plans

 

We currently do not maintain any employee benefit plans of any kind for our employees.

 

Compensation of Directors

 

Members of our company’s directors do not receive cash compensation for service on our company’s board of directors and on all committee thereof, except for Mr. Jonathan Ginsberg who was engaged as our director since December 2018. Jonathan received $1,000 per month as cash compensation for service on our Company’s board during the fiscal year of 2023. In addition, they may be reimbursed for certain expenses in connection with attendance at meetings of our company’s board of directors and committees thereof.

 

 36 
 

 

Limitation of Liability and Indemnification Matters

 

Our articles of incorporation contain provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Nevada law.

 

Our articles of incorporation and bylaws authorize our company to provide indemnification to our directors, officers, and persons who are or were serving at our request as a director, officer, manager or trustee of another corporation or of a partnership, limited liability company, joint venture, trust or other enterprise to the fullest extent permitted by Nevada law. Our articles of incorporation and bylaws also authorize our company, by action of our board of directors, to provide indemnification to employees, agents of our company, and persons who are serving or did serve at our request as an employee or agent of another corporation or of a partnership, limited liability company, joint venture, trust or other enterprise with the same scope and effect as provided to our directors and officers as described above.

 

Our company has not entered into any indemnification agreement with any of its directors or officers.

 

No pending litigation or proceeding involving a director, officer, employee or other agent of our company currently exists as to which indemnification is being sought. We are not aware of any threatened litigation that may result in claims for indemnification by any director, officer, employee or other agent of our company.

 

We anticipate obtaining director and officer liability insurance with respect to possible director and officer liabilities arising out of certain matters, including matters arising under the Securities Act. See “Disclosure of SEC Position on Indemnification for Securities Act Liabilities.”

 

Disclosure of SEC Position on Indemnification for Securities Act Liabilities

 

Section 78.7502 of the Nevada Revised Statutes provides that directors and officers of Nevada corporations may, under certain circumstances, be indemnified against expenses (including attorneys’ fees) and other liabilities actually and reasonably incurred by them as a result of any suit brought against them in their capacity as a director or officer, if they acted in good faith and in a manner that they reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, if they had no reasonable cause to believe their conduct was unlawful. Section 78.7502 of the Nevada Revised Statutes also provides that directors and officers of a Nevada corporation also may be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by them in connection with a derivative suit if they acted in good faith and in a manner that they reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification may be made without court approval if such person was adjudged liable to the corporation.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to the directors, officers or persons controlling the registrant pursuant to the foregoing provisions, the registrant has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

In the event that a claim for indemnification against such liabilities (other than the payment by our Company of expenses incurred or paid by such director, officer or controlling person of our company in the successful defense of any action, suit or proceeding) is asserted by any director, officer or controlling person of our Company in connection with the securities being registered in the registration statement, the registrant will, unless in the opinion of counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by our company is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

Security Ownership of Certain Beneficial Owners and Management

 

The following table sets forth certain information regarding the beneficial ownership of the Common Stock as of April 15, 2024, by (i) each person known by the Company to be the beneficial owner of 5% or more of the outstanding Common Stock; (ii) each of the persons named in the Summary Compensation Table ; (iii) each executive officer and director of the Company, and (iv) all of the Company’s executive officers and directors as a group.

 

Beneficial ownership is determined in accordance with the rules of the SEC. Each stockholder’s percentage of beneficial ownership as of April 15, 2024 set forth in the following table is based on 42,959,574 shares of our common stock outstanding at the date of this annual report.

 

 37 
 

 

Unless otherwise indicated, the principal address of each of the stockholders below is c/o NP Life Sciences Health Industry Group Inc., 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common stock held by them.

 

Name and Address of Beneficial Owner 

Number of

Shares

Beneficially

Owned*

  

Percentage of

Class **

 
Guidong Wang   33,883,504    78.87%
Huaying Zhu   3,750,045    8.73%
Jonathan Ginsberg   33,333    <1 %
Directors and Executive Officers as a Group   37,666,882    87.68%

 

* Beneficial ownership is determined in accordance with the rules of the SEC that generally attribute beneficial ownership of securities to persons who possess sole or shared voting power and/or investment power with respect to those securities. Common stock subject to options or warrants that are currently exercisable or exercisable within 60 days of the date of this annual report are deemed to be outstanding and to be beneficially owned by the person or group holding such options or warrants for the purpose of computing the percentage ownership of such person or group but are not treated as outstanding for the purpose of computing the percentage ownership of any other person or group. Unless otherwise indicated, voting and investment power are exercised solely by the person named above or shared with members of such person’s household.

 

** Percent of class is calculated on the basis of the number of shares outstanding on the date of this annual report plus the number of shares the person has the right to acquire within 60 days of the date of this annual report.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

We have not adopted an Equity Compensation Plan.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 

Related Party Transactions

 

We entered into Business Collaboration Agreement with BEEC Inc. (“BEEC”) for two years, whereby they will serve as our agents for the purpose of selling and promoting our products and services. We also engaged BEEC to design our website and logo and register our domain name and apply for our trademarks in the States. We have leased a section of the office space rented by BEEC located at 4125 Blackhawk Plaza Circle Suite 166, Danville, California for one year beginning on December 15, 2018 and ending on December 31, 2019 and subject to automatic annual renewal unless terminated by either party upon advance written notice. Our director, Jonathan Ginsberg, is Chief Operating Officer of BEEC Inc. and a minority shareholder of BEEC Capital LLC. BEEC Inc. and BEEC Capital, LLC are minority shareholders of our Company.

 

On December 28, 2018, the Company and Jonathan Ginsberg, an individual who is director of the Company (“Purchaser”), entered into a Founder’s Stock Purchase Agreement (the “Agreement”). Pursuant to the Agreement, Purchaser agreed to purchase from the Company, and the Company agreed to sell to Purchaser, an aggregate of 33,333 shares of the Common Stock of the Company (the “Stock”) at $0.003 per share, for an aggregate purchase price of $100 Shares were issued on December 28, 2018.

 

Promoters and Certain Control Persons

 

We don’t have a promoter at any time during the past five fiscal years.

 

Director Independence

 

Under the rules of the national securities exchanges, a majority of a listed company’s board of directors must be comprised of independent directors, and each member of a listed company’s audit, compensation and nominating and corporate governance committees must be independent as well. Under the same rules a director will only qualify as an “independent director” if that company’s board of directors affirmatively determines that such director has no material relationship with that company, either directly or as a partner, shareholder or officer of an organization that has a relationship with that company.

 

 38 
 

 

In addition, the members of that company’s audit committee must satisfy the independence criteria set forth in Rule 10A-3 under the Securities Exchange Act of 1934, as amended (“Rule 10A-3”). In order to be considered to be independent for purposes of Rule 10A-3, no member of the audit committee may, other than in his capacity as a member of the audit committee, the board of directors or any other board committee: (1) accept, directly or indirectly, any consulting, advisory or other compensatory fee from the company or any of its subsidiaries or (2) be an affiliated person of the company or any of its subsidiaries.

 

None of our current directors is considered independent.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

 

The aggregate fees billed for the most recently completed fiscal year ended December 31, 2023 and for the fiscal year ended December 31, 2022 for professional services rendered by the principal accountant for the audit of our annual financial statements and review of the financial statements included in our quarterly reports on Form 10-Q and services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for these fiscal periods were as follows:

 

   Year Ended 
   December 31, 2023
$
   December 31, 2022
$
 
Audit Fees   21,000    21,000 
Audit-Related Fees   [●]    [●] 
Tax Fees   [●]    [●] 
All Other Fees   [●]    [●] 
Total   21,000    21,000 

 

Our Board of Directors pre-approves all services provided by our independent auditors. All of the above services and fees were reviewed and approved by the Board either before or after the respective services were rendered.

 

Our Board of Directors has considered the nature and amount of fees billed by our independent auditors and believes that the provision of services for activities unrelated to the audit is compatible with maintaining our independent auditors’ independence.

 

PART IV

 

ITEM 15. EXHIBITS.

 

Exhibits:

 

4.1   Description of Securities
31   Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Executive Officer and Chief Financial Officer
32   Section 1350 Certification by Chief Executive Officer and Chief Financial Officer
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 39 
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

NP Life Sciences Health Industry Group Inc

 

DATED: April 16, 2024 By: /s/ Gudong Wang
    Guidong Wang
    Chief Executive Officer
   

Chief Financial Officer

 

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Guidong Wang   Chairman   April 16, 2024
Guidong Wang        
         
/s/ Huaying Zhu   Director   April 16, 2024
Huaying Zhu        
         
/s/ Jonathan Ginsberg   Director   April 16, 2024
Jonathan Ginsberg        

 

 40 

 

EX-4.1 2 ex4-1.htm

 

EXHIBIT 4.1

 

DESCRIPTION OF SECURITIES

 

Our authorized capital stock consists of 320,000,000 shares of common stock, par value $0.0001 per share, and 30,000,000 shares of preferred stock, par value $.00001 per share.

 

Authorized and Issued Stock

 

   Number of shares at October 4, 2019 
Title of Class  Authorized   Outstanding   Reserved 
             
Common stock, par value $0.0001 per share   320,000,000    42,959,574    -0- 
                
Preferred stock, $0.0001 par value per share   30,000,000    -0-    -0- 

 

Common Stock

 

Dividends. Each share of our common stock is entitled to receive an equal dividend, if one is declared. We cannot provide any assurance that we will declare or pay cash dividends on our common stock in the future. Any future determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our board of directors may deem relevant. Our board of directors may determine it to be necessary to retain future earnings (if any) to finance our growth. See “Risk Factors” and “Dividend Policy.”

 

Liquidation. If our company is liquidated, then assets that remain (if any) after the creditors are paid and the owners of preferred stock receive liquidation preferences (as applicable) will be distributed to the owners of our common stock pro rata.

 

Voting Rights. Each share of our common stock entitles the owner to one vote. All matters are decided by majority vote other than as required by law and the election of directors. For example, under Nevada law, two-thirds of the voting power of our issued and outstanding stock is required to remove a director, and 60% of the voting power of disinterested shareholders may be required in certain circumstances to approve certain interested transactions. A plurality of votes is sufficient to elect a director at a meeting; election by written consent to fill a vacancy, however, requires a majority vote. There is no cumulative voting.

 

Preemptive Rights. Owners of our common stock have no preemptive rights. We may sell shares of our common stock to third parties without first offering such shares to current stockholders.

 

Redemption Rights. We do not have the right to buy back shares of our common stock except in extraordinary transactions, such as mergers and court approved bankruptcy reorganizations. Owners of our common stock do not ordinarily have the right to require us to buy their common stock. We do not have a sinking fund to provide assets for any buy back.

 

Conversion Rights. Shares of our common stock cannot be converted into any other kind of stock except in extraordinary transactions, such as mergers and court approved bankruptcy reorganizations.

 

Nonassessability. All outstanding shares of our common stock are fully paid and nonassessable.

 

Preferred Stock

 

Our articles of incorporation authorize our board of directors to issue “blank check” preferred stock. The board of directors may divide this preferred stock into series and establish the rights, preferences, and privileges thereof. The board of directors may, without prior stockholder approval, issue any or all of the shares of this preferred stock with dividend, liquidation, conversion, voting or other rights that could adversely affect the relative voting power or other rights of our common stock. Preferred stock could be used as a method of discouraging, delaying or preventing a takeover or other change in control of our company. Issuances of preferred stock in the future could have a dilutive effect on our common stock.

 

As of the date of this prospectus, there are no shares of our preferred stock outstanding.

 

   
 

 

Nevada Anti-Takeover Statutes

 

Nevada law provides that an acquiring person who acquires a controlling interest in a corporation may only exercise the voting rights of control shares if those voting rights are conferred by a majority vote of the corporation’s disinterested stockholders at a special meeting held upon the request of the acquiring person. If the acquiring person is accorded full voting rights and acquires control shares with at least a majority of all the voting power, then stockholders who did not vote in favor of authorizing voting rights for those control shares are entitled to payment for the fair value of such stockholders’ shares. A “controlling interest” is an interest that is sufficient to enable the acquiring person to exercise at least one-fifth of the voting power of the corporation in the election of directors. “Control shares” are outstanding voting shares that an acquiring person or associated persons acquire or offer to acquire in an acquisition and those shares acquired during the 90-day period before the person involved became an acquiring person.

 

These provisions of Nevada law apply only to “issuing corporations” as defined therein. An “issuing corporation” is a Nevada corporation that (a) has 200 or more stockholders, with at least 100 of such stockholders being both stockholders of record and residents of Nevada, and (b) does business in Nevada directly or through an affiliated corporation. As of the date of this prospectus, we do not have 100 stockholders of record that are residents of Nevada. Therefore, these provisions of Nevada law do not apply to acquisitions of our shares and will not so apply until such time as both of the foregoing conditions are satisfied. At such time as these provisions of Nevada law may apply to us, they may discourage companies or persons interested in acquiring a significant interest in or control of our company, regardless of whether such acquisition may be in the interest of our stockholders.

 

Nevada law also restricts the ability of a corporation to engage in any combination with an interested stockholder for three years from when the interested stockholder acquires shares that cause the stockholder to become an interested stockholder, unless the combination or purchase of shares by the interested stockholder is approved by the board of directors before the stockholder became an interested stockholder. If the combination was not previously approved, then the interested stockholder may only effect a combination after the three-year period if the stockholder receives approval from a majority of the disinterested shares or the offer satisfies certain fair price criteria.

 

An “interested stockholder” is a person who is:

 

  the beneficial owner, directly or indirectly, of 10% or more of the voting power of the outstanding voting shares of the corporation; or
     
  an affiliate or associate of the corporation and, at any time within three years immediately before the date in question, was the beneficial owner, directly or indirectly of 10% or more of the voting power of the then outstanding shares of the corporation.

 

Our articles of incorporation and bylaws do not exclude us from these restrictions.

 

These provisions are intended to enhance the likelihood of continuity and stability in the composition of the board of directors and in the policies formulated by the board of directors and to discourage some types of transactions that may involve the actual or threatened change of control of our company. These provisions are designed to reduce our vulnerability to an unsolicited proposal for the potential restructuring or sale of all or a part of our company. However, these provisions could discourage potential acquisition proposals and could delay or prevent a change in control of our company. They also may have the effect of preventing changes in our management.

 

   

 

EX-31 3 ex31.htm

 

EXHIBIT 31

 

CERTIFICATION

 

I, Guidong Wang, certify that:

 

1. I have reviewed this annual report on Form 10-K of NP Life Sciences Health Industry Group Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have significant role in the registrant’s internal control over financial reporting.

 

Date: April 16, 2024 By: /s/ Guidong Wang
    Guidong Wang
    Chief Executive Officer, Chief Financial Officer
    (Principal Executive Officer, Principal Financial Officer)

 

 

 

EX-32 4 ex32.htm

 

EXHIBIT 32

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report on Form 10-K of NP Life Sciences Health Industry Group Inc. (the “Company”) for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in this Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: April 16, 2024 By: /s/ Guidong Wang
    Guidong Wang
   

Chief Executive Officer, Chief Financial Officer

(Principal Executive Officer, Principal Financial Officer)

 

   

 

GRAPHIC 5 form10-k_001.jpg begin 644 form10-k_001.jpg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�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end GRAPHIC 6 form10-k_002.jpg begin 644 form10-k_002.jpg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end GRAPHIC 7 form10-k_003.jpg begin 644 form10-k_003.jpg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

  • 6W4](@;]V.O\ P+K4VWI4<:[14U2@0FVDVTZBJ&%?.'[/?_)% M/"W^Y/\ ^E$E?1]?.'[/?_)%/"W^Y/\ ^E$E=%'XC*IL>B4445V(Y>@4444Q M!1110 4444 %%%% $EK_ ,?4/^^O_H5>9_ 7_D3=<_[&G5__ $IKTRU_X^H? M]]?_ $*O,_@+_P B;KG_ &-.K_\ I37%BO@/1P'\4]%HHHKS+]3W?(****!! M1110 4J]:2E7K31<=SAY/^3DO"O_ &*6I?\ I3!7JM>52?\ )R7A7_L4M2_] M*8*]5KEGN>#B?X@4445F8!1110 4444 %%%%+N!Y7XJ_Y.*\)?\ 8J:I_P"C MXJ[;_/\ *N*\5?\ )Q7A+_L5=3_]'Q5VO^?Y5]!A_P"$CHCL%%%%:HH****8 M!1110 4444 %>>?M#';\&O$Y]!:_^E4%>AUYW^T1_P D9\4?2U_]*H*FILRH M'LLGS2.?\]!3*?\ Q/\ Y["F5\S+XCU(_"@HHHJ2@HHHH **** "BBB@ IUO M_K$_WJ;3K?\ UR#_ &J8F?GY_P $]?\ D_O]I;_KM=?^E]?IC7YG?\$]?^3^ M_P!I;_KM=?\ I?7Z8U[4=D>)+<^8_P#@I'_R9A\2/^O:+_T(_XPU^ M& ]=./\ Z,>J7_!23_DS'XC_ /7M%_Z.2N<_8.^+7@OPW^R7\-;#5/&7A_3; MJWTXB>VO=3ABEB/F/C*E@1^(JA'USY*C..*7RAD-DY%<+_PO[X:?]%"\+?\ M@XM__BZ/^%_?#3_HH7A;_P '%O\ _%T"Z6.]V>])Y?J2:X3_ (7Y\-/^BA>% MO_!Q;_\ Q='_ OSX:?]%"\+?^#BW_\ BZ!G>>6/PHV^YK@_^%^?#3_HH7A; M_P '%O\ _%TG_"_OAI_T4+PM_P"#BW_^+H [W;2[:X'_ (7]\-/^BA>%O_!Q M;_\ Q=+_ ,+\^&G_ $4+PM_X.+?_ .+I6 [WI2UP/_"_/AI_T4+PM_X.+?\ M^+H_X7Y\-/\ HH7A;_P<6_\ \73 [ZBN!_X7Y\-/^BA>%O\ P<6__P 71_PO MSX:?]%"\+?\ @XM__BZ .^KYP_9[_P"2*^%1_P!,YS_Y,25ZE_POSX9?]%%\ M*_\ @ZMO_BZ\"^ OQ<\":;\'_#-M>>-O#EK<1Q3[XY=5@1E_?R'Y@6&"01QU MQST-=%#XC*IL>WT5QG_"[/ARW \?>&<_]A>WQ_Z%3F^-'PZ50?\ A/O#6/7^ MU[?_ .+KMNCEZ'8T5QG_ NSX<_]#]X8_P#!Q;__ !5'_"[/AS_T/WAC_P ' M%O\ _%4[H1V=%<9_PNSX<_\ 0_>&/_!Q;_\ Q5'_ NSX<_]#]X8_P#!Q;__ M !5%T!V=%<9_PNSX<_\ 0_>&/_!Q;_\ Q5'_ NSX<_]#]X8_P#!Q;__ !5% MT!V=%<9_PNSX<_\ 0_>&/_!Q;_\ Q5'_ NSX<_]#]X8_P#!Q;__ !5%T!V] MK_Q]0_[Z_P Z\S^ O_(GZY_V-.L?^E-;-K\;/AS]IC;_ (3_ ,+A59<_\3BW M_O?[U>=_!+XN> ]-\*:U%=>-_#MO(WB7595674X5+*UQE6P6Z$=ZX,1\)Z." M_B7/<**X[_A=7PZX/_"?^&3SSC5[<@#/;Y^>*8_QL^':MC_A/O# !.!_Q-[? M(^OSUP'M\QVE%<9_PNKX=?\ 0_\ AC_P;V__ ,51_P +J^'7_0_^&/\ P;V_ M_P 50',=G17&?\+J^'7_ $/_ (8_\&]O_P#%4?\ "ZOAU_T/_AC_ ,&]O_\ M%4!S'9TO\5<9_P +K^'7?Q_X8_\ !Q;_ /Q='_"ZOAS_ -#_ .&/_!O;_P#Q M="*C+4BD_P"3D/"W_8I:E_Z4P5ZK7S[)\7O 7_"_O#%^/'/AP6B>%]1@:Y_M M2#RUD,\!52=V < GKVKTW_A>'PWX(^(/A<#H=VL0 ?7[U+B&N<[6BN) M;XW_ X_Z*%X6 /W?^)O!R?3[U(?CA\.!Q_PL'PM_P"#BW_^+K)Q?0YCMZ*X MC_A>7PX_Z*%X6_\ !Q!_\51_PN_X;_\ 10O"W_@XM_\ XJIY6MP.WHKB/^%W M_#?_ **%X6_\'%O_ /%4?\+O^&__ $4+PM_X.+?_ .*HLP.WHKA_^%X?#C_H MH7A;_P '%O\ _%4O_"\?AQ@X^(/A;./^@Q!_\55$?^Q5U M/_T?%7;?Q&O'/$WQ>\!2?M >%;L>./#K6PIE<9)\;OAUN8+\0/"['.W;_ &O .>,C[_6D7XW?#D_\U \+D#JW]KP8 M_P#0O\XKYJ47S,]*,ERH[2BN*_X7A\./^BA>%O\ P<6__P 52?\ "[OAQ_T4 M+PM_X.+?_P"*J>4OF.VHKB?^%W?#C_HH7A;_ ,'%O_\ %4?\+N^''_10O"W_ M (.+?_XJCE#F.VHKB?\ A=WPX_Z*%X6_\'%O_P#%4?\ "[OAQ_T4+PM_X.+? M_P"*HY0YCMJ*XG_A=WPX_P"BA>%O_!Q;_P#Q5'_"[OAQ_P!%"\+?^#BW_P#B MJ.4.8[:G0_ZY/]X5P_\ PN[XG MPZ\5^.)/@]J<>@>&=5.C:AFWT\R"Y601N$7S.55B,MGOQ7M7AG7?#.O:A/:7 M7A"TT-K?38=0N9+ZWM3'!Y@)\MV0D!E !.>/FKX1O?V9?&>H?!'XH6LWPF\0 MGQQK7BN34])D:YC$9M7N1(I95N-@;:#D,O!(Y->U2_!_Q#XR^+/Q1U#6/!>N MZ'X?\2^&](M8+VW-LL_VFVYD!3S"'(('RL-K!<$XJHZ[]BI))^Z?0]]XI^'& MF^)/#N@R+X?DU37U9[""**W;S47JX(&".P/<\"N@^Q>#8XKV9[3P^T5FYCN6 M\JW"P-QQ(?X#[-ZU\QQ?!7QGJ7Q ^#OB*^\*:=97.E^']5TJ[GL;:&%=*N90 M3:3F,'"'&"0FX*Q(6N"LOV:1!!H.F:L^H7\=B!86]M(82ZE MO, KQ-:T76+.]UV2)(/M%KY=MY+22?O/FP,/!_P)\3 MZ?WUKXF+<-976IWDJ/'K]L]WY@EW!P9"J,,+(!]W'2I[C?0]A^*'Q,\" M?#!?",EQX5M-9M/$VJQZ-:WFEVUK+%',_P!UFYR5_P!W/TKU*V\':!)&"^@Z M23G&5LXR/SVU\'6_[/\ \2/#OA71=#@\&W]S%9?%=?$,26DL'E6^FX!WIEU M7);Y0.W K]"+%?D("[5R2/7GFGTT)N^>W0H?\(3X=_Z &E_^ 4?_ ,367J7A M[PSIL4T]SI6C6=I#DO//;0HBCCJS#'YD5UWXYKQ3]IC0==\2>&=%TO0_"UKX MG2YUFW%_'=;6%M;88/,$8A78<#!R #G'%1Z%+<[.XM/!=OY7F6WAV#ST\R+S M8[<&11_$N>HQSD9%8_Q"U+PM\/\ P7J?B*3P]I6HQ6ELUS%!#%;1O=*%W8B9 M\*QV@GKZ<5\9Q_L^^/=/\)? VQU3X?:EKD_AB#Q#;ZE%YD,IB2X61+50PW%C$)45QG# +U%>3 M?L_^'='F^#7A9Y='T^61HYP[O9QLS?Z1)U)'/_UJ]'_9ST75?#?P/\"Z3KNG M3Z7JVGZ7!:W5K.REXY$&U@2I*D?C7$?L\Y_X4OX4P,GR[CC_ +>)*ZJ%N9G- M)NRN2>-H/#_MYH;21(;6+=#*[K\I&W(XSBNK7PKHJ*%;0],? M: FXV41Z=_NUY[XX\%ZC'\3O"^L:';(VF:E,EOKFT;1M@!:&;'KD[3]17JQ; MSC8[1<8 Y7H!7KMK_ ,?4/^^O M_H5>:? 3_D3=<_[&G5__ $IKAQ/P'HX+^*6/& \,1^'/$,%C::,NJ6L2HZQV MD1DMVD.V,-\O' _.NFLO!^B6UC;POHFF,\<*(S-91$DA1G)V^N:\_P#BGX)U M.Z\7>&M7T.U1XKVY33]=51@&UWAUF;U*.!GV->L,VYC[G->?]D]K[1E_\(OH M?_0"TO\ \ 8O_B:/^$7T/_H!:7_X Q?_ !-:5%3J59&;_P (OH?_ $ M+_\ M &+_ .)H_P"$7T/_ * 6E_\ @#%_\36E11J%D9O_ B^A_\ 0"TO_P 8O\ MXFA?"^A_] /2_P#P"B_^)K2I5ZTUN":]%NM+\):;>6$%WINA6]Q>2>7;QRVD(:9L9VJ-O7 KBI./V MD/"Y'7_A$M1_]*8*ZCXH>$'\7>#;Z"R1$UFUVWFF7&!N2ZC^>/![9(VGV8US M3O<\2M_$92\"^'])U&SU>\FTC3I5EU2X$:R6<1V+&?+P/E]JZ3_A$= 7 &@: M3@,7_P 363\*8-0M_AWH/]KVRV>KRVXFO8%Z).QW./SKJZF3=SCB97_" M):!_T -)_P# &+_XFC_A$M _Z &D_P#@#%_\36K14W99E?\ "):!_P! #2?_ M !B_P#B:/\ A$M _P"@!I/_ ( Q?_$UJT478&5_PB6@?] #2?\ P!B_^)I1 MX3T$$$:#I61S_P >,7_Q-:E%%WJ!XSXH\,Z*O[0WA*(:-IWE?\(MJ3&/[)'M M)$\0!QMKM?\ A%M"_P"@%I?_ ( Q?_$USGBK_DXKPG_V*FJ?^CXJ[;_/\J]W M#?P4S>.QF?\ "+:%_P! +2__ !B_P#B:/\ A%M"_P"@%I?_ ( Q?_$UIT5O MJ69G_"+:%_T M+_\ 8O_ (FC_A%M"_Z 6E_^ ,7_ ,36G10!F?\ "+:%_P! M+2__ !B_P#B:/\ A%M"_P"@%I?_ ( Q?_$UIT4 9G_"+:%_T M+_P# &+_X MFC_A%M"_Z 6E_P#@#%_\36G10!F?\(MH7_0"TO\ \ 8O_B:\_P#V@/#FCVWP M@\2S0Z1I\$RBU"RQVD:LO^E0YP0O&=_M$?\ )&?%'TM?_2J"IJ;, MN!Z/J?AWPUIL%S=7.BZ1;P0KYCRRV40 &,LV=M@7$,5P)4FB6:-A@QR $,,#@@UY7\(_!^L>$/&' MBS3[R!1X?L/+BT";O]ED9I&C]MCY4#TQ7S5W=G=961WY\)Z"?^8#I7_@#%_\ M33?^$1T#_H :5_X Q?\ Q-:]%1=FMD9'_"(Z!_T -*_\ 8O_ (FC_A$= _Z M&E?^ ,7_ ,36O11=A9&1_P (CH'_ $ -*_\ &+_ .)H_P"$1T#_ * &E?\ M@#%_\36O11=A9&1_PB.@?] #2O\ P!B_^)H_X1'0/^@!I7_@#%_\36O11=A9 M&1_PB.@?] #2O_ &+_XFI+?PCH'G)_Q(-+^\/^7&+_XFM.EM_P#6)_O546[" M:1^?/_!/2*./]O3]I*%$6.&.6Y5(T 55 O\ X ]J_36OS._X)Z_\ )_?[ M2W_7:Z_]+Z_3&O9C\*/&>Y\Q_P#!2/\ Y,P^)'_7M%_Z.2K?_!//'_#&?PRS MT_LTY_[[:JG_ 4C_P"3,/B1_P!>T7_HY*E_8!:>/]B7X=-:J'N5TES$IZ%] MSX'YU0CWBX\2:1:ZM%I4^J6,&HS#?'937,:S2+ZK&3N/UQ6A<86,R(0>X[YQ M]*^//V-;7PYXD^$7B#5?B!':W7Q#FUJ^B\23:L1]MAE$I"QJ6^=(PFW9MP,5 MF_$;]HWQQX#\?>)M#L?$EI;V>D^+] TRSL[JQB\QK"[3]XF3RQ'.'Z^]3?1 MMV?8^GZYINJ1W#6>H6=]%;N89OL\Z2+&XZJV"=I]CS6FL:MCY1QRO3%?F-+J M6I^'?^%AP>&_$+>&X;_XY065U+8I&28GC5LG@X&1R.AYKUSQK^T=\0?"7Q(U MO01XLM?L]AX\TC188KC3[=))K"YAW.N0.?F/#@>U-QZ@?;Y16_A'KTK.UK6M M.T..&74=0M-/CD<1QO>3)&K.>B@L1DD]A7RC\/\ XV>,M2T7XS^(/$/CFPM- M'\!^(-1TX2'3(V!MHXU,+.(V4ED9CQGY^AKPWXQ?%SQ!\3/@1XTT[Q9J-MK# M>&_'/AU+#4I+>*"9X9GCE^=8_E##...W7-%M6B5HS]'=0UBRT2UDO-1U"WL+ M&+Y7N;N98HESQ@LV,<].:LV]TDRJT,RS))\RM&P(8=N>G^->%_M-^']0\36_ M@E?#^N:/8>)K.XDO--TWQ'%YNEZOMBP\$PZ*<$,K=01D5Y5H/QX\0:KI_P . MO"^B6MG\*[WQ-J.JV5YJ15;VRBOK7)\JW:0[725LX/7 .,8H:M./B)JOPA_:,^*GB31]3TJ&^)\+VM_'Y,?EWPF?RY!@DLG!+#'S<#FO4%_ M:*\87GQ0DL;L0RZ-=>+;GPBWA=K=/.CM4M3)]O+\L=QYP?EV]LT)V)O9GU5I M>IV&N6:WEA=V^I6SL<3VLJRQL1Z,I(XK36&/:I"+ZC K\R/AM\:M4^#_ .R7 M9Q^$?$=IHVMBZ\1:K#8K8Q3BX2VF+,2[95(@.",;VS@8Q7T)X/\ B_X_^(7Q MUTOPU;>*+'3=)U+P/I_BF6O_'U#_OK_P"A5YG\!?\ D3=<_P"QIU?_ -*:XL7\!Z. M_BGHV3R.QXI***\O4]P****>H!1111J 4J]:2E7K0BX[G#R?\G)>%A_U*6I? M^E,%>J_Y_2O*I/\ DY+PK_V*6I?^E,%>JUS3W/!Q/\0"Q/)Y-%%%9F 4444 M%%%% !1111W \K\5?\G%>$_^Q4U3_P!'Q5VW^?Y5Q/BK_DXKPG_V*FJ?^CXJ M[;_/\J][#?PD=$=@HHHK?4H****-0"BBBC4 HHHHU *\[_:(_P"2,^*/I:_^ ME4%>B5YW^T1_R1GQ1]+7_P!*H*FILRX'LK?>?_/84S_'-/\ XG_SV%,KYB7Q M,]2/PA1112&%%%% !1110 4444 %.M_]8G^]3:=;_P"L3_>IB9^?G_!/7_D_ MO]I;_KM=?^E]?IC7YG?\$]?^3^_VEO\ KM=?^E]?IC7M1V1XCW/F/_@I'_R9 MA\2/^O:+_P!')5S_ ()Y?\F:_#+U_LT_^AM5/_@I'_R9A\2/^O:+_P!')5S_ M ()XL/\ AC;X7X(_Y!Q_]&/5"/9IO ?AVX\10^(IO#NES^((AMCU0V:&Y5?: M3;NJIKWPO\*>)+PWNK^%M(U:_944W5Y8QRR_(=R'F*[3(HR* .%M M?A/X,TZWOK:V\'Z-%;WTZW-U''IT2K<3(0W458UCX7^$_$>H'4- M7\+:+J>H'R]UU>6,H:9)'Y)M[J!9(MF,;=A'3 P M.*K7W@/P[J6DV>E7GA[3;O2[%T>TL9K2-HK=T^XT:%=JE>Q%=5D49% 'G^K? M!7P'X@U"YO\ 4O!/A_4KZY=&GNKO3(9))&3[K,2N20 ,'MCBMEO _A[^V9-9 M.@V']KR6_P!CEOOLB&X:#IY9?&=F.,=,5T^11D4 <'8_"'P/I]K%;VG@[0[> MWA,ABMXM-B5$,HQ)M&W #CAO7'-6M.^'7AS2M:CU>T\,:3::K#;+:QW]O8QQ MS) /E$:N!N50H'RCBNRR*,B@!:^_^2*>%O\ A_P 6 M5\+?[EP?_)B2NBC\1E4V/0Z***[$B44NTT;37FZGN"44NTT;31J E%+M-&TT:@)2KU MHVFC'(IJY<=SAY/^3DO"O_8I:E_Z4P5ZK7EYX.)_B"44;31M-9F 44;31M- !11M-&TT %%%&0O)X%'<#RKQ5_R< M5X1_[%35/_1\5=O_ )_E7$^*/F_:*\)*.67PKJ08>A\Z+BNVQDGO7O8;^"CH MCL%%+M/I1M/I6^I0E%+M/I1M/I1J E%+M/I1M/I1J E%+M/I1M/I1J E>=_M M$?\ )&?%'TM?_2J"O1=I]*\Z_:(_Y(QXH/;%K_Z50U-39EP/9?XG_P ]A3*> MW#/]?Z"F5\S/XCTX_"@HI,BC(J2A:*3(HR* %HI,BC(H 6BDR*,B@!:=;_ZQ M/]ZF9%/A_P!Y\Q_\%)/^3,?B/_U[1?\ HY*XC]AGQ9X]TW]E M'XT7_HY M*M_\$]&"?L9?#-F. --))/\ OM5".U_X6-\4MV/^%26N?3_A*K?_ .-4?\+% M^*?_ $22USG'_(U6_P#\:KA?%?[0%SX7_:P\(^#WU+33X3\0V5SI_EHZ-/%J ML6'42#.Y04.!G&]\=>-?"5IX3UJ^U3PG-"MY)&8/*,&_VOO#^L?#%/'EWX'].@T MHS:!JXU2Z\2#PK?Z6K0M+IE^5W*LF'VL",8="1SS7'3?M#>*M#_:2UK1KVTU M*?2)/"-KJ>G^"Y!:QWOV^2Z:(QQR%@'.U2V"QXIVOH![%_PL+XJ]!\(K?_PJ M8/\ XU2_\+"^*W_1(K?_ ,*F#_XU7HNCW;WEC;SRV[VCRQJ[6\C!FC8CE21P M2#P<$UJ4MM /)O\ A87Q6_Z)%;_^%3!_\:H_X6%\5O\ HD5O_P"%3!_\:KUF MB@#R;_A87Q6_Z)%;_P#A4P?_ !JC_A87Q6_Z)%;_ /A4P?\ QJO6:* /)O\ MA87Q5_Z)%;_^%3!_\:KPSX%^+OB);_"3PW%:?#*VOK41S;+G_A(X(O,/GR9R MAC.T\XZ_PY&,XK[,KYQ_9Y7_ (LKX6 P#LGY_P"WB2NBC\1E4V*VH?$3X@Z5 M9RW5Y\+;6WMHP"\C^*8,#) '_++U(J<>-OB2<8^%%N!=2DLYM+GBS^_@\S]XC9ZNC*,X]:]8;"L0.F<<#@8[5V(Y> MAYS_ ,)I\2O^B3V__A4V_P#\:H_X33XE?]$GM_\ PJ;?_P"-5Z+Q[4<>U,1Y MU_PFGQ*_Z)/;_P#A4V__ ,:H_P"$T^)7_1)[?_PJ;?\ ^-5Z+Q[4<>U 'G7_ M FGQ*_Z)/;_ /A4V_\ \:H_X33XE?\ 1)[?_P *FW_^-5Z+Q[4<>U 'G7_" M:?$K_HD]O_X5-O\ _&J/^$T^)7_1)[?_ ,*FW_\ C5>B\>U''M0!Y_;^-OB7 M]HBQ\*+;[R_+_P )3!S\W_7.O.O@QXN^(5OX5UE;/X;0WL;>(]4>21O$<,9# MFX^9""F3@\9!YKZ*M!]]?\ T*O,?@*O_%'Z[P/^1IUC_P!*:X<1\)Z. M"^.P[_A-/B7_ -$IM_\ PJ;?_P"-4?\ ":?$O_HE-O\ ^%3;_P#QJO1>/2CC MTK@/:M+N>=?\)I\2_P#HE-O_ .%3;_\ QJC_ (33XE_]$IM__"IM_P#XU7HO M'I1QZ4!:7<\Z_P"$T^)?_1*;?_PJ;?\ ^-4?\)I\2_\ HE-O_P"%3;__ !JO M1>/2CCTH"TNYYU_PFGQ+_P"B4V__ (5-O_\ &J/^$T^)>X?\6IM\?]C3;_\ MQJO1>/2@8R.!05%.YX3)XN^(;?'CP],?AG;KJ"^&=02*T/B.!M\9GAW/O\O MP0!C'.:](7QQ\4.<_"2WS_V-=O\ _&JJR8_X:0\+<#_D4M2_]*8*]5_ 5R3W M/%K_ !GFO_";_$__ *));_\ A5V__P :H_X3?XG_ /1)+?\ \*NW_P#C5>E< M>U''M61SGFO_ F_Q/\ ^B26_P#X5=O_ /&J/^$W^)__ $22W_\ "KM__C5> ME<>U''M0!YK_ ,)O\3_^B26__A5V_P#\:H_X3?XG_P#1)+?_ ,*NW_\ C5>E M<>U''M0!YK_PFWQ._P"B26__ (5=O_\ &J&\:?$QAAOA);X[_P#%5P?_ !NO M2N/:C:/05406Y\T:_P"+/B*/CYX8N)/AI"M\/#>H*MG_ ,)) 593-'N??Y>! MCCCOFNT_X33XFJ>/A3;=?^AIM_\ XU5[Q4/^,BO"/ _Y%75/_1\5=QQZ5[6' M^ W1YU_PFWQ-_P"B4VW_ (5%O_\ &J/^$V^)O_1*;;_PJ+?_ .-5Z+Q_LTB\?[-'' M^S0!YU_PFWQ-_P"B4VW_ (5%O_\ &J/^$V^)O_1*;;_PJ+?_ .-5Z+Q_LT_#2"QM,6VZ9?$<$ MOEXNHB/D$8W9.![9KZ X]J\]_:'X^#/B<@#(%K_Z505%39E0-2;QQ\3PS$?" M:#'7GQ3!D^_^KXX[56D^)'Q&AOH+-_A5:K=7"LT47_"5P$L .3_JNG->GZLM MW):W0T_R1>,G[MKC)0-C@\=LUYG\-?%TWC[Q1'>W44-MJ>EZ:]CJ5DG_ "[7 M7GD,H]B%W#U!KYU>\VV=_1$W_";?%'_HDEO_ .%5;_\ QJC_ (3CXH_]$DM_ M_"JM_P#XU7IGU HX]JB\>QIRR[GF?_"U%X]@Y9=SS/\ X3;XH?\ 1)+;_P *JW_^-4?\ M)Q\4?^B26_\ X55O_P#&J],X]J./:B\>PU%X]@Y9=SS+_ (3CXH?]$DM__"JM M_P#XU4L'CCXGK-'_ ,6EMSS_ -#5!_\ &J](X]JDM\>=&<#K335T)IVW/SQ_ MX)V37-Y^W'^T/)=VWV"]8SO/:+,)5A?[;\R;@ &P?X@!7Z1+=GS)_P4C_Y,P^)'_7M%_Z.2I?^"?\ !+MKCQ4]AXIT?5!JW_ EUCH]K'J%S,I)C M\QMO09P?4 "NL\#?L]MX1\?>./%=UXENM:N?%\$,-]:26L4,2&.,IN0H,@D$ M]:/"_P"T?:>.M0U67PKX9U;Q#X5TN>6TN?$5JT8A>>/B1((V;?-M/!91C.:] M)MO%6FW5Q%9I0OB/(]%_9)T#2_ MA#X<^'4VK:A>Z1H&J1:I874A5+B%HYC*D8(&-N25)ZD&K=U^R?X.O/ _B[PQ MBYBL_$.LMKQ=& -G=^8)$:$= $=00._.>M#8U\*ZQ:1^)/$ ME[X62262%OLUW;9W&0!B2C8X*Y]Z]^M_%&E7D=R\.HVLR6KF.Y:.X1EMV RR MN0?E('7--:*R&>#ZI^QK8ZA:Z1(OB_48==@\4IXNU'5EM82^IWR*%7>F-L:! M1C:@[T_XI?L=V'Q5^)&L>-KOQ3?Z=J]YI<&G6;VMM"6TQH9/,CN+=V&X2ALY M)[,17J&M?&KP=H.I>&;.?7K%IO$DQATIH[J-DN2!DLK!L;>,9[GCK71/XOT5 M/MX;5;$'3VQ>C[2G^B^GF\_)Q@_-BC6*N%^X_P -Z3=:/HME:7VHR:Q>PQ+' M-J$D:QO<,!@NRKP">^*V%K)TWQ%IVKMBQO;>](4,WV6990H(RI.TG /8]ZU( MV$BY'2C?4-"2BBB@ HHHH *^FR?_THDKZ/KYP_9[_Y(IX6 M_P!R?_THDKHH_$95-CI/$7@?3/%&M>'M6OXB]_H-R]S9RJ<89UVL#[8[>O-; MZ]^^232T5V(Y>@4444Q!1110 4444 %%%% $EK_Q]0_[Z_\ H5>9_ 7_ )$W M7/\ L:=7_P#2FO3+7_CZA_WU_P#0J\S^ O\ R)NN?]C3J_\ Z4UQ8OX#TYX.)_B!11169@%%%% !1110 4444=P/*_%7 M_)Q7A/\ [%35/_1\5=M_%_GVKB?%7_)Q7A/_ +%35/\ T?%7;?Y_E7NX;^$C MHCL%%%%;HH****8!1110 4444 %>=_M$?\D9\4?2U_\ 2J"O1*\\_:(_Y(SX MH^EK_P"E4%34V9<#V1OO/_GL*YO0O VE>'?%'B/7[&$Q7^OO#)>G/#O$I56' MN5(!^E=(WWG_ ,]A3*^:;Y6TCT4KI-A1114&@4444 %%%% !1110 4ZW_P!8 MG^]3:=;_ .L3_>IB9^?G_!/7_D_O]I;_ *[77_I?7Z8U^9W_ 3U_P"3^_VE MO^NUU_Z7U^F->U'9'B2W/F/_ (*1_P#)F'Q(_P"O:+_T_!__ K6_P#"\FM6]GJ%U+IWB.SN8ELY+>20NIN M6$B2@$@X5LXKE=6^!'CVZ^.VHZC#!YR7?C"S\2P>*_.3_1=.AAV2:<.?,RQR M F-A!R37V-]C&W&[M@<=*8UB'SF5L]NG%3;2P+1'YW^%?V?_ (KVL7@.VD\% MZCILVG>/-;UF:^^U6I^SVUTKK#. )*V-!_98^)5C^SSXDTI+S4 MAXY_T."?3YY;6.SU>&UNC*_E21'<_G)E2\V&YPW%??368;J[8Q@BC["NX$,0 M>/TJEL'6Y\K>*/@K=:I\2?@GXGT/P!:Z'I&CW&H2:GHK?9S)ITMS%_K=H)5@ MLG.(R><8 S7FV@_LX_$32]/O[*XT9[FXL?"VO:-J5UY\3?\ "67=U(6MI 6; M)\O.;6@;J[=01^%,6P11]X]AQQQ0FT)GCO[*/PWD^'?P3\&6. MIZ N@>*K?1[6PU9'V/,[PIM 9U)# AKVN-/+7%1QVXC;(;/.>@J>@844 M44 %%%% !7SA^SW_ ,D4\+?[D_\ Z425]'U\X?L]_P#)%?"H_P"F$O^Q5U M/_T?%7;?Q&O=PW\)(WCL%%%%=&I84444 %%%% !1110 5YW^T1_R1GQ1]+7_ M -*H*]$KSS]HC_DC/BCZ6O\ Z505-39EP/9/XG_SV%,I_P#$_P#GL*97S,OB M9Z%'D)]S\_/^">O_ M "?W^TM_UVNO_2^OTP'2OS/_ .">O_)_7[2Q_P"FUU_Z7U^F"]*]N/PH\66Y M\R?\%)/^3,?B/_U[1?\ HY*M_P#!/1BO['/PN ((_LX]NO[Q^E5/^"D?_)F' MQ(_Z]HO_ $N-<\0_&'Q]I.EVY DN)=6C/).% 00%F;T !)J[X<^%MIXMT6RU?2OBQX M_N],O8EFM[A-70+(I P1F#(ZCK@^U*X'N>X^E'S>E>/?\*)NER#\3/B)N]/[ M8B_GY%9>F_"^RU;6=4TJT^+GQ FU#2V1;RW75H]T)==R9S!SE<'C-%T![K\W MI1N/I7CS? NXY*_$[XAGT_XF\0].N8./QI/^%&S-G;\3OB,3TQ_:T0[X[P47 M ]BW'TH^;TKYVT?PQX5;:K&D2#[0_ M1?*.,D9/O711WT,JFQ]#[3Z-^5,VGT;\J\@\6?#.[\.^'[O4(OB)X_GEB*!( MWUB(99F"@$^5[Y_"MC_A2TX!+?$KX@ C&<:Q%C)'./W7K79J;_\*9E_Z*5\0/\ P;Q?_&J/^%,R_P#12OB!_P"#>+_XU1J!Z1M/HWY4 M;3Z-^5>;_P#"F9?^BE?$#_P;Q?\ QJC_ (4S+_T4KX@?^#>+_P"-4:@>D;3Z M-^5&T^C?E7F__"F9?^BE?$#_ ,&\7_QJC_A3,O\ T4KX@?\ @WB_^-4:@>D; M3Z-^5&T^C?E7F_\ PIF7_HI7Q _\&\7_ ,:H_P"%,R_]%*^('_@WB_\ C5&H M'IMLI^U0C'.]>/\ @5>9_ 92OA'7588/_"4ZQ@C/_/SZ8_"I+7X+S?:(Q_PL MSX@?,RC/]KQ9'S?]_\)ZRX^('CBT"^)-4AV6^JQJK;;C&X@Q'Y MCU)[FN+$_ >C@?XECZ&VGT?\J-I]'_*O)?$WPMGT'P]?ZDGQ(\?326\19(SK M$05GSA0?W61DU>@^#5Q);P/)\2?B LCHK.BZQ%A25!(SY78FO/Z7/:YI7L>E M[3[_ )4;3[_E7FW_ I>3_HI7Q _\&\7_P :H_X4O)_T4KX@?^#>+_XU1<=Y M'I.T^_Y4;3[_ )5YM_PI>3_HI7Q _P#!O%_\:H_X4O)_T4KX@?\ @WB_^-47 M"\CTK:?0_E2;3V4Y^E>;?\*9D_Z*5\0!_P!Q>+_XU2K\&9<_\E*\?_CJ\7_Q MJF5'FN:4R,O[1GA9R.!X4U,'.>1]I@Z<=N/S%>I8?CY2?TKYKD^$,@^/GANS M_P"%A^.<2>&K^?[2=5C\U"+B$;5;RN%.?\ BYWQ"_\ !S%_\9K-P@CFO<]*Q)_E8D_N'\Z,/_ '=O^TQX%>:_\*1E_P"BG?$/_P ',7_QF@? ^4G!^)WQ M"Q_V&8O_ (U0E "OXH0M^T=X0SPK>%=3QUS_ *^(UVVTY/!SFO!O$7PAF7X] M>%[0_$/QTQF\-ZA,;EM5C,R[9HQM5O*X!SR.^!78_P#"F9MRG_A9?Q P3@_\ M3>+//?\ U5>SA[D[3Z/^5&T^C_E7D.E?"^ZU+6M:M#\1_'R0:?* MD*R+K$99G*AF!'E<8S6K_P *7F_Z*7\0!_W%XO\ XU74-'I.T^C_ )4;3Z/^ M5>;?\*7F_P"BE_$#_P &\7_QJC_A2\W_ $4OX@?^#>+_ .-4#/2=I]'_ "HV MGT?\J\V_X4O-_P!%+^('_@WB_P#C5'_"EYO^BE_$#_P;Q?\ QJ@#TG:?1_RH MVGT?\J\V_P"%+S?]%+^('_@WB_\ C5'_ I>;_HI?Q _\&\7_P :H ])\MCP M%;/TKSG]H?\ Y(QXEX)++:[<#AO]+A'7VQS3#\%YL'_BY?Q _P#!O%_\:K@_ MCO\ ".2P^$WB*X'Q"\<7)06O[JZU2)XV_P!)A W+Y7.,G'O4U-F5 ^I)%82, M I'."3]!3=K>E>:2?!&;S&'_ L[XA>G_(9BZ=?^>--_X4A-_P!%.^(7_@XB M_P#C-?-R4>9GHQF[6]*-K>E>9?\*1F_P"BF_$(_P#<8B_^,T?\*1F_ MZ*;\0A_W&(O_ (S1:(KR/3=K>E&UO2O,O^%(2_\ 13?B%_X.(O\ XS1_PI"7 M_HIOQ"_\'$7_ ,9HM$?-(]-VMZ4;6]*\R_X4A+_T4WXA?^#B+_XS1_PI"7_H MIOQ"_P#!Q%_\9HM$.:1Z;M/H:=;C]\@P?O5YA_PI.?\ Z*;\0?\ P<1?_&:? M#\$Y?.CQ\3OB#U_Z#$7_ ,9IJ,-V2Y2M8^1?^"?;;/V^OVE/DP?/NA@GO_:' MK7Z95^8O_!.>Q-A^W)^T78M>75_]G:XB^TW1)N[N?,?_!2/_DS#XD?]>T7_HY*G_X)]S+!^Q?\,Y681I'IK.SGH 'O[QZHD\0_9L^'-M\:I M]:O-3\2%?#/AKQ_J/B.WTBWL'@N))2W[J=KACEHB"6 1 >/O&JWPW\0?$34O MV5_&/BK1=?\ $6I>+]/U_4+#R;NXF8Q:>]ZI:14DY9T@W,C=>?:OT"^SQ@$! M !UXXH:%&8$J,CH?2FG960/WG=GYP_$S4+CQ%\-(!J>H:U>>#+/XDZ=_PB%_ M//<-6VMA&8799?G+E@V01C%?:8C3GCMC\*&@21-C+E<8H32Z ?!D>K>++ M3X6Q2'5M7NYO#NMM'J,::O>>7XEX5=]G&5IFN-/TEXQ]N>!L9 4\,8R=IZ< 5^@@4+T&.U,, M$9*DHI*\@XZ4^;R _.O7OB!XPMX?AG)J_B'Q%IV@7'B[6;2UO(;JY26[T%87 M^S/./$7[,7@C[+?\ C(^-!X=U#4UU"U:>(-+:W 55 ME4*&EFV?PN=NT9PQK],$C6/(48S2^6N[..?6ITM8#XX^!NN'6/VV?'6H2-,[ M7G@G15,\L+(LDP4,ZEBH&[GD#I7V'#EE!;K3_+7TSSGFE50O % "[11M%+10 M FT5\Y?L\N5^"OA8Y(^2?G./^7B2OHZOG']GDD?!7PJ1_]/R:\WI8]NWO7#)HR:2BD,7)HR:2B M@!LOQ5_P G%>$?^Q5U M3_T?%7;5[>'7[I,Z:>B. ^".LW7BCP;<>(+ZQDTW4-6OYI;FVE7:R2(?+.!V M7*DCV-=_QZG\Z%4+G: ,DL<#N>IHKJU!"Y-&3244#%R:,FDHH 7)HR:2B@ K MSS]HAC_PIGQ1SVM?_2J"O0Z\[_:(_P"2,^*/I:_^E4%34V9<#V5N6?\ SV%, MS3_XG_SV%,KYF7Q'J1^%!FC-%%2,,T9HHH ,T9HHH ,T9HHH ,T^#[T?^]3* M=;_ZQ/\ >IB9^?G_ 3UY_;\_:6/_3:Z_P#2^OTQK\SO^">O_)_?[2W_ %VN MO_2^OTQKVH[(\26Y\Q_\%(_^3,/B1_U[1?\ HY*E_P""?\9F_8M^&T:R/$6T MME$D9PR9=^1GN*B_X*1_\F8?$C_KVB_]')4W_!/V.23]BSX;I#*T,S:6P295 M#%&WO@@'@X]^*;V$>;_LH^-?&_Q.US7K?6_'GC2\N=&\27]I%<_8K3^R;FU@ MEVK"T@A#-(5/8@]_:J_PQ_:/\5KK4>D^(M9U;4Q=?%&Y\,V=Y!#;86!8R4MY ME(4[#@_.HW?+WS7JOPR_97U'X6P:C::7\4/$+:7J.L2:W?V4EG9@7,\K[Y!Y MHCW*C'L"#BLK3_V+=,TW6;74O^$[UYGM/%[>,UC:VMBOVPJ5VY,>1'M) &?? M-*WO)]D*6NQ1\(_MI#_A%==USQ/HYAB2*&0L RHQ#3 ,-I\K M(7C/6L6Z_8X\)W6AS:7'J>I1>7XEE\5:=+-'#.-/NI.9$5'4K(C9.5<'J*[? M6O@K8:SKWA759[QXU\-3+<6=E!;11JD@0*-K(@9%ZDQIA3FJ)5SU.UD,D>6. M3]>#[BK-4=/+F,[U(/TP/PYX^E7J"PHHHH **** "BBB@ KYP_9[_P"2*>%O M]R?_ -*)*^CZ^_\ DBGA;_9H>X%%%%/0 HHHHT M*5>M)2KUH1<=SAY/^3DO"O\ V*6I?^E,%>JUY5)_RYX.)_B!11169@%%%% !1110 4444=P/*_%7_)Q7A/_ +%35/\ T?%7;?Y_ ME7$^*O\ DXKPG_V*FJ?^CXJ[;_/\J][#?PD=$=@HHHK?4H****- "BBBC0 H MHHHT *\[_:(_Y(SXH^EK_P"E4%>B5YW^T1_R1GQ1]+7_ -*H*FILRX'LO\3_ M .>PIE/_ (G_ ,]A3*^9E\1ZD?A"BBBI&%%%% !1110 4444 %.M_P#6)_O4 MVG6_^L3_ 'J8F?GY_P $]?\ D_O]I;_KM=?^E]?IC7YG?\$]?^3^_P!I;_KM M=?\ I?7Z8U[4=D>(]SYC_P""D?\ R9A\2/\ KVB_]')5W_@GB1_PQO\ "X9Y M_LX_^C'JC_P4D8']C#XCX/\ R[1?^CDKY\_8^_X*"_ [X2_LW^!O"?B;Q;-9 M:[I=EY-U;QZ;".E4(_1]NE-*[A7R1_P]0_9N_P"AWNO_ 3W M?_QNC_AZA^S=_P!#O=?^">[_ /C= 'UOM^6G*NVOD;_AZA^S=_T.]U_X)[O_ M .-T?\/4/V;O^AWNO_!/=_\ QN@#ZZHKY%_X>H?LW?\ 0[W7_@GN_P#XW1_P M]0_9N_Z'>Z_\$]W_ /&Z /KJBOD7_AZA^S=_T.]U_P"">[_^-T?\/4/V;O\ MH=[K_P $]W_\;H ^NJ*^1?\ AZA^S=_T.]U_X)[O_P"-T?\ #U#]F[_H=[K_ M ,$]W_\ &Z /KJBOD7_AZA^S=_T.]U_X)[O_ .-T?\/4/V;O^AWNO_!/=_\ MQN@#ZY-?./[//S?!7PMCGY)__2B2N5'_ 50_9OS_P CO^$/ M_!0KX$>$_AGH.D:EXLNK>_M8Y1-$-+N'"EIG8#<$^;AE.1[>AK:E+E=S*I=J MR/L^BOF+_AY3^SQ_T.MW_P""BZ_^(H_X>5?L\?\ 0ZWG_@INO_B*Z_:(PY9' MT[17S%_P\J_9X_Z'6\_\%-U_\11_P\J_9X_Z'6\_\%-U_P#$4^>(?^"FZ_^(H_X>5?L\?]#K>?^"FZ_P#B*.>(?^"FZ_^(H_X>5?L\?]#K>?^"FZ_P#B*.>(?^"FZ_^(H_X>5?L\?]#K>?^"FZ_P#B*.>(70?\ !2S]GA9HF/C6Z"*P)SH]SGK_ +E<+\)_^"@_ MP)\,^'=4M=2\5W-M<3Z]J-]&J:7<-^ZEFW1MD)_=YQZUR8AJ4;([,)^[GS,^ MT**^8O\ AY1^SS_T.MW_ ."BZ_\ B*/^'E'[//\ T.MW_P""BZ_^(KSN5]CV MO;4^Y].T5\Q?\/*/V>?^AUN__!1=?_$4?\/*/V>?^AUN_P#P477_ ,11ROL+ MVM/N?3M%?,7_ \H_9Y_Z'6[_P#!1=?_ !%'_#RC]GG_ *'6[_\ !1=?_$4< MK[![6GW/IVE7K7S#_P /*/V>?^AUN_\ P477_P 12K_P4G_9YY/_ FET?\ MN$7)_P#9*$GV'&M"^Y[+)G_AI+PKQ_S*6I#_ ,F;>O5:^'9O^"AOP&D^,NA: M^OBNX_LNUT&^L9IFTJX!662:)D &W/*HW/;BN[_X>;?LY?\ 0[WA_P"X/=_R MV5C.G+HCQZWO3NCZGHKY9_X>;?LY?]#O>?\ @GNO_B*/^'FW[.7_ $.]Y_X) M[K_XBL?9U.QA9GU-17RS_P /-OV;?LY?]#O>?\ M@GNO_B*/9U.P69]34=.O%?+/_#S;]G+_ *'>\_\ !/=?_$4J_P#!3C]G,$$> M-[P-V_XD]UU_[XIJG/L%F>H^*O\ DXSPE_V*NI_^CXJ[:OCO7/\ @H=\!;KX MSZ#XAA\6W#Z5::#>V4L_]E7(;S))49!MV9Z*:Z@_\%*/V>.WC6[QDG_D$77_ M ,17LT'R4U%F\=M3Z4?L\?\ 0ZW?_@HNO_B*/^'E'[/'_0ZW?_@H MNO\ XBMTT7='T[17S%_P\H_9X_Z'6[_\%%U_\11_P\H_9X_Z'6[_ /!1=?\ MQ%%T%T?3M%?,7_#RC]GC_H=;O_P477_Q%'_#RC]GC_H=;O\ \%%U_P#$4707 M1].T5\Q?\/*/V>/^AUN__!1=?_$4?\/*/V>/^AUN_P#P477_ ,11S(+H^G:\ M[_:(_P"2,^*!WQ:_^E4%>3_\/*OV>1_S.EV?^X3=?_$5QGQD_P""@GP'\7?# M/6]&TOQ;=7%Y=" 1QOI-PJMMN(W;DKD8"GZXXK.I+W=!Q:1]WM]Y_K_04VOE MI_\ @IM^SGYA(\:W8_[@US],?<]NM)_P\V_9R_Z'>\_\$]U_\17A.C.]['H* MM"UKGU-17RS_ ,/-OV\_P#!/=__ !%3 M[*?8KVT.Y]345\L_\/-OV\_\$]W_P#$4?\ #S;]G+_H=[S_ ,$]U_\ M$4>RGV#VT.Y]345\L_\ #S;]G+_H=[S_ ,$]W_\ $4?\/-OVZ_\ B*:HSVL3*K#>YY!_P3VX_;Z_:6SQ^^NC_P"3]?IC M7Y:_\$T_$VF^-/VSOCYXAT6=KO2-4CFO;68Q%"\O\ GQ\1?^#=O_B:/^'0?[/7_/CXB_\ !NW_ ,37VQ10!\3_ M /#H/]GK_GQ\1?\ @W;_ .)H_P"'0?[/7_/CXB_\&[?_ !-?;%% 'Q/_ ,.@ M_P!GK_GQ\1?^#=O_ (FC_AT'^SU_SX^(O_!NW_Q-?;%% 'Q/_P .@_V>O^?' MQ%_X-V_^)H_X=!_L]_\ /CXB_P#!NW_Q-?;%% 'Q-_PZ%_9[_P"?#Q%_X-V_ M^)I?^'0?[/7_ #X^(O\ P;M_\37VQ10!\3_\.@_V>O\ GQ\1?^#=O_B:/^'0 M?[/7_/CXB_\ !NW_ ,37VQ10!\3_ /#H/]GK_GQ\1?\ @W;_ .)H_P"'0?[/ M7_/CXB_\&[?_ !-?;%% 'Q/_ ,.@_P!GK_GQ\1?^#=O_ (FC_AT'^SU_SX^( MO_!NW_Q-?;%% 'Q/_P .@_V>O^?'Q%_X-V_^)H_X=!_L]?\ /CXB_P#!NW_Q M-?;%% 'Q/_PZ#_9[_P"?'Q%_X-V_^)H_X=!_L]_\^/B+_P &[?\ Q-?;%% ' MQ/\ \.@_V>O^?'Q%_P"#=O\ XFC_ (=!_L]?\^/B+_P;M_\ $U]L44 ?$_\ MPZ#_ &>O^?'Q%_X-V_\ B:/^'0?[/7_/CXB_\&[?_$U]L44 ?$__ Z#_9Z_ MY\?$7_@W;_XFC_AT'^SU_P ^/B+_ ,&[?_$U]L44 ?$__#H/]GK_ )\?$7_@ MW;_XFC_AT)^SW_SX^(O_ ;M_P#$U]L44 ?$_P#PZ$_9[_Y\?$7_ (-V_P#B M:/\ AT'^SW_SX^(O_!NW_P 37VQ10!\3_P##H/\ 9Z_Y\?$7_@W;_P")H_X= M!_L]?\^/B+_P;M_\37VQ10!\3_\ #H/]GK_GQ\1?^#=O_B:/^'0?[/7_ #X^ M(O\ P;M_\37VQ10!\3_\.@_V>O\ GQ\1?^#=O_B:/^'0?[/7_/CXB_\ !NW_ M ,37VQ10!\3_ /#H/]GK_GQ\1?\ @W;_ .)H_P"'0?[/7_/CXB_\&[?_ !-? M;%% 'Q/_ ,.@_P!GK_GQ\1?^#=O_ (FC_AT'^SU_SX^(O_!NW_Q-?;%% 'Q/ M_P .@_V>O^?'Q%_X-V_^)H_X=!_L]?\ /CXB_P#!NW_Q-?;%% 'Q/_PZ#_9Z M_P"?'Q%_X-V_^)H_X=!_L]?\^/B+_P &[?\ Q-?;%% 'Q/\ \.@_V>O^?'Q% M_P"#=O\ XFC_ (=!_L]?\^/B+_P;M_\ $U]L44 ?$_\ PZ#_ &>O^?'Q%_X- MV_\ B:/^'0?[/7_/CXB_\&[?_$U]L44 ?$__ Z#_9[_ .?'Q%_X-V_^)H_X M=!_L]_\ /CXB_P#!NW_Q-?;%% 'Q/_PZ#_9Z_P"?'Q%_X-V_^)H_X=!_L]?\ M^/B+_P &[?\ Q-?;%% 'Q/\ \.@_V>O^?'Q%_P"#=O\ XFC_ (=!_L]?\^/B M+_P;M_\ $U]L44 ?$_\ PZ#_ &>O^?'Q%_X-V_\ B:/^'0?[/7_/CXB_\&[? M_$U]L44 ?$__ Z#_9Z_Y\?$7_@W;_XFC_AT'^SU_P ^/B+_ ,&[?_$U]L44 M ?$__#H/]GK_ )\?$7_@W;_XFC_AT'^SU_SX^(O_ ;M_P#$U]L44 ?$_P#P MZ#_9Z_Y\?$7_ (-V_P#B:/\ AT'^SW_SX^(O_!NW_P 37VQ10!\_?L[_ +%7 GPW_9?U_5=7\#6NJ0W6IVJVEP;^^,ZF,,'& 0,'(KZ 7[HI:* /_9 end GRAPHIC 8 form10-k_004.jpg begin 644 form10-k_004.jpg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end GRAPHIC 9 form10-k_005.jpg begin 644 form10-k_005.jpg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

    PJ>7WK_ #.X\6'=X7U@?]._P#(C^'O^P?!_P"BUKS_ %KX MH:EJ>CWMK%X:*O<0O$"^J6^ 64C)YKI_"/BC2])\-Z193:K:B6UM8H9%!S@K M& 0/7D'FDG=W)E%QIZ]S2\6?\C+X/_["$O\ Z32UTZ_>_"O-O&7B^U>\\/WF MFRP:I)8W332VZW"Q,5:%T!!;CJPI?^%O7"\_\(__ .5.W_QJS(]+HKS5?B_< M-_S ,?\ <3@_QI?^%O7'_0 _\J4'^- 'I-4KUMJE@#N4;AMZG / XZUP?_"W MKC_H ?\ E2@_QJ.3XM2R?>\/*_UU*W_QH \0\)-?>![K2-;@TBQ\86UT]ZVE MZY9B:WU7*P2RV M N9@DK1+%P(@.%\SY@<<=:]G'Q599-X\.*'QC=_:=OG^=._X6PXR1X<4$\'& MI6X_K0!X?XLU;Q%I_BSQ'J$?B6X\2-I^E6NGB%K#-M-(-29&)0C!E"@*S+QG MD<58\6?%SQWH?A!M;LM58WVK6=_,^GO8JZZ));RJD84=3G)4ANIYKV?_ (6M M)_T+BX]/[2@Q_.D;XJ%LD^&TZY_Y"5N/ZT 0?"G5M7D\2^,=!U?4IM871[FW M^RW]Q"$DD2>+S"A*@*VU@<$= <&O6*\P_P"%M2+_ ,RZH_[B5O\ XU>T_P") MFIZI.8+3PRUQ.%W;$U* \?G0!Z#17'_\)1XI_P"A*G_\&5O_ (T?\)1XI_Z$ MJ?\ \&5O_C0!V%?"\7_ %_VG_HY*/\ A*/%/_0E3_\ @RM_\:Q?%%SX MI\36-M8?\(H]BANX)9+F34(&6-4D5B2 :_D*/)C_YYK^0J6B@"+R8_^>:_D*/) MC_YYK^0J6B@"+R8_^>:_D*/)C_YYK^0J6B@"+R8_^>:_D*/)C_YYK^0J6B@" M+R8_^>:_D*/)C_YYK^0J6B@"+R8_^>:_D*3R8^GEK_WR*FHI-7 JFQMF;)MX MB?78*3[#;?\ /M#_ -\#_"K=%0X1;O8=V5/L-M_S[0_]\#_"C[#;?\^T/_? M_P *LT4N2/9!=E;[#;?\^T/_ 'P/\*/L-M_S[0_]\#_"K-%')'L@NRM]AMO^ M?:'_ +X'^%'V&V_Y]H?^^!_A5FBCDCV0796^PVW_ #[0_P#? _PH^PVW_/M# M_P!\#_"K-%')'L@NRK]A@_Y]X_\ O@?X4GV&W_Y]X_\ O@?X5;X]:./6GR1" M[[E?[#;=/L\)_P"V8IO]GVIY^S0Y]?+'^%6S0*=GMT$5/[/M?^?>+_O@4?V? M:_\ /O%_WP*MYHS2Y%V J?V?:_\ /O%_WP*/[/M?^?>+_O@5;S1FCD78"I_9 M]K_S[Q?]\"C^S[7_ )]XO^^!5O-&:.1=@*G]GVO_ #[Q?]\"C^S[7_GWB_[X M%6\T9HY%V J?V?:_\^\7_? H_L^U_P"?>+_O@5;S1FCD78"I_9]K_P ^\7_? M I?L-K_S[P_]^Q5NDVBFHI; 51I]JO2WA'TC%-_LRTY_T6'GK^[%7::5JDK" ML5?[-M%Y%K"/^V8I?[.M?^?>'_OV*L\4?+Z4]1\J[%;^SK7_ )]X?^_8I/[/ MM?\ GWA_[]BK7R^E'R^E&H'_ +]BC^SK7_GWA_[]BK/R^E'R^E&H'_O MV*/L%K_S[P_]\"K-% %;[!:_\^\/_? H_L^V_P"?>'_OV*LT4 5O[/M?^?:' M_OV/\*/[/M?^?:'_ +]C_"K-% %;^S[7_GVA_P"_8_PH_L^U_P"?:'_OV/\ M"K-% %;^S[7_ )]H?^_8_P *6.S@A;?'#'&_3 GRAPHIC 10 report_001.jpg begin 644 report_001.jpg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report_002.jpg begin 644 report_002.jpg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end EX-101.SCH 12 npls-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - PREPAID EXPENSES link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - DEFERRED INCOME – CONTRACT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - LONG-TERM LOAN – RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - CONCENTRATION OF RISK link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - INCOME TAX link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - PREPAID EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - DEFERRED INCOME – CONTRACT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - CONCENTRATION OF RISK (Tables) link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - NATURE OF OPERATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES (Details) link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED (Details) link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - SCHEDULE OF PREPAID EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - PREPAID EXPENSES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - DEFERRED INCOME – CONTRACT LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - LONG-TERM LOAN – RELATED PARTY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - SCHEDULE OF CONCENTRATION RISK (Details) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - INCOME TAX (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 13 npls-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 14 npls-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 15 npls-20231231_lab.xml XBRL LABEL FILE Related Party, Type [Axis] Related Party [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Ownership [Axis] NP Life Sciences Health (Singapore) Pte. Ltd. [Member] Individual Holder [Member] GW Health Consulting Management Inc [Member] NLPL Health Industry Group Co., Limited [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Product and Service [Axis] Traditional Culture And Education [Member] Career Planning Experience Sharing And Guidance [Member] Customer [Axis] Two Customer [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Loan Agreement [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Four Customers [Member] Customer A [Member] Customer B [Member] Customer C [Member] Customer D [Member] Product Concentration Risk [Member] Customer E [Member] Customer F [Member] Customer G [Member] Customer H [Member] Customers [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Document Financial Statement Error Correction [Flag] Auditor Name Auditor Firm ID Auditor Location Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets Cash and cash equivalents Prepaid expenses Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payables Other payables Accrued liabilities Deferred income - contract liabilities Total current liabilities Non-current liabilities Long-term loan- related party Total non-current liabilities Total liabilities Commitments and Contingencies Stockholders’ Equity Preferred stock, $0.0001 par value, 30,000,000 shares authorized, no shares issued and outstanding as of December 31, 2023, and 2022 Common stock, $0.0001 par value, 320,000,000 shares authorized, 42,959,574 shares issued and outstanding as of December 31, 2023, and 2022 Additional paid in capital Accumulated deficit Non-controlling interest Total stockholders’ equity Total liabilities and stockholders’ equity Statement of Financial Position [Abstract] Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares, outstanding Income Statement [Abstract] Revenue General and administrative expenses Loss from operations Interest expense Loss before income taxes Income taxes Net loss Less: net loss attributable to the non-controlling interest Net loss attributed to the Company Total comprehensive loss Basic loss per common share Diluted loss per common share Weighted average number of common shares- Basic Weighted average number of common shares- Diluted Statement [Table] Statement [Line Items] Balance Balance shares Net loss Balance Balance shares Statement of Cash Flows [Abstract] Cash flows from operating activities: (Increase)/Decrease in Prepaid expenses Increase/(Decrease) in Other payable Increase/(Decrease) in Accounts payable Increase/(Decrease) in Accrued liabilities Increase/(Decrease) in Deferred income – contract liabilities Net cash provided by (used in) operating activities Cash flows from financing activities Long-term loan from related parties Net cash provided by financing activities Net change in cash and cash equivalents Cash and cash equivalents – Beginning of period Cash and cash equivalents – End of period Interest paid Income tax paid Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Prepaid Expenses PREPAID EXPENSES Revenue from Contract with Customer [Abstract] DEFERRED INCOME – CONTRACT LIABILITIES Debt Disclosure [Abstract] LONG-TERM LOAN – RELATED PARTY Risks and Uncertainties [Abstract] CONCENTRATION OF RISK Income Tax Disclosure [Abstract] INCOME TAX Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Basis of Consolidation Going Concern Use of Estimates and Assumptions Cash and Cash Equivalents Fair Value of Financial Instruments Revenue Recognition General and Administrative Expenses Basic and Diluted Net Loss Per Share Comprehensive income (loss) Recently Issued Accounting Pronouncements SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED SCHEDULE OF PREPAID EXPENSES SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES SCHEDULE OF CONCENTRATION RISK Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Ownership percentage Ownership percentage Schedule of Product Information [Table] Product Information [Line Items] Total Net loss used in computing earnings per share Basic loss per share Diluted loss per share Accumulated deficit Net loss Cash insured account Dilutive securities, shares Schedule Of Prepaid Expenses Prepayment to OTCQB annual fee (unamortized portion) Total Balance Addition Recognize Balance Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Deferred income contract liabilities received long term loan Related party transaction, description Loan annual interest rate Accrued interest Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk, percentage Revenue Subsequent Event [Table] Subsequent Event [Line Items] Annual interest rate percentage NP Life Sciences Health (Singapore) Pte. Ltd. [Member] Individual Holder [Member] GW Health Consulting Management Inc [Member] NLPL Health Industry Group Co., Limited [Member] Going Concern [Policy Text Block] The entire disclosure for prepaid expenses. Amount of asset related to consideration paid in advance for Prepayment to annual fee unamortized portion that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Customer A [Member] Customer B [Member] Customer C [Member] Customer D [Member] Customer E [Member] Customer F [Member] Customer G [Member] Customer H [Member] Loan Agreement [Member] Traditional Culture And Education [Member] Career Planning Experience Sharing And Guidance [Member] Two Customer [Member] Customers [Member] Four Customers [Member] Assets Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Income (Loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Prepaid Expense Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Subsidiary, Ownership Percentage, Noncontrolling Owner Deferred Income Deferred Income, Revenue Recognized Revenue from Contract with Customer, Including Assessed Tax EX-101.PRE 16 npls-20231231_pre.xml XBRL PRESENTATION FILE XML 18 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Cover - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Apr. 15, 2024
    Jun. 30, 2023
    Cover [Abstract]      
    Document Type 10-K    
    Amendment Flag false    
    Document Annual Report true    
    Document Transition Report false    
    Document Period End Date Dec. 31, 2023    
    Document Fiscal Period Focus FY    
    Document Fiscal Year Focus 2023    
    Current Fiscal Year End Date --12-31    
    Entity File Number 000-56140    
    Entity Registrant Name NP Life Sciences Health Industry Group Inc.    
    Entity Central Index Key 0001781726    
    Entity Tax Identification Number 83-2912878    
    Entity Incorporation, State or Country Code NV    
    Entity Address, Address Line One 4125 Blackhawk Plaza Circle    
    Entity Address, Address Line Two Suite 166    
    Entity Address, City or Town Danville    
    Entity Address, State or Province CA    
    Entity Address, Postal Zip Code 94506    
    City Area Code (925)    
    Local Phone Number 362-3169    
    Title of 12(b) Security Common Stock, $0.0001 par value    
    Trading Symbol NPLS    
    Entity Well-known Seasoned Issuer No    
    Entity Voluntary Filers No    
    Entity Current Reporting Status Yes    
    Entity Interactive Data Current Yes    
    Entity Filer Category Non-accelerated Filer    
    Entity Small Business true    
    Entity Emerging Growth Company true    
    Elected Not To Use the Extended Transition Period true    
    Entity Shell Company false    
    Entity Public Float     $ 0
    Entity Common Stock, Shares Outstanding   42,959,574  
    Document Financial Statement Error Correction [Flag] false    
    Auditor Name WWC, P.C.    
    Auditor Firm ID 1171    
    Auditor Location San Mateo, CA    

    XML 19 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Consolidated Balance Sheets - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Current assets    
    Cash and cash equivalents $ 70,614 $ 121,859
    Prepaid expenses 6,250 5,925
    Total assets 76,864 127,784
    Current liabilities    
    Accounts payables 6,130 6,130
    Other payables 6,894 239
    Accrued liabilities 25,097 2,500
    Deferred income - contract liabilities 99,599
    Total current liabilities 38,121 108,468
    Non-current liabilities    
    Total non-current liabilities 22,362
    Total liabilities 60,483 108,468
    Commitments and Contingencies
    Stockholders’ Equity    
    Preferred stock, $0.0001 par value, 30,000,000 shares authorized, no shares issued and outstanding as of December 31, 2023, and 2022
    Common stock, $0.0001 par value, 320,000,000 shares authorized, 42,959,574 shares issued and outstanding as of December 31, 2023, and 2022 4,296 4,296
    Additional paid in capital 360,330 360,330
    Accumulated deficit (348,245) (345,310)
    Non-controlling interest
    Total stockholders’ equity 16,381 19,316
    Total liabilities and stockholders’ equity 76,864 127,784
    Related Party [Member]    
    Non-current liabilities    
    Long-term loan- related party $ 22,362
    XML 20 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Consolidated Balance Sheets (Parenthetical) - $ / shares
    Dec. 31, 2023
    Dec. 31, 2022
    Statement of Financial Position [Abstract]    
    Preferred stock, par value $ 0.0001 $ 0.0001
    Preferred stock, shares authorized 30,000,000 30,000,000
    Preferred stock, shares issued 0 0
    Preferred stock, shares outstanding 0 0
    Common stock, par value $ 0.0001 $ 0.0001
    Common stock, shares authorized 320,000,000 320,000,000
    Common stock, shares issued 42,959,574 42,959,574
    Common stock, shares, outstanding 42,959,574 42,959,574
    XML 21 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Consolidated Statements of Operations and Comprehensive Loss - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Income Statement [Abstract]    
    Revenue $ 164,621 $ 102,002
    General and administrative expenses 165,311 120,857
    Loss from operations (690) (18,855)
    Interest expense 645 1
    Loss before income taxes (1,335) (18,856)
    Income taxes 1,600
    Net loss (2,935) (18,856)
    Less: net loss attributable to the non-controlling interest
    Net loss attributed to the Company (2,935) (18,856)
    Total comprehensive loss $ (2,935) $ (18,856)
    Basic loss per common share $ (0) $ (0)
    Diluted loss per common share $ (0) $ (0)
    Weighted average number of common shares- Basic 42,959,574 42,959,574
    Weighted average number of common shares- Diluted 42,959,574 42,959,574
    XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Consolidated Statements of Stockholders' Equity - USD ($)
    Preferred Stock [Member]
    Common Stock [Member]
    Additional Paid-in Capital [Member]
    Retained Earnings [Member]
    Total
    Balance at Dec. 31, 2021 $ 4,296 $ 360,330 $ (326,454) $ 38,172
    Balance shares at Dec. 31, 2021 42,959,574      
    Net loss (18,856) (18,856)
    Balance at Dec. 31, 2022 $ 4,296 360,330 (345,310) 19,316
    Balance shares at Dec. 31, 2022 42,959,574      
    Net loss (2,935) (2,935)
    Balance at Dec. 31, 2023 $ 4,296 $ 360,330 $ (348,245) $ 16,381
    Balance shares at Dec. 31, 2023 42,959,574      
    XML 23 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Consolidated Statements of Cash Flows - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Cash flows from operating activities:    
    Net loss $ (2,935) $ (18,856)
    (Increase)/Decrease in Prepaid expenses (325) 4,500
    Increase/(Decrease) in Other payable 6,655
    Increase/(Decrease) in Accounts payable 6,130
    Increase/(Decrease) in Accrued liabilities 22,597 2,500
    Increase/(Decrease) in Deferred income – contract liabilities (99,599) 99,599
    Net cash provided by (used in) operating activities (73,607) 93,873
    Cash flows from financing activities    
    Long-term loan from related parties 22,362
    Net cash provided by financing activities 22,362
    Net change in cash and cash equivalents (51,245) 93,873
    Cash and cash equivalents – Beginning of period 121,859 27,986
    Cash and cash equivalents – End of period 70,614 121,859
    Interest paid 1
    Income tax paid $ 1,600
    XML 24 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Pay vs Performance Disclosure - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Pay vs Performance Disclosure [Table]    
    Net Income (Loss) Attributable to Parent $ (2,935) $ (18,856)
    XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Insider Trading Arrangements
    3 Months Ended
    Dec. 31, 2023
    Insider Trading Arrangements [Line Items]  
    Rule 10b5-1 Arrangement Adopted false
    Non-Rule 10b5-1 Arrangement Adopted false
    Rule 10b5-1 Arrangement Terminated false
    Non-Rule 10b5-1 Arrangement Terminated false
    XML 26 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    NATURE OF OPERATIONS
    12 Months Ended
    Dec. 31, 2023
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    NATURE OF OPERATIONS

    1. NATURE OF OPERATIONS

     

    NP Life Sciences Health Industry Group Inc. (the “Company”) is a for profit corporation established under the corporation laws in the State of Nevada, United States on December 20, 2018. The Company was originally incorporated as “Guojiang Cultural Industry US, Inc.” and amended the name to “GJ Culture Group US, Inc.” on February 20, 2019. On September 8, 2022, the Company filed a Certificate of Amendment to its Articles of Incorporation with the State of Nevada to reflect its corporate name change from “GJ Culture Group US, Inc.” to “NP Life Sciences Health Industry Group Inc.”. Unless the context otherwise requires, all references to “NP Life Sciences Health Industry Group Inc.,” “GJ Culture Group US, Inc.,” “we,” “us,” “our” or the “Company” are to NP Life Sciences Health Industry Group Inc.

     

    The Company is dedicated to providing educational services based on classical Chinese studies and culture. The Company’s goal is to serve as cultural and educational meeting point between China and the U.S. The Company intends to pursue its business objective by providing education and training courses based on classical Chinese studies, organizing China-U.S. international study tour activities for participants of all ages, as well as organizing and promoting China-U.S. cultural events, art fairs, exhibitions, and other activities promoting Chinese culture.

     

    On November 8, 2022, the Company established a wholly owned subsidiary, GW Health Consulting Management Inc. (herein after referred to as “GW”), a California Corporation. GW’s current business is limited to providing online career planning experience sharing and guidance related consulting services.

     

    On March 8, 2023, GW established a wholly owned subsidiary, NLPL Health Industry Group Co., Limited, a Hong Kong based company, which had no business transactions in the reporting period.

     

    On August 16, 2023, the Company established a subsidiary named NP Life Sciences Health (Singapore) Pte. Ltd., a Singapore based company in which the Company holds 90% of the shares and an individual holds 10% of the shares; there was no business transaction in the reporting period by this subsidiary.

     

    XML 27 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
    12 Months Ended
    Dec. 31, 2023
    Accounting Policies [Abstract]  
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

    2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     

    Basis of Presentation

     

    The Consolidated Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“GAAP”) and presented in US dollars.

     

    Basis of Consolidation

     

    The Consolidated Financial Statements includes the accounts of the Company and its current owned subsidiary, GW Health Consulting Management Inc (100%), NLPL Health Industry Group Co., Limited (100%), and NP Life Sciences Health (Singapore) Pte. Ltd. (90% of the shares). All significant intercompany transactions and accounts have been eliminated in consolidation.

     

    Going Concern

     

    The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern. As of December 31, 2023, there was an accumulated deficit of $348,245 and the net loss of 2023 was $2,935. The circumstances give rise to substantial doubt to the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued, and in order to remain solvent that the Company is dependent upon its ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock.

     

     

    Management plans to fund operations of the Company through the proceeds from an offering pursuant to a Registration Statement on Form S-1, private placements of restricted securities, or the issuance of stock in lieu of cash for payment of services until such a time as profitable operations are achieved. If the Company do not raise all of the money it needs from public offerings or private placements of equity, the Company will need alternative sources, such as loans or advances from our officers, directors or others. Such additional financing may not become available on acceptable terms and there can be no assurance that any additional financing that the Company does obtain will be sufficient to meet its needs in the long term. There are no written agreements in place for such funding or issuance of securities and there can be no assurance that such will be available in the future. The failure to achieve the necessary levels of profitability or obtain the additional funding would be detrimental to the Company.

     

    These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides an opportunity for the Company to continue as a going concern.

     

    Use of Estimates and Assumptions

     

    The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

     

    Due to the limited level of operations, the Company has not needed to make material assumptions or estimates other than the assumption that the Company is a going concern.

     

    Cash and Cash Equivalents

     

    The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has two bank accounts in Bank of America. The balance of each bank account is less than $250,000; thus, the amount is insured by Federal Deposit Insurance Corporation.

     

    Fair Value of Financial Instruments

     

    ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management at the time of this report. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

     

    Level 1—Quoted prices in active markets for identical assets or liabilities.

     

    Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.

     

    Level 3—Unobservable inputs based on the Company’s assumptions.

     

    The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts and other payable, accrued liabilities, and related party payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value.

     

    Revenue Recognition

     

    The Company will recognize revenue in accordance with Accounting Standards Codification No. 606, “Revenue from Contracts with Customers” (“ASC-606”). ASC-606 requires that the criteria must be met before revenue can be recognized:

     

      executed contract(s) with customers that the Company believes is legally enforceable;
      identification of performance obligation in the respective contract;

     

     

      determination of the transaction price for each performance obligation in the respective contract;
      allocation of the transaction price to each performance obligation;
      recognition of revenue only when the Company satisfies each performance obligation.

     

    The Company provides consulting services to clients through our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. The Company enters into a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year, and all of the Company’s contracts are short-term. The Company typically satisfies its performance obligations in contracts with customers upon completion of service rendered. Generally, payment is advance payment from customers. The Company recognizes the revenue at a single point in time after every service rendered and the transaction price is stated in the contract. Historically, there was no sales returns.

     

    When above criteria were met, the Company will recognize revenue accordingly.

     

    Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.

     

       2023   2022 
      

    For the years ended

    December 31,
     
       2023   2022 
             
    Consulting service relating to China traditional culture and education  $65,022   $102,002 
    Consulting service on career planning experience sharing and guidance   99,599    - 
               
    Total  $164,621   $102,002 

     

    General and Administrative Expenses

     

    The general and administrative expense mainly consists of service fees occurred by the law firm, auditor, and accountant, etc.

     

    Basic and Diluted Net Loss Per Share

     

    Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

     

    Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. There were no adjustments to net loss required for purposes of computing diluted earnings per share.

     

     

       2023   2022 
      

    For the years ended

    December 31,

     
       2023   2022 
    Loss per share:          
    Numerator:          
    Net loss used in computing earnings per share  $(2,935)  $(18,856)
               
    Denominator:          
    Weighted average common shares outstanding   42,959,574    42,959,574 
               
    Basic and diluted loss per share  $(0.00)  $(0.00)

     

    The Company has no potentially dilutive securities, such as options or warrants, currently issued and outstanding.

     

    Comprehensive income (loss)

     

    The Company follows the provisions of the Financial Accounting Standards Board (the “FASB”) ASC 220 Reporting Comprehensive Income and establishes standards for the reporting and display of comprehensive income, its components and accumulated balances in a full set of general purpose financial statements. The Company’s comprehensive loss consists of net loss.

     

    Recently Issued Accounting Pronouncements

     

    In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses”, which will require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Further, the FASB issued ASU No. 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-02 to provide additional guidance on the credit losses standard. The amendments for ASU 2016-13 are effective for fiscal years beginning after December 15, 2022. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is in the process of evaluating the effect of the adoption of this ASU.

     

    In February 2018, the FASB issued Accounting Standards Update No. 2018-02 Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (ASU 2018-02). The standard provides financial statement preparers with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income (AOCI) to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (or portion thereof) is recorded. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. We adopted this ASU in the 2019 and it did not have a material impact on our consolidated financial statements.

     

    In December 2018, the FASB issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (ASU 2018-05). The ASU adds various Securities and Exchange Commission (“SEC”) paragraphs pursuant to the issuance of the December 2017 SEC Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which was effective immediately. The SEC issued SAB 118 to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Cuts and Jobs Act in the period of enactment. SAB 118 allows disclosure that timely determination of some or all of the income tax effects from the Tax Cuts and Jobs Act are incomplete by the due date of the financial statements and if possible, to provide a reasonable estimate. We adopted this ASU in the 2018 and it did not have a material impact on our consolidated financial statements.

     

    In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.

     

    As of December 31, 2023, except for the above, there are no recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.

     

     

    XML 28 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    PREPAID EXPENSES
    12 Months Ended
    Dec. 31, 2023
    Prepaid Expenses  
    PREPAID EXPENSES

    3. PREPAID EXPENSES

     

    As of December 31, 2023 and 2022, prepaid expenses amounted to $6,250 and $5,925, respectively. Prepaid expenses consists of the following:

     

       December 31,   December 31, 
       2023   2022 
       (Audited)   (Audited) 
             
    Prepayment to OTCQB annual fee (unamortized portion)  $6,250   $5,925 
               
    Total  $6,250   $5,925 

     

    XML 29 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    DEFERRED INCOME – CONTRACT LIABILITIES
    12 Months Ended
    Dec. 31, 2023
    Revenue from Contract with Customer [Abstract]  
    DEFERRED INCOME – CONTRACT LIABILITIES

    4. DEFERRED INCOME – CONTRACT LIABILITIES

     

    In 2022, GW received $99,599 from two customers and recorded such amounts as deferred income - contract liabilities. GW delivered the career planning, experience sharing and guidance services during the year of 2023 and recorded the revenue accordingly.

     

    The movement is as follows:

       Deferred income 
       (Audited) 
    Balance – January 1, 2022  $- 
    Addition   99,599 
    Recognize   - 
    Balance – December 31, 2022  $99,599 
    Addition   - 
    Recognize   (99,599)
    Balance – December 31, 2023  $- 

     

    XML 30 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    LONG-TERM LOAN – RELATED PARTY
    12 Months Ended
    Dec. 31, 2023
    Debt Disclosure [Abstract]  
    LONG-TERM LOAN – RELATED PARTY

    5. LONG-TERM LOAN – RELATED PARTY

     

    As of December 31, 2023, the Company had a long-term loan of $22,362 from one of the shareholders. According to the original loan agreement signed on April 8, 2023, the Company is required to repay the loan before April 7, 2024; after the agreement renewal, the repayment date was extended to April 11, 2025. The renewed loan agreement has a term of 12 months with an annual interest rate of 4% with no collateral is required. Additionally, the loan agreement will be automatically extended to additional one year if the repayment is not completed before due date.

     

    As of December 31, 2023, the accrued interest amount to $645.

     

    XML 31 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    CONCENTRATION OF RISK
    12 Months Ended
    Dec. 31, 2023
    Risks and Uncertainties [Abstract]  
    CONCENTRATION OF RISK

    6. CONCENTRATION OF RISK

     

    There is a concentration of risk associated with the Company’s services revenue. In 2023, revenue from four customers constituted 88% of the total revenue. In 2022, all revenue came from four customers, comprising 100% of the total. It’s important to note that these customer compositions are not identical.

     

     

      

    For the years ended

    December 31,

     
       2023   2022 
                     
    Customer A   52,059    32%          
    Customer B   47,540    29%          
    Customer C   30,000    18%          
    Customer D   15,000    9%          
    Customer E             41,000    40%
    Customer F             26,020    25%
    Customer G             20,000    20%
    Customer H             14,982    15%
    Subtotal  $

    144,599

        88%   102,002    100%

     

    XML 32 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    INCOME TAX
    12 Months Ended
    Dec. 31, 2023
    Income Tax Disclosure [Abstract]  
    INCOME TAX

    7. INCOME TAX

     

    The Company was established in the State of Nevada in United States and is subject to Nevada State and US Federal tax laws. The Company has not recognized an income tax benefit for its operating losses based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the periods presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses and other temporary differences, the realization of which could not be considered more likely than not. Further, the benefit from utilization of NOL (“net operating loss”) carry forwards could be subject to limitations due to material ownership changes that could occur in the Company as it continues to raise additional capital. Based on such limitations, the Company has significant NOLs for which realization of tax benefits is uncertain. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not.

     

     

    As of December 31, 2023, and 2022, the Company has accumulated deficit of $348,245 and $345,310. In 2023, the Company incurred a net loss of $2,935, as the management is not yet able to reliably estimate when the Company will generate profits that would enable the Company to make use of such potential future tax benefits. Consequently, a valuation allowance has been set up for the entire amount of the net deferred tax asset. Management continually assesses its future earnings potential and related tax impacts. If circumstances change in the future that will enable Management to accurately forecast future profits, the Company may carryover of such tax assets.

     

    XML 33 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SUBSEQUENT EVENTS
    12 Months Ended
    Dec. 31, 2023
    Subsequent Events [Abstract]  
    SUBSEQUENT EVENTS

    8. SUBSEQUENT EVENTS

     

    On April 5, 2024, the Company and one of the shareholders renewed the loan agreement and extended the repayment date to April 11, 2025, subject to an automatic extension for an additional one year. The annual interest rate is 4% with no collateral.

     

    The Company has evaluated subsequent events that have occurred after the date of the balance sheet through April 14, 2024 and determined that no subsequent events require recognition or disclosure to the financial statements other than the above matter.

    XML 34 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
    12 Months Ended
    Dec. 31, 2023
    Accounting Policies [Abstract]  
    Basis of Presentation

    Basis of Presentation

     

    The Consolidated Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“GAAP”) and presented in US dollars.

     

    Basis of Consolidation

    Basis of Consolidation

     

    The Consolidated Financial Statements includes the accounts of the Company and its current owned subsidiary, GW Health Consulting Management Inc (100%), NLPL Health Industry Group Co., Limited (100%), and NP Life Sciences Health (Singapore) Pte. Ltd. (90% of the shares). All significant intercompany transactions and accounts have been eliminated in consolidation.

     

    Going Concern

    Going Concern

     

    The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern. As of December 31, 2023, there was an accumulated deficit of $348,245 and the net loss of 2023 was $2,935. The circumstances give rise to substantial doubt to the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued, and in order to remain solvent that the Company is dependent upon its ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock.

     

     

    Management plans to fund operations of the Company through the proceeds from an offering pursuant to a Registration Statement on Form S-1, private placements of restricted securities, or the issuance of stock in lieu of cash for payment of services until such a time as profitable operations are achieved. If the Company do not raise all of the money it needs from public offerings or private placements of equity, the Company will need alternative sources, such as loans or advances from our officers, directors or others. Such additional financing may not become available on acceptable terms and there can be no assurance that any additional financing that the Company does obtain will be sufficient to meet its needs in the long term. There are no written agreements in place for such funding or issuance of securities and there can be no assurance that such will be available in the future. The failure to achieve the necessary levels of profitability or obtain the additional funding would be detrimental to the Company.

     

    These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides an opportunity for the Company to continue as a going concern.

     

    Use of Estimates and Assumptions

    Use of Estimates and Assumptions

     

    The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

     

    Due to the limited level of operations, the Company has not needed to make material assumptions or estimates other than the assumption that the Company is a going concern.

     

    Cash and Cash Equivalents

    Cash and Cash Equivalents

     

    The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has two bank accounts in Bank of America. The balance of each bank account is less than $250,000; thus, the amount is insured by Federal Deposit Insurance Corporation.

     

    Fair Value of Financial Instruments

    Fair Value of Financial Instruments

     

    ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management at the time of this report. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

     

    Level 1—Quoted prices in active markets for identical assets or liabilities.

     

    Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.

     

    Level 3—Unobservable inputs based on the Company’s assumptions.

     

    The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts and other payable, accrued liabilities, and related party payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value.

     

    Revenue Recognition

    Revenue Recognition

     

    The Company will recognize revenue in accordance with Accounting Standards Codification No. 606, “Revenue from Contracts with Customers” (“ASC-606”). ASC-606 requires that the criteria must be met before revenue can be recognized:

     

      executed contract(s) with customers that the Company believes is legally enforceable;
      identification of performance obligation in the respective contract;

     

     

      determination of the transaction price for each performance obligation in the respective contract;
      allocation of the transaction price to each performance obligation;
      recognition of revenue only when the Company satisfies each performance obligation.

     

    The Company provides consulting services to clients through our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. The Company enters into a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year, and all of the Company’s contracts are short-term. The Company typically satisfies its performance obligations in contracts with customers upon completion of service rendered. Generally, payment is advance payment from customers. The Company recognizes the revenue at a single point in time after every service rendered and the transaction price is stated in the contract. Historically, there was no sales returns.

     

    When above criteria were met, the Company will recognize revenue accordingly.

     

    Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.

     

       2023   2022 
      

    For the years ended

    December 31,
     
       2023   2022 
             
    Consulting service relating to China traditional culture and education  $65,022   $102,002 
    Consulting service on career planning experience sharing and guidance   99,599    - 
               
    Total  $164,621   $102,002 

     

    General and Administrative Expenses

    General and Administrative Expenses

     

    The general and administrative expense mainly consists of service fees occurred by the law firm, auditor, and accountant, etc.

     

    Basic and Diluted Net Loss Per Share

    Basic and Diluted Net Loss Per Share

     

    Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

     

    Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. There were no adjustments to net loss required for purposes of computing diluted earnings per share.

     

     

       2023   2022 
      

    For the years ended

    December 31,

     
       2023   2022 
    Loss per share:          
    Numerator:          
    Net loss used in computing earnings per share  $(2,935)  $(18,856)
               
    Denominator:          
    Weighted average common shares outstanding   42,959,574    42,959,574 
               
    Basic and diluted loss per share  $(0.00)  $(0.00)

     

    The Company has no potentially dilutive securities, such as options or warrants, currently issued and outstanding.

     

    Comprehensive income (loss)

    Comprehensive income (loss)

     

    The Company follows the provisions of the Financial Accounting Standards Board (the “FASB”) ASC 220 Reporting Comprehensive Income and establishes standards for the reporting and display of comprehensive income, its components and accumulated balances in a full set of general purpose financial statements. The Company’s comprehensive loss consists of net loss.

     

    Recently Issued Accounting Pronouncements

    Recently Issued Accounting Pronouncements

     

    In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses”, which will require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Further, the FASB issued ASU No. 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-02 to provide additional guidance on the credit losses standard. The amendments for ASU 2016-13 are effective for fiscal years beginning after December 15, 2022. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is in the process of evaluating the effect of the adoption of this ASU.

     

    In February 2018, the FASB issued Accounting Standards Update No. 2018-02 Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (ASU 2018-02). The standard provides financial statement preparers with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income (AOCI) to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (or portion thereof) is recorded. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. We adopted this ASU in the 2019 and it did not have a material impact on our consolidated financial statements.

     

    In December 2018, the FASB issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 (ASU 2018-05). The ASU adds various Securities and Exchange Commission (“SEC”) paragraphs pursuant to the issuance of the December 2017 SEC Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which was effective immediately. The SEC issued SAB 118 to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Cuts and Jobs Act in the period of enactment. SAB 118 allows disclosure that timely determination of some or all of the income tax effects from the Tax Cuts and Jobs Act are incomplete by the due date of the financial statements and if possible, to provide a reasonable estimate. We adopted this ASU in the 2018 and it did not have a material impact on our consolidated financial statements.

     

    In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.

     

    As of December 31, 2023, except for the above, there are no recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.

    XML 35 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
    12 Months Ended
    Dec. 31, 2023
    Accounting Policies [Abstract]  
    SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES

    Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.

     

       2023   2022 
      

    For the years ended

    December 31,
     
       2023   2022 
             
    Consulting service relating to China traditional culture and education  $65,022   $102,002 
    Consulting service on career planning experience sharing and guidance   99,599    - 
               
    Total  $164,621   $102,002 
    SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED

       2023   2022 
      

    For the years ended

    December 31,

     
       2023   2022 
    Loss per share:          
    Numerator:          
    Net loss used in computing earnings per share  $(2,935)  $(18,856)
               
    Denominator:          
    Weighted average common shares outstanding   42,959,574    42,959,574 
               
    Basic and diluted loss per share  $(0.00)  $(0.00)
    XML 36 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    PREPAID EXPENSES (Tables)
    12 Months Ended
    Dec. 31, 2023
    Prepaid Expenses  
    SCHEDULE OF PREPAID EXPENSES

     

       December 31,   December 31, 
       2023   2022 
       (Audited)   (Audited) 
             
    Prepayment to OTCQB annual fee (unamortized portion)  $6,250   $5,925 
               
    Total  $6,250   $5,925 
    XML 37 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    DEFERRED INCOME – CONTRACT LIABILITIES (Tables)
    12 Months Ended
    Dec. 31, 2023
    Revenue from Contract with Customer [Abstract]  
    SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES

    The movement is as follows:

       Deferred income 
       (Audited) 
    Balance – January 1, 2022  $- 
    Addition   99,599 
    Recognize   - 
    Balance – December 31, 2022  $99,599 
    Addition   - 
    Recognize   (99,599)
    Balance – December 31, 2023  $- 
    XML 38 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    CONCENTRATION OF RISK (Tables)
    12 Months Ended
    Dec. 31, 2023
    Risks and Uncertainties [Abstract]  
    SCHEDULE OF CONCENTRATION RISK

    There is a concentration of risk associated with the Company’s services revenue. In 2023, revenue from four customers constituted 88% of the total revenue. In 2022, all revenue came from four customers, comprising 100% of the total. It’s important to note that these customer compositions are not identical.

     

     

      

    For the years ended

    December 31,

     
       2023   2022 
                     
    Customer A   52,059    32%          
    Customer B   47,540    29%          
    Customer C   30,000    18%          
    Customer D   15,000    9%          
    Customer E             41,000    40%
    Customer F             26,020    25%
    Customer G             20,000    20%
    Customer H             14,982    15%
    Subtotal  $

    144,599

        88%   102,002    100%
    XML 39 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    NATURE OF OPERATIONS (Details Narrative)
    Dec. 31, 2023
    Aug. 16, 2023
    NP Life Sciences Health (Singapore) Pte. Ltd. [Member]    
    Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
    Ownership percentage 90.00% 90.00%
    Individual Holder [Member]    
    Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]    
    Ownership percentage   10.00%
    XML 40 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Product Information [Line Items]    
    Total $ 164,621 $ 102,002
    Traditional Culture And Education [Member]    
    Product Information [Line Items]    
    Total 65,022 102,002
    Career Planning Experience Sharing And Guidance [Member]    
    Product Information [Line Items]    
    Total $ 99,599
    XML 41 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Accounting Policies [Abstract]    
    Net loss used in computing earnings per share $ (2,935) $ (18,856)
    Weighted average number of common shares- Basic 42,959,574 42,959,574
    Weighted average number of common shares- Diluted 42,959,574 42,959,574
    Basic loss per share $ (0) $ (0)
    Diluted loss per share $ (0) $ (0)
    XML 42 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Aug. 16, 2023
    Accumulated deficit $ 348,245 $ 345,310  
    Net loss 2,935 $ 18,856  
    Cash insured account $ 250,000    
    Share-Based Payment Arrangement, Option [Member]      
    Dilutive securities, shares 0    
    Warrant [Member]      
    Dilutive securities, shares 0    
    GW Health Consulting Management Inc [Member]      
    Ownership percentage 100.00%    
    NLPL Health Industry Group Co., Limited [Member]      
    Ownership percentage 100.00%    
    NP Life Sciences Health (Singapore) Pte. Ltd. [Member]      
    Ownership percentage 90.00%   90.00%
    XML 43 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SCHEDULE OF PREPAID EXPENSES (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Prepaid Expenses    
    Prepayment to OTCQB annual fee (unamortized portion) $ 6,250 $ 5,925
    Total $ 6,250 $ 5,925
    XML 44 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    PREPAID EXPENSES (Details Narrative) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Prepaid Expenses    
    Prepaid expenses $ 6,250 $ 5,925
    XML 45 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Revenue from Contract with Customer [Abstract]    
    Balance $ 99,599
    Addition 99,599
    Recognize (99,599)
    Balance $ 99,599
    XML 46 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    DEFERRED INCOME – CONTRACT LIABILITIES (Details Narrative) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Disaggregation of Revenue [Line Items]    
    Deferred income contract liabilities received $ 99,599
    Two Customer [Member]    
    Disaggregation of Revenue [Line Items]    
    Deferred income contract liabilities received   $ 99,599
    XML 47 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    LONG-TERM LOAN – RELATED PARTY (Details Narrative)
    12 Months Ended
    Dec. 31, 2023
    USD ($)
    Defined Benefit Plan Disclosure [Line Items]  
    Accrued interest $ 645
    Related Party [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    long term loan $ 22,362
    Related party transaction, description the Company is required to repay the loan before April 7, 2024; after the agreement renewal, the repayment date was extended to April 11, 2025. The renewed loan agreement has a term of 12 months with an annual interest rate of 4% with no collateral is required. Additionally, the loan agreement will be automatically extended to additional one year if the repayment is not completed before due date
    Related Party [Member] | Loan Agreement [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Loan annual interest rate 4.00%
    XML 48 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SCHEDULE OF CONCENTRATION RISK (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Concentration Risk [Line Items]    
    Revenue $ 144,599 $ 102,002
    Customer A [Member]    
    Concentration Risk [Line Items]    
    Revenue 52,059  
    Customer B [Member]    
    Concentration Risk [Line Items]    
    Revenue 47,540  
    Customer C [Member]    
    Concentration Risk [Line Items]    
    Revenue 30,000  
    Customer D [Member]    
    Concentration Risk [Line Items]    
    Revenue $ 15,000  
    Customer E [Member]    
    Concentration Risk [Line Items]    
    Revenue   41,000
    Customer F [Member]    
    Concentration Risk [Line Items]    
    Revenue   26,020
    Customer G [Member]    
    Concentration Risk [Line Items]    
    Revenue   20,000
    Customer H [Member]    
    Concentration Risk [Line Items]    
    Revenue   $ 14,982
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Four Customers [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage 88.00% 100.00%
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage 32.00%  
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage 29.00%  
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer C [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage 18.00%  
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer E [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage   40.00%
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer F [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage   25.00%
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer G [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage   20.00%
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer H [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage   15.00%
    Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customers [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage 88.00% 100.00%
    Revenue Benchmark [Member] | Product Concentration Risk [Member] | Customer D [Member]    
    Concentration Risk [Line Items]    
    Concentration risk, percentage 9.00%  
    XML 49 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    INCOME TAX (Details Narrative) - USD ($)
    12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Income Tax Disclosure [Abstract]    
    Accumulated deficit $ 348,245 $ 345,310
    Net loss $ 2,935 $ 18,856
    XML 50 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    SUBSEQUENT EVENTS (Details Narrative)
    Apr. 05, 2024
    Subsequent Event [Member] | Loan Agreement [Member]  
    Subsequent Event [Line Items]  
    Annual interest rate percentage 4.00%
    EXCEL 51 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 52 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 55 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 65 133 1 false 29 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://gjcc.us/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://gjcc.us/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://gjcc.us/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://gjcc.us/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://gjcc.us/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995512 - Disclosure - NATURE OF OPERATIONS Sheet http://gjcc.us/role/NatureOfOperations NATURE OF OPERATIONS Notes 9 false false R10.htm 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://gjcc.us/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 995514 - Disclosure - PREPAID EXPENSES Sheet http://gjcc.us/role/PrepaidExpenses PREPAID EXPENSES Notes 11 false false R12.htm 995515 - Disclosure - DEFERRED INCOME ??? CONTRACT LIABILITIES Sheet http://gjcc.us/role/DeferredIncomeContractLiabilities DEFERRED INCOME ??? CONTRACT LIABILITIES Notes 12 false false R13.htm 995516 - Disclosure - LONG-TERM LOAN ??? RELATED PARTY Sheet http://gjcc.us/role/Long-termLoanRelatedParty LONG-TERM LOAN ??? RELATED PARTY Notes 13 false false R14.htm 995517 - Disclosure - CONCENTRATION OF RISK Sheet http://gjcc.us/role/ConcentrationOfRisk CONCENTRATION OF RISK Notes 14 false false R15.htm 995518 - Disclosure - INCOME TAX Sheet http://gjcc.us/role/IncomeTax INCOME TAX Notes 15 false false R16.htm 995519 - Disclosure - SUBSEQUENT EVENTS Sheet http://gjcc.us/role/SubsequentEvents SUBSEQUENT EVENTS Notes 16 false false R17.htm 995520 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 17 false false R18.htm 995521 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://gjcc.us/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 995522 - Disclosure - PREPAID EXPENSES (Tables) Sheet http://gjcc.us/role/PrepaidExpensesTables PREPAID EXPENSES (Tables) Tables http://gjcc.us/role/PrepaidExpenses 19 false false R20.htm 995523 - Disclosure - DEFERRED INCOME ??? CONTRACT LIABILITIES (Tables) Sheet http://gjcc.us/role/DeferredIncomeContractLiabilitiesTables DEFERRED INCOME ??? CONTRACT LIABILITIES (Tables) Tables http://gjcc.us/role/DeferredIncomeContractLiabilities 20 false false R21.htm 995524 - Disclosure - CONCENTRATION OF RISK (Tables) Sheet http://gjcc.us/role/ConcentrationOfRiskTables CONCENTRATION OF RISK (Tables) Tables http://gjcc.us/role/ConcentrationOfRisk 21 false false R22.htm 995525 - Disclosure - NATURE OF OPERATIONS (Details Narrative) Sheet http://gjcc.us/role/NatureOfOperationsDetailsNarrative NATURE OF OPERATIONS (Details Narrative) Details http://gjcc.us/role/NatureOfOperations 22 false false R23.htm 995526 - Disclosure - SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES (Details) Sheet http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES (Details) Details 23 false false R24.htm 995527 - Disclosure - SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED (Details) Sheet http://gjcc.us/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED (Details) Details 24 false false R25.htm 995528 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 995529 - Disclosure - SCHEDULE OF PREPAID EXPENSES (Details) Sheet http://gjcc.us/role/ScheduleOfPrepaidExpensesDetails SCHEDULE OF PREPAID EXPENSES (Details) Details 26 false false R27.htm 995530 - Disclosure - PREPAID EXPENSES (Details Narrative) Sheet http://gjcc.us/role/PrepaidExpensesDetailsNarrative PREPAID EXPENSES (Details Narrative) Details http://gjcc.us/role/PrepaidExpensesTables 27 false false R28.htm 995531 - Disclosure - SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES (Details) Sheet http://gjcc.us/role/ScheduleOfDeferredIncomeContractLiabilitiesDetails SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES (Details) Details 28 false false R29.htm 995532 - Disclosure - DEFERRED INCOME ??? CONTRACT LIABILITIES (Details Narrative) Sheet http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative DEFERRED INCOME ??? CONTRACT LIABILITIES (Details Narrative) Details http://gjcc.us/role/DeferredIncomeContractLiabilitiesTables 29 false false R30.htm 995533 - Disclosure - LONG-TERM LOAN ??? RELATED PARTY (Details Narrative) Sheet http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative LONG-TERM LOAN ??? RELATED PARTY (Details Narrative) Details http://gjcc.us/role/Long-termLoanRelatedParty 30 false false R31.htm 995534 - Disclosure - SCHEDULE OF CONCENTRATION RISK (Details) Sheet http://gjcc.us/role/ScheduleOfConcentrationRiskDetails SCHEDULE OF CONCENTRATION RISK (Details) Details 31 false false R32.htm 995535 - Disclosure - INCOME TAX (Details Narrative) Sheet http://gjcc.us/role/IncomeTaxDetailsNarrative INCOME TAX (Details Narrative) Details http://gjcc.us/role/IncomeTax 32 false false R33.htm 995536 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://gjcc.us/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://gjcc.us/role/SubsequentEvents 33 false false All Reports Book All Reports form10-k.htm npls-20231231.xsd npls-20231231_cal.xml npls-20231231_def.xml npls-20231231_lab.xml npls-20231231_pre.xml form10-k_001.jpg form10-k_002.jpg form10-k_003.jpg form10-k_004.jpg form10-k_005.jpg report_001.jpg report_002.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 57 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "NPLS", "nsuri": "http://gjcc.us/20231231", "dts": { "inline": { "local": [ "form10-k.htm" ] }, "schema": { "local": [ "npls-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "npls-20231231_cal.xml" ] }, "definitionLink": { "local": [ "npls-20231231_def.xml" ] }, "labelLink": { "local": [ "npls-20231231_lab.xml" ] }, "presentationLink": { "local": [ "npls-20231231_pre.xml" ] } }, "keyStandard": 130, "keyCustom": 3, "axisStandard": 10, "axisCustom": 0, "memberStandard": 11, "memberCustom": 18, "hidden": { "total": 43, "http://xbrl.sec.gov/dei/2023": 3, "http://fasb.org/us-gaap/2023": 40 }, "contextCount": 65, "entityCount": 1, "segmentCount": 29, "elementCount": 322, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 247, "http://xbrl.sec.gov/dei/2023": 37, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://gjcc.us/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://gjcc.us/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R3": { "role": "http://gjcc.us/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R4": { "role": "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:GeneralAndAdministrativeExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R5": { "role": "http://gjcc.us/role/StatementsOfStockholdersEquity", "longName": "00000005 - Statement - Consolidated Statements of Stockholders' Equity", "shortName": "Consolidated Statements of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://gjcc.us/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://gjcc.us/role/NatureOfOperations", "longName": "995512 - Disclosure - NATURE OF OPERATIONS", "shortName": "NATURE OF OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://gjcc.us/role/SummaryOfSignificantAccountingPolicies", "longName": "995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://gjcc.us/role/PrepaidExpenses", "longName": "995514 - Disclosure - PREPAID EXPENSES", "shortName": "PREPAID EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "NPLS:PrepaidExpensesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "NPLS:PrepaidExpensesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://gjcc.us/role/DeferredIncomeContractLiabilities", "longName": "995515 - Disclosure - DEFERRED INCOME \u2013 CONTRACT LIABILITIES", "shortName": "DEFERRED INCOME \u2013 CONTRACT LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://gjcc.us/role/Long-termLoanRelatedParty", "longName": "995516 - Disclosure - LONG-TERM LOAN \u2013 RELATED PARTY", "shortName": "LONG-TERM LOAN \u2013 RELATED PARTY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://gjcc.us/role/ConcentrationOfRisk", "longName": "995517 - Disclosure - CONCENTRATION OF RISK", "shortName": "CONCENTRATION OF RISK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://gjcc.us/role/IncomeTax", "longName": "995518 - Disclosure - INCOME TAX", "shortName": "INCOME TAX", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://gjcc.us/role/SubsequentEvents", "longName": "995519 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "995520 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "995521 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://gjcc.us/role/PrepaidExpensesTables", "longName": "995522 - Disclosure - PREPAID EXPENSES (Tables)", "shortName": "PREPAID EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "NPLS:PrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "NPLS:PrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://gjcc.us/role/DeferredIncomeContractLiabilitiesTables", "longName": "995523 - Disclosure - DEFERRED INCOME \u2013 CONTRACT LIABILITIES (Tables)", "shortName": "DEFERRED INCOME \u2013 CONTRACT LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DeferredIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://gjcc.us/role/ConcentrationOfRiskTables", "longName": "995524 - Disclosure - CONCENTRATION OF RISK (Tables)", "shortName": "CONCENTRATION OF RISK (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://gjcc.us/role/NatureOfOperationsDetailsNarrative", "longName": "995525 - Disclosure - NATURE OF OPERATIONS (Details Narrative)", "shortName": "NATURE OF OPERATIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_NPLifeSciencesHealthSingaporePteLtdMember", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-08-16_custom_IndividualHolderMember", "name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:NatureOfOperations", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R23": { "role": "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails", "longName": "995526 - Disclosure - SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES (Details)", "shortName": "SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_TraditionalCultureAndEducationMember", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R24": { "role": "http://gjcc.us/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "longName": "995527 - Disclosure - SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED (Details)", "shortName": "SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R25": { "role": "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995528 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashFDICInsuredAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R26": { "role": "http://gjcc.us/role/ScheduleOfPrepaidExpensesDetails", "longName": "995529 - Disclosure - SCHEDULE OF PREPAID EXPENSES (Details)", "shortName": "SCHEDULE OF PREPAID EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "NPLS:PrepaymentToAnnualFeeUnamortizedPortion", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "NPLS:PrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "NPLS:PrepaymentToAnnualFeeUnamortizedPortion", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "NPLS:PrepaidExpensesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://gjcc.us/role/PrepaidExpensesDetailsNarrative", "longName": "995530 - Disclosure - PREPAID EXPENSES (Details Narrative)", "shortName": "PREPAID EXPENSES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R28": { "role": "http://gjcc.us/role/ScheduleOfDeferredIncomeContractLiabilitiesDetails", "longName": "995531 - Disclosure - SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES (Details)", "shortName": "SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:DeferredIncome", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredIncomeTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:DeferredIncomeAddition", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredIncomeTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R29": { "role": "http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative", "longName": "995532 - Disclosure - DEFERRED INCOME \u2013 CONTRACT LIABILITIES (Details Narrative)", "shortName": "DEFERRED INCOME \u2013 CONTRACT LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_TwoCustomerMember", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R30": { "role": "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative", "longName": "995533 - Disclosure - LONG-TERM LOAN \u2013 RELATED PARTY (Details Narrative)", "shortName": "LONG-TERM LOAN \u2013 RELATED PARTY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtInstrumentIncreaseAccruedInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtInstrumentIncreaseAccruedInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails", "longName": "995534 - Disclosure - SCHEDULE OF CONCENTRATION RISK (Details)", "shortName": "SCHEDULE OF CONCENTRATION RISK (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://gjcc.us/role/IncomeTaxDetailsNarrative", "longName": "995535 - Disclosure - INCOME TAX (Details Narrative)", "shortName": "INCOME TAX (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R33": { "role": "http://gjcc.us/role/SubsequentEventsDetailsNarrative", "longName": "995536 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2024-04-05_us-gaap_SubsequentEventMember_custom_LoanAgreementMember", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-04-05_us-gaap_SubsequentEventMember_custom_LoanAgreementMember", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payables", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r10", "r396" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r12" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r457" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r57", "r396", "r527" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r223", "r224", "r225", "r325", "r508", "r509", "r510", "r518", "r529" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r463" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r463" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r463" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r463" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r427", "r439", "r449", "r475" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r430", "r442", "r452", "r478" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r463" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r470" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r434", "r443", "r453", "r470", "r479", "r483", "r491" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r435" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dilutive securities, shares", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r138" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r24" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r24" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative", "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r238" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r73", "r94", "r114", "r141", "r148", "r152", "r157", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r240", "r244", "r255", "r293", "r347", "r396", "r408", "r515", "r516", "r521" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r435" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r420", "r422", "r435" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r420", "r422", "r435" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r420", "r422", "r435" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r486" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r487" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r482" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r482" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r482" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r482" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r482" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r482" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r485" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r484" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r483" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r483" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "NPLS_CareerPlanningExperienceSharingAndGuidanceMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CareerPlanningExperienceSharingAndGuidanceMember", "presentation": [ "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails" ], "lang": { "en-us": { "role": { "label": "Career Planning Experience Sharing And Guidance [Member]", "documentation": "Career Planning Experience Sharing And Guidance [Member]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r21", "r93", "r381" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r22" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents \u2013 Beginning of period", "periodEndLabel": "Cash and cash equivalents \u2013 End of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r21", "r63", "r112" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r63" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash insured account", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r461" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r462" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r462" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r17", "r50", "r294", "r334" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r398", "r399", "r400", "r402", "r403", "r404", "r405", "r508", "r509", "r518", "r526", "r529" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r56" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r56", "r335" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r56" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares, outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r7", "r56", "r335", "r353", "r529", "r530" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.0001 par value, 320,000,000 shares authorized, 42,959,574 shares issued and outstanding as of December 31, 2023, and 2022", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r56", "r296", "r396" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r467" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r466" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r468" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r465" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r45", "r70", "r98", "r100", "r105", "r290", "r304" ] }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Comprehensive income (loss)", "documentation": "Disclosure of accounting policy for comprehensive income." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r27", "r30", "r47", "r48", "r156", "r378" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r27", "r30", "r47", "r48", "r156", "r318", "r378" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r27", "r30", "r47", "r48", "r156", "r378", "r502" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://gjcc.us/role/ConcentrationOfRisk" ], "lang": { "en-us": { "role": { "label": "CONCENTRATION OF RISK", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r378" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r27", "r30", "r47", "r48", "r156" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r26", "r27", "r30", "r31", "r47", "r72", "r378" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r27", "r30", "r47", "r48", "r156", "r378" ] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary." } } }, "auth_ref": [ "r6", "r46" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r42", "r383" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred income - contract liabilities", "verboseLabel": "Deferred income contract liabilities received", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r174", "r175", "r194" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "NPLS_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerAMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer A [Member]", "documentation": "Customer A [Member]" } } }, "auth_ref": [] }, "NPLS_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerBMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer B [Member]", "documentation": "Customer B [Member]" } } }, "auth_ref": [] }, "NPLS_CustomerCMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerCMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer C [Member]", "documentation": "Customer C [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r28", "r156" ] }, "NPLS_CustomerDMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerDMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer D [Member]", "documentation": "Customer D [Member]" } } }, "auth_ref": [] }, "NPLS_CustomerEMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerEMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer E [Member]", "documentation": "Customer E [Member]" } } }, "auth_ref": [] }, "NPLS_CustomerFMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerFMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer F [Member]", "documentation": "Customer F [Member]" } } }, "auth_ref": [] }, "NPLS_CustomerGMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerGMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer G [Member]", "documentation": "Customer G [Member]" } } }, "auth_ref": [] }, "NPLS_CustomerHMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomerHMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer H [Member]", "documentation": "Customer H [Member]" } } }, "auth_ref": [] }, "NPLS_CustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "CustomersMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customers [Member]", "documentation": "Customers [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentIncreaseAccruedInterest", "crdr": "credit", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued interest", "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period." } } }, "auth_ref": [ "r506" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative", "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan annual interest rate", "verboseLabel": "Annual interest rate percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r14", "r171" ] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://gjcc.us/role/PrepaidExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PREPAID EXPENSES", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncome", "crdr": "credit", "presentation": [ "http://gjcc.us/role/ScheduleOfDeferredIncomeContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Deferred Income", "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r500", "r523", "r525" ] }, "us-gaap_DeferredIncomeAddition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeAddition", "crdr": "credit", "presentation": [ "http://gjcc.us/role/ScheduleOfDeferredIncomeContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Addition", "documentation": "Amount of increase in deferred income not accounted for under Topic 606." } } }, "auth_ref": [ "r523", "r525" ] }, "us-gaap_DeferredIncomeRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeRevenueRecognized", "crdr": "credit", "presentation": [ "http://gjcc.us/role/ScheduleOfDeferredIncomeContractLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Recognize", "label": "Deferred Income, Revenue Recognized", "documentation": "Amount of revenue recognized previously reported as deferred income not accounted for under Topic 606." } } }, "auth_ref": [ "r523", "r525" ] }, "us-gaap_DeferredIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTableTextBlock", "presentation": [ "http://gjcc.us/role/DeferredIncomeContractLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES", "documentation": "Tabular disclosure of deferred income not accounted for under Topic 606." } } }, "auth_ref": [ "r523", "r525" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r193", "r387", "r388", "r389", "r390", "r391", "r392", "r393" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r193", "r387", "r388", "r389", "r390", "r391", "r392", "r393" ] }, "NPLS_DisclosurePrepaidExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://gjcc.us/20231231", "localname": "DisclosurePrepaidExpensesAbstract", "lang": { "en-us": { "role": { "label": "Prepaid Expenses", "verboseLabel": "Schedule Of Prepaid Expenses" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r422" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r420", "r422", "r435" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r420", "r422", "r435", "r471" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r421" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r409" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r422" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r422" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r456" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r412" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://gjcc.us/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Basic loss per common share", "verboseLabel": "Basic loss per share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r106", "r123", "r124", "r125", "r126", "r127", "r131", "r133", "r135", "r136", "r137", "r139", "r253", "r254", "r291", "r305", "r384" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://gjcc.us/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Diluted loss per common share", "verboseLabel": "Diluted loss per share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r106", "r123", "r124", "r125", "r126", "r127", "r133", "r135", "r136", "r137", "r139", "r253", "r254", "r291", "r305", "r384" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basic and Diluted Net Loss Per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r24", "r25" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r415" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r411" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r411" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r499" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r411" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r496" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r435" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r411" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r411" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r411" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r411" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r497" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r7", "r89", "r101", "r102", "r103", "r118", "r119", "r120", "r122", "r128", "r130", "r140", "r158", "r159", "r173", "r223", "r224", "r225", "r231", "r232", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r256", "r257", "r258", "r259", "r260", "r261", "r267", "r313", "r314", "r315", "r325", "r373" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r464" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r427", "r439", "r449", "r475" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r424", "r436", "r446", "r472" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r470" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r3", "r8" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r431", "r443", "r453", "r479" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r431", "r443", "r453", "r479" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r431", "r443", "r453", "r479" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r431", "r443", "r453", "r479" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r431", "r443", "r453", "r479" ] }, "NPLS_FourCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "FourCustomersMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Four Customers [Member]", "documentation": "Four Customers [Member]" } } }, "auth_ref": [] }, "NPLS_GWHealthConsultingManagementIncMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "GWHealthConsultingManagementIncMember", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "GW Health Consulting Management Inc [Member]", "documentation": "GW Health Consulting Management Inc [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r62", "r357" ] }, "NPLS_GoingConcernPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gjcc.us/20231231", "localname": "GoingConcernPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Going Concern", "documentation": "Going Concern [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Loss before income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r60", "r76", "r141", "r147", "r151", "r153", "r292", "r300", "r386" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://gjcc.us/role/IncomeTax" ], "lang": { "en-us": { "role": { "label": "INCOME TAX", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r115", "r226", "r228", "r229", "r230", "r233", "r235", "r236", "r237", "r322" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income taxes", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r80", "r86", "r129", "r130", "r145", "r227", "r234", "r306" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income tax paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r23" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase/(Decrease) in Accounts payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase/(Decrease) in Accrued liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase/(Decrease) in Deferred income \u2013 contract liabilities", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r276", "r505" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase/(Decrease) in Other payable", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "(Increase)/Decrease in Prepaid expenses", "label": "Increase (Decrease) in Prepaid Expense", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r2" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r434", "r443", "r453", "r470", "r479", "r483", "r491" ] }, "NPLS_IndividualHolderMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "IndividualHolderMember", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Individual Holder [Member]", "documentation": "Individual Holder [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r489" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r423", "r495" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r423", "r495" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r423", "r495" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r49", "r78", "r104", "r144", "r263", "r358", "r406", "r528" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r107", "r110", "r111" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r11", "r114", "r157", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r241", "r244", "r245", "r255", "r333", "r385", "r408", "r515", "r521", "r522" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r59", "r75", "r299", "r396", "r507", "r512", "r519" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r13", "r92", "r114", "r157", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r241", "r244", "r245", "r255", "r396", "r515", "r521", "r522" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r9", "r51", "r52", "r53", "r54", "r114", "r157", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r241", "r244", "r245", "r255", "r515", "r521", "r522" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "NPLS_LoanAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "LoanAgreementMember", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative", "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan Agreement [Member]", "documentation": "Loan Agreement [Member]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTextBlock", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedParty" ], "lang": { "en-us": { "role": { "label": "LONG-TERM LOAN \u2013 RELATED PARTY", "documentation": "The entire disclosure for long-term debt." } } }, "auth_ref": [ "r68" ] }, "us-gaap_LongTermLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermLoansPayable", "crdr": "credit", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "long term loan", "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r15" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative", "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r156", "r389", "r517", "r523", "r524" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r462" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r462" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-controlling interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r19", "r74", "r114", "r157", "r162", "r164", "r165", "r166", "r169", "r170", "r255", "r298", "r337" ] }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Ownership percentage", "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner", "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity." } } }, "auth_ref": [] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership percentage", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r482" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r490" ] }, "NPLS_NLPLHealthIndustryGroupCoLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "NLPLHealthIndustryGroupCoLimitedMember", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NLPL Health Industry Group Co., Limited [Member]", "documentation": "NLPL Health Industry Group Co., Limited [Member]" } } }, "auth_ref": [] }, "NPLS_NPLifeSciencesHealthSingaporePteLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "NPLifeSciencesHealthSingaporePteLtdMember", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NP Life Sciences Health (Singapore) Pte. Ltd. [Member]", "documentation": "NP Life Sciences Health (Singapore) Pte. Ltd. [Member]" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative", "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "auth_ref": [ "r156", "r389", "r517", "r523", "r524" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r463" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://gjcc.us/role/NatureOfOperations" ], "lang": { "en-us": { "role": { "label": "NATURE OF OPERATIONS", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r81", "r87" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r109" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r63", "r64", "r65" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributed to the Company", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r61", "r65", "r77", "r91", "r97", "r99", "r103", "r114", "r121", "r123", "r124", "r125", "r126", "r129", "r130", "r134", "r141", "r147", "r151", "r153", "r157", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r254", "r255", "r303", "r355", "r371", "r372", "r386", "r406", "r515" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Less: net loss attributable to the non-controlling interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r44", "r71", "r97", "r99", "r129", "r130", "r302", "r504" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r462" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r460" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r459" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r490" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r490" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r141", "r147", "r151", "r153", "r386" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term loan- related party", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r16" ] }, "us-gaap_OtherNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNotesPayableCurrent", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other payables", "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r12" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r462" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r422" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r429", "r441", "r451", "r477" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r432", "r444", "r454", "r480" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r432", "r444", "r454", "r480" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://gjcc.us/role/NatureOfOperationsDetailsNarrative", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r458" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r461" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r461" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r460" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r463" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r459" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r416" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r417" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r398", "r399", "r402", "r403", "r404", "r405", "r526", "r529" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r55", "r172" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r55", "r335" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r55", "r172" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://gjcc.us/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r55", "r335", "r353", "r529", "r530" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, $0.0001 par value, 30,000,000 shares authorized, no shares issued and outstanding as of December 31, 2023, and 2022", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r55", "r295", "r396" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://gjcc.us/role/ScheduleOfPrepaidExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/PrepaidExpensesDetailsNarrative", "http://gjcc.us/role/ScheduleOfPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses", "totalLabel": "Total", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r96", "r160", "r161", "r382" ] }, "NPLS_PrepaidExpensesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://gjcc.us/20231231", "localname": "PrepaidExpensesDisclosureTextBlock", "presentation": [ "http://gjcc.us/role/PrepaidExpenses" ], "lang": { "en-us": { "role": { "label": "PREPAID EXPENSES", "documentation": "The entire disclosure for prepaid expenses." } } }, "auth_ref": [] }, "NPLS_PrepaymentToAnnualFeeUnamortizedPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://gjcc.us/20231231", "localname": "PrepaymentToAnnualFeeUnamortizedPortion", "crdr": "debit", "calculation": { "http://gjcc.us/role/ScheduleOfPrepaidExpensesDetails": { "parentTag": "us-gaap_PrepaidExpenseCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/ScheduleOfPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Prepayment to OTCQB annual fee (unamortized portion)", "documentation": "Amount of asset related to consideration paid in advance for Prepayment to annual fee unamortized portion that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Long-term loan from related parties", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r20", "r320" ] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r29" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r154", "r277", "r307", "r308", "r309", "r310", "r311", "r312", "r380", "r387", "r397", "r503", "r513", "r514", "r517", "r523" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails" ], "auth_ref": [ "r154", "r277", "r307", "r308", "r309", "r310", "r311", "r312", "r380", "r387", "r397", "r503", "r513", "r514", "r517", "r523" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://gjcc.us/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/IncomeTaxDetailsNarrative", "http://gjcc.us/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://gjcc.us/role/StatementsOfCashFlows", "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss", "http://gjcc.us/role/StatementsOfStockholdersEquity", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "verboseLabel": "Net loss used in computing earnings per share", "negatedLabel": "Net loss", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r91", "r97", "r99", "r108", "r114", "r121", "r129", "r130", "r141", "r147", "r151", "r153", "r157", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r239", "r242", "r243", "r254", "r255", "r292", "r301", "r324", "r355", "r371", "r372", "r386", "r394", "r395", "r407", "r504", "r515" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r458" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r458" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r424", "r436", "r446", "r472" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r196", "r269", "r270", "r328", "r329", "r330", "r331", "r332", "r352", "r354", "r376" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r116", "r117", "r269", "r270", "r271", "r272", "r328", "r329", "r330", "r331", "r332", "r352", "r354", "r376" ] }, "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDescriptionOfTransaction", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related party transaction, description", "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates." } } }, "auth_ref": [ "r79", "r95", "r264", "r265", "r266", "r268" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r196", "r269", "r270", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r328", "r329", "r330", "r331", "r332", "r352", "r354", "r376", "r520" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r425", "r437", "r447", "r473" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r426", "r438", "r448", "r474" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r433", "r445", "r455", "r481" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/IncomeTaxDetailsNarrative", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r58", "r69", "r297", "r316", "r317", "r321", "r336", "r396" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r89", "r118", "r119", "r120", "r122", "r128", "r130", "r158", "r159", "r223", "r224", "r225", "r231", "r232", "r246", "r248", "r249", "r251", "r252", "r313", "r315", "r325", "r529" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails", "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Revenue", "verboseLabel": "Total", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r142", "r143", "r146", "r149", "r150", "r154", "r155", "r156", "r192", "r193", "r277" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r142", "r143", "r146", "r149", "r150", "r154", "r155", "r156", "r192", "r193", "r277" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r88", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r379" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://gjcc.us/role/DeferredIncomeContractLiabilities" ], "lang": { "en-us": { "role": { "label": "DEFERRED INCOME \u2013 CONTRACT LIABILITIES", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r88", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r195" ] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r490" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r490" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://gjcc.us/role/ScheduleOfConcentrationRiskDetails" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r156", "r501" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r4", "r36", "r37", "r38", "r39" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r511" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES", "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r35" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://gjcc.us/role/ConcentrationOfRiskTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CONCENTRATION RISK", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r26", "r27", "r30", "r31", "r47", "r72" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r410" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r414" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r413" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r418" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expenses", "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance shares", "periodEndLabel": "Balance shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r66", "r113" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r419" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r7", "r18", "r89", "r101", "r102", "r103", "r118", "r119", "r120", "r122", "r128", "r130", "r140", "r158", "r159", "r173", "r223", "r224", "r225", "r231", "r232", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r256", "r257", "r258", "r259", "r260", "r261", "r267", "r313", "r314", "r315", "r325", "r373" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r118", "r119", "r120", "r140", "r277", "r319", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r335", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r348", "r349", "r350", "r351", "r352", "r354", "r356", "r357", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r373", "r401" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://gjcc.us/role/StatementsOfStockholdersEquity", "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r118", "r119", "r120", "r140", "r277", "r319", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r335", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r348", "r349", "r350", "r351", "r352", "r354", "r356", "r357", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r373", "r401" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r428", "r440", "r450", "r476" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://gjcc.us/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://gjcc.us/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://gjcc.us/role/BalanceSheets", "http://gjcc.us/role/StatementsOfStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r40", "r41", "r43", "r89", "r90", "r102", "r118", "r119", "r120", "r122", "r128", "r158", "r159", "r173", "r223", "r224", "r225", "r231", "r232", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r256", "r257", "r261", "r267", "r314", "r315", "r323", "r337", "r353", "r374", "r375", "r377", "r407", "r507", "r512", "r519", "r529" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r262", "r274" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r262", "r274" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r262", "r274" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r262", "r274" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r262", "r274" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://gjcc.us/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r273", "r275" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r469" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r461" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r468" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "NPLS_TraditionalCultureAndEducationMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "TraditionalCultureAndEducationMember", "presentation": [ "http://gjcc.us/role/ScheduleOfRevenueRecognizedConsultingServicesDetails" ], "lang": { "en-us": { "role": { "label": "Traditional Culture And Education [Member]", "documentation": "Traditional Culture And Education [Member]" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r492" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r493" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r491" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r491" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r494" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r492" ] }, "NPLS_TwoCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://gjcc.us/20231231", "localname": "TwoCustomerMember", "presentation": [ "http://gjcc.us/role/DeferredIncomeContractLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Customer [Member]", "documentation": "Two Customer [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://gjcc.us/role/Long-termLoanRelatedPartyDetailsNarrative", "http://gjcc.us/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r238" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r488" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates and Assumptions", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r32", "r33", "r34", "r82", "r83", "r84", "r85" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://gjcc.us/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r398", "r399", "r402", "r403", "r404", "r405" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://gjcc.us/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares- Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r132", "r137" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://gjcc.us/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails", "http://gjcc.us/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares- Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r131", "r137" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://gjcc.us/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r498" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4M", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-1" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-7" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-4" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r380": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r381": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r384": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r385": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r386": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r387": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r388": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r389": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r390": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r391": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r392": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r393": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r394": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r395": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r396": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r397": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r400": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r405": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r407": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r408": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r409": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r410": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r411": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r413": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r415": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r416": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r417": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r418": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r419": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r420": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r421": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r422": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r423": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r424": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r425": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r426": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r427": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r428": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r429": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r430": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r431": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r432": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r433": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r434": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r435": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r436": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r437": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r438": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r439": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r440": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r441": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r442": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r443": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r444": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r445": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r446": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r447": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r448": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r449": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r450": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r451": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r452": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r453": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r454": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r455": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r456": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r458": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r459": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r460": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r461": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r462": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r463": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r464": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r465": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r466": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r467": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r468": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r469": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r470": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r471": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r472": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r473": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r474": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r475": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r476": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r477": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r478": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r479": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r480": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r481": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r482": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r483": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r484": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r485": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r486": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r487": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r488": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r489": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r490": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r491": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r492": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r493": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r494": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r495": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r496": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r497": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r498": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r499": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r500": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "2", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481174/470-10-25-2" }, "r501": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r502": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r503": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r504": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r505": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r506": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r507": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r508": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r509": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r510": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r511": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r512": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r513": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r514": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r515": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r516": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r517": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r518": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r519": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r520": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r521": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r522": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r523": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r524": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r525": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r526": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r527": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r528": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r529": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 58 0001493152-24-014774-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-014774-xbrl.zip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�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form10-k_htm.xml IDEA: XBRL DOCUMENT 0001781726 2023-01-01 2023-12-31 0001781726 2023-06-30 0001781726 2024-04-15 0001781726 2023-12-31 0001781726 2022-12-31 0001781726 us-gaap:RelatedPartyMember 2023-12-31 0001781726 us-gaap:RelatedPartyMember 2022-12-31 0001781726 2022-01-01 2022-12-31 0001781726 us-gaap:PreferredStockMember 2021-12-31 0001781726 us-gaap:CommonStockMember 2021-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001781726 us-gaap:RetainedEarningsMember 2021-12-31 0001781726 2021-12-31 0001781726 us-gaap:PreferredStockMember 2022-12-31 0001781726 us-gaap:CommonStockMember 2022-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001781726 us-gaap:RetainedEarningsMember 2022-12-31 0001781726 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001781726 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001781726 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001781726 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001781726 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001781726 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001781726 us-gaap:PreferredStockMember 2023-12-31 0001781726 us-gaap:CommonStockMember 2023-12-31 0001781726 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001781726 us-gaap:RetainedEarningsMember 2023-12-31 0001781726 NPLS:NPLifeSciencesHealthSingaporePteLtdMember 2023-08-16 0001781726 NPLS:IndividualHolderMember 2023-08-16 0001781726 NPLS:GWHealthConsultingManagementIncMember 2023-12-31 0001781726 NPLS:NLPLHealthIndustryGroupCoLimitedMember 2023-12-31 0001781726 NPLS:NPLifeSciencesHealthSingaporePteLtdMember 2023-12-31 0001781726 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001781726 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001781726 NPLS:TraditionalCultureAndEducationMember 2023-01-01 2023-12-31 0001781726 NPLS:TraditionalCultureAndEducationMember 2022-01-01 2022-12-31 0001781726 NPLS:CareerPlanningExperienceSharingAndGuidanceMember 2023-01-01 2023-12-31 0001781726 NPLS:CareerPlanningExperienceSharingAndGuidanceMember 2022-01-01 2022-12-31 0001781726 NPLS:TwoCustomerMember 2022-12-31 0001781726 us-gaap:RelatedPartyMember 2023-01-01 2023-12-31 0001781726 us-gaap:RelatedPartyMember NPLS:LoanAgreementMember 2023-12-31 0001781726 NPLS:FourCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:FourCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerAMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerBMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerCMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerDMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomerEMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerFMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerFMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerGMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerGMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerHMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomerHMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 NPLS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001781726 NPLS:CustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001781726 us-gaap:SubsequentEventMember NPLS:LoanAgreementMember 2024-04-05 0001781726 2023-10-01 2023-12-31 iso4217:USD shares iso4217:USD shares pure false FY 0001781726 10-K true 2023-12-31 --12-31 2023 false 000-56140 NP Life Sciences Health Industry Group Inc. NV 83-2912878 4125 Blackhawk Plaza Circle Suite 166 Danville CA 94506 (925) 362-3169 Common Stock, $0.0001 par value NPLS No No Yes Yes Non-accelerated Filer true true true false false 0 42959574 WWC, P.C. 1171 San Mateo, CA 70614 121859 6250 5925 76864 127784 6130 6130 6894 239 25097 2500 99599 38121 108468 22362 22362 60483 108468 0.0001 0.0001 30000000 30000000 0 0 0 0 0.0001 0.0001 320000000 320000000 42959574 42959574 42959574 42959574 4296 4296 360330 360330 -348245 -345310 16381 19316 76864 127784 164621 102002 165311 120857 -690 -18855 645 1 -1335 -18856 1600 -2935 -18856 -2935 -18856 -2935 -18856 -0 -0 -0 -0 42959574 42959574 42959574 42959574 42959574 4296 360330 -326454 38172 -18856 -18856 42959574 4296 360330 -345310 19316 42959574 4296 360330 -345310 19316 -2935 -2935 42959574 4296 360330 -348245 16381 42959574 4296 360330 -348245 16381 -2935 -18856 325 -4500 6655 6130 22597 2500 -99599 99599 -73607 93873 22362 22362 -51245 93873 121859 27986 70614 121859 1 1600 <p id="xdx_806_eus-gaap--NatureOfOperations_zwdj1dWW9c5c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zNfq7QUrWZwb">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NP Life Sciences Health Industry Group Inc. (the “Company”) is a for profit corporation established under the corporation laws in the State of Nevada, United States on December 20, 2018. The Company was originally incorporated as “Guojiang Cultural Industry US, Inc.” and amended the name to “GJ Culture Group US, Inc.” on February 20, 2019. On September 8, 2022, the Company filed a Certificate of Amendment to its Articles of Incorporation with the State of Nevada to reflect its corporate name change from “GJ Culture Group US, Inc.” to “NP Life Sciences Health Industry Group Inc.”. Unless the context otherwise requires, all references to “NP Life Sciences Health Industry Group Inc.,” “GJ Culture Group US, Inc.,” “we,” “us,” “our” or the “Company” are to NP Life Sciences Health Industry Group Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is dedicated to providing educational services based on classical Chinese studies and culture. The Company’s goal is to serve as cultural and educational meeting point between China and the U.S. The Company intends to pursue its business objective by providing education and training courses based on classical Chinese studies, organizing China-U.S. international study tour activities for participants of all ages, as well as organizing and promoting China-U.S. cultural events, art fairs, exhibitions, and other activities promoting Chinese culture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 8, 2022, the Company established a wholly owned subsidiary, GW Health Consulting Management Inc. (herein after referred to as “GW”), a California Corporation. GW’s current business is limited to providing online career planning experience sharing and guidance related consulting services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 8, 2023, GW established a wholly owned subsidiary, NLPL Health Industry Group Co., Limited, a Hong Kong based company, which had no business transactions in the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2023, the Company established a subsidiary named NP Life Sciences Health (Singapore) Pte. Ltd., a Singapore based company in which the Company holds <span id="xdx_905_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20230816__srt--OwnershipAxis__custom--NPLifeSciencesHealthSingaporePteLtdMember_zwYNoErINp4g" title="Ownership percentage">90</span>% of the shares and an individual holds <span id="xdx_905_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_uPure_c20230816__srt--OwnershipAxis__custom--IndividualHolderMember_zZctbQCTv4Ie" title="Ownership percentage">10</span>% of the shares; there was no business transaction in the reporting period by this subsidiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.90 0.10 <p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zRdogACh9QS8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_zadzmS6EogSl">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlQ1Zi2HRUW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zbGwI2QIl9cb">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Consolidated Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“GAAP”) and presented in US dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_z3Nvk9gJgM95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zaiGPD7qeEi7">Basis of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Consolidated Financial Statements includes the accounts of the Company and its current owned subsidiary, GW Health Consulting Management Inc (<span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--GWHealthConsultingManagementIncMember_zLL0kC1VZW64" title="Ownership percentage">100</span>%), NLPL Health Industry Group Co., Limited (<span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--NLPLHealthIndustryGroupCoLimitedMember_zsHsL9V1imF7" title="Ownership percentage">100</span>%), and NP Life Sciences Health (Singapore) Pte. Ltd. (<span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--NPLifeSciencesHealthSingaporePteLtdMember_zJRoAkj0wtY6" title="Ownership percentage">90</span>% of the shares). All significant intercompany transactions and accounts have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_846_ecustom--GoingConcernPolicyTextBlock_z7PyMUAEEDga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zsaeazoV1Yuf">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern. As of December 31, 2023, there was an accumulated deficit of $<span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20231231_zsC3EBzPEB7b" title="Accumulated deficit">348,245</span> and the net loss of 2023 was $<span id="xdx_90E_eus-gaap--ProfitLoss_iN_di_c20230101__20231231_zjmrE1nWdlri" title="Net loss">2,935</span>. The circumstances give rise to substantial doubt to the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued, and in order to remain solvent that the Company is dependent upon its ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management plans to fund operations of the Company through the proceeds from an offering pursuant to a Registration Statement on Form S-1, private placements of restricted securities, or the issuance of stock in lieu of cash for payment of services until such a time as profitable operations are achieved. If the Company do not raise all of the money it needs from public offerings or private placements of equity, the Company will need alternative sources, such as loans or advances from our officers, directors or others. Such additional financing may not become available on acceptable terms and there can be no assurance that any additional financing that the Company does obtain will be sufficient to meet its needs in the long term. There are no written agreements in place for such funding or issuance of securities and there can be no assurance that such will be available in the future. The failure to achieve the necessary levels of profitability or obtain the additional funding would be detrimental to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides an opportunity for the Company to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--UseOfEstimates_z3YAF3EkiTyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z4UhMlmeoXY4">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the limited level of operations, the Company has not needed to make material assumptions or estimates other than the assumption that the Company is a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ztz99Wyofand" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z5CCiHyaBZEc">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has two bank accounts in Bank of America. The balance of each bank account is less than $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20231231_znymcM3zmv51" title="Cash insured account">250,000</span>; thus, the amount is insured by Federal Deposit Insurance Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z1u0cwHp1jSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zZM7HiVgqLZ7">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management at the time of this report. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts and other payable, accrued liabilities, and related party payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKp3B4rlkNXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zzflgOLr2gBi">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will recognize revenue in accordance with Accounting Standards Codification No. 606, “Revenue from Contracts with Customers” (“ASC-606”). ASC-606 requires that the criteria must be met before revenue can be recognized:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">executed contract(s) with customers that the Company believes is legally enforceable;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification of performance obligation in the respective contract;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determination of the transaction price for each performance obligation in the respective contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocation of the transaction price to each performance obligation; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognition of revenue only when the Company satisfies each performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides consulting services to clients through our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. The Company enters into a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year, and all of the Company’s contracts are short-term. The Company typically satisfies its performance obligations in contracts with customers upon completion of service rendered. Generally, payment is advance payment from customers. The Company recognizes the revenue at a single point in time after every service rendered and the transaction price is stated in the contract. Historically, there was no sales returns.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When above criteria were met, the Company will recognize revenue accordingly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zj9gXEb9gHx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zgy5ezXNJ2ad" style="display: none">SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20231231_zgOdKoNJBMXb" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20221231_z5pYVOXSCDTe" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the years ended</p>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TraditionalCultureAndEducationMember_zCT9qDubVst6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Consulting service relating to China traditional culture and education</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">65,022</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">102,002</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--CareerPlanningExperienceSharingAndGuidanceMember_ztH8Vf0cWvjh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Consulting service on career planning experience sharing and guidance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">99,599</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z98xitqH2X53" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">164,621</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">102,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zhyJm0wT2EA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zIJ1UWZ9XSo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zDVc4T4Kelt6">General and Administrative Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The general and administrative expense mainly consists of service fees occurred by the law firm, auditor, and accountant, etc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zu0wQK4cmxfl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zXfgGypcNuOa">Basic and Diluted Net Loss Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. There were no adjustments to net loss required for purposes of computing diluted earnings per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwOLGMgAr0fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B5_zUozVeN8vPHd" style="display: none">SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_zZvGCHeHHVCb" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zP6dLDPBTeM4" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ProfitLoss_z9pzDe1qNpOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 10pt">Net loss used in computing earnings per share</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(2,935</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(18,856</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231_zcJsoPpfLFk5" title="Weighted average number of common shares- Basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20231231_zGtYAGm3O3L4" title="Weighted average number of common shares- Diluted">42,959,574</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231_zl5A4RF2gJa6" title="Weighted average number of common shares- Basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20221231_zzbj6boELcBd" title="Weighted average number of common shares- Diluted">42,959,574</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Basic and diluted loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zj33knCyyNv6" title="Basic loss per share"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zel1d6BPi1w" title="Diluted loss per share">(0.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zsP2DSGBnsTa" title="Basic loss per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zs3AcOSvUbF" title="Diluted loss per share">(0.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AF_zJbQ5IirdWR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zp6dF7H1IF9d" title="Dilutive securities, shares"><span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zImNKj6GVEJ3" title="Dilutive securities, shares">no</span></span> potentially dilutive securities, such as options or warrants, currently issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z9hDMPlKN1W6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zyuToax59OB3">Comprehensive income (loss)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the provisions of the Financial Accounting Standards Board (the “FASB”) ASC 220 <i>Reporting Comprehensive Income</i> and establishes standards for the reporting and display of comprehensive income, its components and accumulated balances in a full set of general purpose financial statements. The Company’s comprehensive loss consists of net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLXuOMcIlIn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zeswg1g3cPNf">Recently Issued Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses”, which will require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Further, the FASB issued ASU No. 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-02 to provide additional guidance on the credit losses standard. The amendments for ASU 2016-13 are effective for fiscal years beginning after December 15, 2022. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is in the process of evaluating the effect of the adoption of this ASU.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2018, the FASB issued Accounting Standards Update No. 2018-02 <i>Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</i> (ASU 2018-02). The standard provides financial statement preparers with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income (AOCI) to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (or portion thereof) is recorded. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. We adopted this ASU in the 2019 and it did not have a material impact on our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, the FASB issued Accounting Standards Update No. 2018-05, <i>Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118</i> (ASU 2018-05). The ASU adds various Securities and Exchange Commission (“SEC”) paragraphs pursuant to the issuance of the December 2017 SEC Staff Accounting Bulletin No. 118, <i>Income Tax Accounting Implications of the Tax Cuts and Jobs Act</i> (“SAB 118”), which was effective immediately. The SEC issued SAB 118 to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Cuts and Jobs Act in the period of enactment. SAB 118 allows disclosure that timely determination of some or all of the income tax effects from the Tax Cuts and Jobs Act are incomplete by the due date of the financial statements and if possible, to provide a reasonable estimate. We adopted this ASU in the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018 and it did not have a material impact on our consolidated financial statements.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, except for the above, there are no recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.</span></p> <p id="xdx_853_z7HOtLf7G2b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlQ1Zi2HRUW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zbGwI2QIl9cb">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Consolidated Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“GAAP”) and presented in US dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eus-gaap--ConsolidationPolicyTextBlock_z3Nvk9gJgM95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zaiGPD7qeEi7">Basis of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Consolidated Financial Statements includes the accounts of the Company and its current owned subsidiary, GW Health Consulting Management Inc (<span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--GWHealthConsultingManagementIncMember_zLL0kC1VZW64" title="Ownership percentage">100</span>%), NLPL Health Industry Group Co., Limited (<span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--NLPLHealthIndustryGroupCoLimitedMember_zsHsL9V1imF7" title="Ownership percentage">100</span>%), and NP Life Sciences Health (Singapore) Pte. Ltd. (<span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231231__srt--OwnershipAxis__custom--NPLifeSciencesHealthSingaporePteLtdMember_zJRoAkj0wtY6" title="Ownership percentage">90</span>% of the shares). All significant intercompany transactions and accounts have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1 1 0.90 <p id="xdx_846_ecustom--GoingConcernPolicyTextBlock_z7PyMUAEEDga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zsaeazoV1Yuf">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern. As of December 31, 2023, there was an accumulated deficit of $<span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20231231_zsC3EBzPEB7b" title="Accumulated deficit">348,245</span> and the net loss of 2023 was $<span id="xdx_90E_eus-gaap--ProfitLoss_iN_di_c20230101__20231231_zjmrE1nWdlri" title="Net loss">2,935</span>. The circumstances give rise to substantial doubt to the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued, and in order to remain solvent that the Company is dependent upon its ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management plans to fund operations of the Company through the proceeds from an offering pursuant to a Registration Statement on Form S-1, private placements of restricted securities, or the issuance of stock in lieu of cash for payment of services until such a time as profitable operations are achieved. If the Company do not raise all of the money it needs from public offerings or private placements of equity, the Company will need alternative sources, such as loans or advances from our officers, directors or others. Such additional financing may not become available on acceptable terms and there can be no assurance that any additional financing that the Company does obtain will be sufficient to meet its needs in the long term. There are no written agreements in place for such funding or issuance of securities and there can be no assurance that such will be available in the future. The failure to achieve the necessary levels of profitability or obtain the additional funding would be detrimental to the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides an opportunity for the Company to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -348245 -2935 <p id="xdx_845_eus-gaap--UseOfEstimates_z3YAF3EkiTyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_z4UhMlmeoXY4">Use of Estimates and Assumptions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to the limited level of operations, the Company has not needed to make material assumptions or estimates other than the assumption that the Company is a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_ztz99Wyofand" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_z5CCiHyaBZEc">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has two bank accounts in Bank of America. The balance of each bank account is less than $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20231231_znymcM3zmv51" title="Cash insured account">250,000</span>; thus, the amount is insured by Federal Deposit Insurance Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 <p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z1u0cwHp1jSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zZM7HiVgqLZ7">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 825, “Disclosures about Fair Value of Financial Instruments”, requires disclosure of fair value information about financial instruments. ASC 820, “Fair Value Measurements” defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management at the time of this report. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts and other payable, accrued liabilities, and related party payable. Fair values were assumed to approximate carrying values for these financial instruments since they are short term in nature and their carrying amounts approximate fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zKp3B4rlkNXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zzflgOLr2gBi">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will recognize revenue in accordance with Accounting Standards Codification No. 606, “Revenue from Contracts with Customers” (“ASC-606”). ASC-606 requires that the criteria must be met before revenue can be recognized:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">executed contract(s) with customers that the Company believes is legally enforceable;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identification of performance obligation in the respective contract;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determination of the transaction price for each performance obligation in the respective contract;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocation of the transaction price to each performance obligation; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognition of revenue only when the Company satisfies each performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides consulting services to clients through our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. The Company enters into a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year, and all of the Company’s contracts are short-term. The Company typically satisfies its performance obligations in contracts with customers upon completion of service rendered. Generally, payment is advance payment from customers. The Company recognizes the revenue at a single point in time after every service rendered and the transaction price is stated in the contract. Historically, there was no sales returns.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When above criteria were met, the Company will recognize revenue accordingly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zj9gXEb9gHx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zgy5ezXNJ2ad" style="display: none">SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20231231_zgOdKoNJBMXb" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20221231_z5pYVOXSCDTe" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the years ended</p>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TraditionalCultureAndEducationMember_zCT9qDubVst6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Consulting service relating to China traditional culture and education</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">65,022</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">102,002</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--CareerPlanningExperienceSharingAndGuidanceMember_ztH8Vf0cWvjh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Consulting service on career planning experience sharing and guidance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">99,599</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z98xitqH2X53" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">164,621</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">102,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zhyJm0wT2EA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zj9gXEb9gHx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues are comprised of providing consulting services to our partner who gives international study tour services, and career planning experience sharing and guidance consulting services. In general, the payment term is advance payment from the customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zgy5ezXNJ2ad" style="display: none">SCHEDULE OF REVENUE RECOGNIZED CONSULTING SERVICES</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230101__20231231_zgOdKoNJBMXb" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20221231_z5pYVOXSCDTe" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the years ended</p>December 31,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TraditionalCultureAndEducationMember_zCT9qDubVst6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Consulting service relating to China traditional culture and education</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">65,022</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">102,002</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--CareerPlanningExperienceSharingAndGuidanceMember_ztH8Vf0cWvjh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Consulting service on career planning experience sharing and guidance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">99,599</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z98xitqH2X53" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">164,621</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">102,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 65022 102002 99599 164621 102002 <p id="xdx_84E_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zIJ1UWZ9XSo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zDVc4T4Kelt6">General and Administrative Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The general and administrative expense mainly consists of service fees occurred by the law firm, auditor, and accountant, etc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zu0wQK4cmxfl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zXfgGypcNuOa">Basic and Diluted Net Loss Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our computation of earnings per share (“EPS”) includes basic and diluted EPS. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the respective periods. Basic and diluted (loss) per common share is the same for periods in which the company reported an operating loss because all warrants and stock options outstanding are anti-dilutive. There were no adjustments to net loss required for purposes of computing diluted earnings per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwOLGMgAr0fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B5_zUozVeN8vPHd" style="display: none">SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_zZvGCHeHHVCb" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zP6dLDPBTeM4" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ProfitLoss_z9pzDe1qNpOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 10pt">Net loss used in computing earnings per share</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(2,935</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(18,856</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231_zcJsoPpfLFk5" title="Weighted average number of common shares- Basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20231231_zGtYAGm3O3L4" title="Weighted average number of common shares- Diluted">42,959,574</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231_zl5A4RF2gJa6" title="Weighted average number of common shares- Basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20221231_zzbj6boELcBd" title="Weighted average number of common shares- Diluted">42,959,574</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Basic and diluted loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zj33knCyyNv6" title="Basic loss per share"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zel1d6BPi1w" title="Diluted loss per share">(0.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zsP2DSGBnsTa" title="Basic loss per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zs3AcOSvUbF" title="Diluted loss per share">(0.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AF_zJbQ5IirdWR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zp6dF7H1IF9d" title="Dilutive securities, shares"><span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_do_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zImNKj6GVEJ3" title="Dilutive securities, shares">no</span></span> potentially dilutive securities, such as options or warrants, currently issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwOLGMgAr0fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B5_zUozVeN8vPHd" style="display: none">SCHEDULE OF EARNINGS PER SHARE, BASIC AND DILUTED</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20231231_zZvGCHeHHVCb" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zP6dLDPBTeM4" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ProfitLoss_z9pzDe1qNpOl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 10pt">Net loss used in computing earnings per share</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(2,935</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(18,856</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Weighted average common shares outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231_zcJsoPpfLFk5" title="Weighted average number of common shares- Basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20231231_zGtYAGm3O3L4" title="Weighted average number of common shares- Diluted">42,959,574</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20220101__20221231_zl5A4RF2gJa6" title="Weighted average number of common shares- Basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220101__20221231_zzbj6boELcBd" title="Weighted average number of common shares- Diluted">42,959,574</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Basic and diluted loss per share</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zj33knCyyNv6" title="Basic loss per share"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zel1d6BPi1w" title="Diluted loss per share">(0.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zsP2DSGBnsTa" title="Basic loss per share"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zs3AcOSvUbF" title="Diluted loss per share">(0.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -2935 -18856 42959574 42959574 42959574 42959574 -0.00 -0.00 -0.00 -0.00 0 0 <p id="xdx_84B_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z9hDMPlKN1W6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zyuToax59OB3">Comprehensive income (loss)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the provisions of the Financial Accounting Standards Board (the “FASB”) ASC 220 <i>Reporting Comprehensive Income</i> and establishes standards for the reporting and display of comprehensive income, its components and accumulated balances in a full set of general purpose financial statements. The Company’s comprehensive loss consists of net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLXuOMcIlIn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zeswg1g3cPNf">Recently Issued Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses”, which will require the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Further, the FASB issued ASU No. 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-02 to provide additional guidance on the credit losses standard. The amendments for ASU 2016-13 are effective for fiscal years beginning after December 15, 2022. ASU 2016-13 will be effective for the Company beginning January 1, 2023. The Company is in the process of evaluating the effect of the adoption of this ASU.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2018, the FASB issued Accounting Standards Update No. 2018-02 <i>Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</i> (ASU 2018-02). The standard provides financial statement preparers with an option to reclassify stranded tax effects within Accumulated Other Comprehensive Income (AOCI) to retained earnings in each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (or portion thereof) is recorded. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. We adopted this ASU in the 2019 and it did not have a material impact on our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, the FASB issued Accounting Standards Update No. 2018-05, <i>Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118</i> (ASU 2018-05). The ASU adds various Securities and Exchange Commission (“SEC”) paragraphs pursuant to the issuance of the December 2017 SEC Staff Accounting Bulletin No. 118, <i>Income Tax Accounting Implications of the Tax Cuts and Jobs Act</i> (“SAB 118”), which was effective immediately. The SEC issued SAB 118 to address concerns about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of the Tax Cuts and Jobs Act in the period of enactment. SAB 118 allows disclosure that timely determination of some or all of the income tax effects from the Tax Cuts and Jobs Act are incomplete by the due date of the financial statements and if possible, to provide a reasonable estimate. We adopted this ASU in the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018 and it did not have a material impact on our consolidated financial statements.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In December 2023, the FASB issued Accounting Standards Update No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, except for the above, there are no recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.</span></p> <p id="xdx_80C_ecustom--PrepaidExpensesDisclosureTextBlock_zlsxc3f5uh13" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zcpbdF4XtxH6">PREPAID EXPENSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, prepaid expenses amounted to $<span id="xdx_909_eus-gaap--PrepaidExpenseCurrent_iI_c20231231_zwJ1SxdeNmYd" title="Prepaid expenses">6,250</span> and $<span id="xdx_907_eus-gaap--PrepaidExpenseCurrent_iI_c20221231_zNA6gTeYABq7" title="Prepaid expenses">5,925</span>, respectively. Prepaid expenses consists of the following:</span></p> <p id="xdx_894_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zAyWwKBPG5v5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_z7IyCOLUDj2d" style="display: none">SCHEDULE OF PREPAID EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt; text-align: center"> </td><td> </td> <td colspan="2" id="xdx_49D_20231231_z5u19OLrzxK8" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_498_20221231_z7bauwYwZ5o" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt; text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40B_ecustom--PrepaymentToAnnualFeeUnamortizedPortion_iI_maPECzNfZ_zmu0xv1ec7X6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 0pt">Prepayment to OTCQB annual fee (unamortized portion)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,925</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PrepaidExpenseCurrent_iTI_mtPECzNfZ_zcIx8Sn62pu1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,925</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zHF3k4NgPtD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6250 5925 <p id="xdx_894_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zAyWwKBPG5v5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BD_z7IyCOLUDj2d" style="display: none">SCHEDULE OF PREPAID EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt; text-align: center"> </td><td> </td> <td colspan="2" id="xdx_49D_20231231_z5u19OLrzxK8" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" id="xdx_498_20221231_z7bauwYwZ5o" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt; text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0pt"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40B_ecustom--PrepaymentToAnnualFeeUnamortizedPortion_iI_maPECzNfZ_zmu0xv1ec7X6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-left: 0pt">Prepayment to OTCQB annual fee (unamortized portion)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,925</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0pt; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PrepaidExpenseCurrent_iTI_mtPECzNfZ_zcIx8Sn62pu1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,925</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6250 5925 6250 5925 <p id="xdx_80B_eus-gaap--RevenueFromContractWithCustomerTextBlock_zb7be6agyV82" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82F_zUbt5vgOlwU6">DEFERRED INCOME – CONTRACT LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2022, GW received $<span id="xdx_905_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_c20221231__srt--MajorCustomersAxis__custom--TwoCustomerMember_z5VSNFUekxc4" title="Deferred income contract liabilities received">99,599</span> from two customers and recorded such amounts as deferred income - contract liabilities. GW delivered the career planning, experience sharing and guidance services during the year of 2023 and recorded the revenue accordingly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--DeferredIncomeTableTextBlock_zLcQ5Pqn2FQ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The movement is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8BF_zgnSSx29e7Ge" style="display: none">SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_4B8_zMvbOXrilBfj" style="text-align: center">Deferred income</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Audited)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_435_c20220101__20221231_eus-gaap--DeferredIncome_iS_zIRvpcwcJS58" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance – January 1, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeAddition_zEwMoD00hI2g" style="vertical-align: bottom; background-color: White"> <td style="width: 80%">Addition</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">99,599</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeRevenueRecognized_iN_di_z9cygRX9M6u4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Recognize</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_43C_c20230101__20231231_eus-gaap--DeferredIncome_iS_zoqWjZYiSHVc" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance – December 31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">99,599</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_43A_c20230101__20231231_eus-gaap--DeferredIncome_iS_zIdYkPTAPKO5" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">99,599</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredIncomeAddition_z6grFjXXTHH3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Addition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0419">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeRevenueRecognized_iN_di_zVONJvIs8U4j" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Recognize</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(99,599</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43A_c20230101__20231231_eus-gaap--DeferredIncome_iE_zYcBVKcoOAJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance – December 31, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_43B_c20230101__20231231_eus-gaap--DeferredIncome_iE_znmLJxBeiL46" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zn8Ek04gocE4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 99599 <p id="xdx_896_eus-gaap--DeferredIncomeTableTextBlock_zLcQ5Pqn2FQ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The movement is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8BF_zgnSSx29e7Ge" style="display: none">SCHEDULE OF DEFERRED INCOME CONTRACT LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" id="xdx_4B8_zMvbOXrilBfj" style="text-align: center">Deferred income</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">(Audited)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_435_c20220101__20221231_eus-gaap--DeferredIncome_iS_zIRvpcwcJS58" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance – January 1, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredIncomeAddition_zEwMoD00hI2g" style="vertical-align: bottom; background-color: White"> <td style="width: 80%">Addition</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">99,599</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeRevenueRecognized_iN_di_z9cygRX9M6u4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Recognize</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_43C_c20230101__20231231_eus-gaap--DeferredIncome_iS_zoqWjZYiSHVc" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance – December 31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">99,599</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_43A_c20230101__20231231_eus-gaap--DeferredIncome_iS_zIdYkPTAPKO5" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">99,599</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredIncomeAddition_z6grFjXXTHH3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Addition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0419">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredIncomeRevenueRecognized_iN_di_zVONJvIs8U4j" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Recognize</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(99,599</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43A_c20230101__20231231_eus-gaap--DeferredIncome_iE_zYcBVKcoOAJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance – December 31, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_43B_c20230101__20231231_eus-gaap--DeferredIncome_iE_znmLJxBeiL46" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 99599 99599 99599 99599 <p id="xdx_80E_eus-gaap--LongTermDebtTextBlock_z1A4C5MSqo3a" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_zDSjAkKJQWDe">LONG-TERM LOAN – RELATED PARTY </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company had a long-term loan of $<span id="xdx_90B_eus-gaap--LongTermLoansPayable_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQso5lgTPsh1" title="long term loan">22,362</span> from one of the shareholders. According to the original loan agreement signed on April 8, 2023, <span id="xdx_90B_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zm2UcUPhkZX" title="Related party transaction, description">the Company is required to repay the loan before April 7, 2024; after the agreement renewal, the repayment date was extended to April 11, 2025. The renewed loan agreement has a term of 12 months with an annual interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zP9mTRXkNAUh" title="Loan annual interest rate">4</span>% with no collateral is required. Additionally, the loan agreement will be automatically extended to additional one year if the repayment is not completed before due date</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">As of December 31, 2023, the accrued interest amount to $<span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20230101__20231231_zd4R7Gx2yoSl" title="Accrued interest">645</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 22362 the Company is required to repay the loan before April 7, 2024; after the agreement renewal, the repayment date was extended to April 11, 2025. The renewed loan agreement has a term of 12 months with an annual interest rate of 4% with no collateral is required. Additionally, the loan agreement will be automatically extended to additional one year if the repayment is not completed before due date 0.04 645 <p id="xdx_80B_eus-gaap--ConcentrationRiskDisclosureTextBlock_zmxC7eVQ8vq5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_829_zO9YiHBEJgX">CONCENTRATION OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zuUbAHNElLq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is a concentration of risk associated with the Company’s services revenue. In 2023, revenue from four customers constituted <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zTzcs0b9I5i">88</span>% of the total revenue. In 2022, all revenue came from four customers, comprising </span><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zCiGkWUCFem2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> of the total. It’s important to note that these customer compositions are not identical.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zfhtaXCOUJa4" style="display: none">SCHEDULE OF CONCENTRATION RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the years ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31,</p></td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerAMember_zBFMx9CKyOH8" style="width: 12%; text-align: right" title="Revenue">52,059</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zGAjfkBv3xLh" title="Concentration risk, percentage">32</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerBMember_zLzhhofgngk4" style="text-align: right" title="Revenue">47,540</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z00WWl4TYUtj" title="Concentration risk, percentage">29</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerCMember_zm7u1PJQSRu4" style="text-align: right" title="Revenue">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfKIIsZkjzZc" title="Concentration risk, percentage">18</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerDMember_z8hGL34cpxS6" style="text-align: right" title="Revenue">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zF5kM1iD0aj1" title="Concentration risk, percentage">9</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerEMember_zUAZvELjvYRf" style="text-align: right" title="Revenue">41,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzazMK4kYUk7" title="Concentration risk, percentage">40</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerFMember_zl6TGvD7TZv5" style="text-align: right" title="Revenue">26,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgpLGil1LfT2" title="Concentration risk, percentage">25</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerGMember_z86kL4ObzHZh" style="text-align: right" title="Revenue">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerGMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zA1gt9YOK125" title="Concentration risk, percentage">20</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Customer H</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerHMember_zdpaODQr9wx5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">14,982</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerHMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdQfXM3ArmE3" title="Concentration risk, percentage">15</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Subtotal</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231_zdPLGWwB8UY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Revenue">144,599</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zHC4lXjhR5Kc" title="Concentration risk, percentage">88</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zrPfPpR7sfj2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">102,002</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zu54PEowlcUl" title="Concentration risk, percentage">100</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8A4_zqgQdoptIBF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p> <p id="xdx_895_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zuUbAHNElLq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is a concentration of risk associated with the Company’s services revenue. In 2023, revenue from four customers constituted <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zTzcs0b9I5i">88</span>% of the total revenue. In 2022, all revenue came from four customers, comprising </span><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zCiGkWUCFem2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> of the total. It’s important to note that these customer compositions are not identical.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zfhtaXCOUJa4" style="display: none">SCHEDULE OF CONCENTRATION RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the years ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31,</p></td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerAMember_zBFMx9CKyOH8" style="width: 12%; text-align: right" title="Revenue">52,059</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zGAjfkBv3xLh" title="Concentration risk, percentage">32</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerBMember_zLzhhofgngk4" style="text-align: right" title="Revenue">47,540</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z00WWl4TYUtj" title="Concentration risk, percentage">29</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerCMember_zm7u1PJQSRu4" style="text-align: right" title="Revenue">30,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfKIIsZkjzZc" title="Concentration risk, percentage">18</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerDMember_z8hGL34cpxS6" style="text-align: right" title="Revenue">15,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zF5kM1iD0aj1" title="Concentration risk, percentage">9</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerEMember_zUAZvELjvYRf" style="text-align: right" title="Revenue">41,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzazMK4kYUk7" title="Concentration risk, percentage">40</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerFMember_zl6TGvD7TZv5" style="text-align: right" title="Revenue">26,020</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgpLGil1LfT2" title="Concentration risk, percentage">25</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerGMember_z86kL4ObzHZh" style="text-align: right" title="Revenue">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerGMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zA1gt9YOK125" title="Concentration risk, percentage">20</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Customer H</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerHMember_zdpaODQr9wx5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">14,982</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerHMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdQfXM3ArmE3" title="Concentration risk, percentage">15</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Subtotal</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p id="xdx_982_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20230101__20231231_zdPLGWwB8UY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Revenue">144,599</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zHC4lXjhR5Kc" title="Concentration risk, percentage">88</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20220101__20221231_zrPfPpR7sfj2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">102,002</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zu54PEowlcUl" title="Concentration risk, percentage">100</span></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> </table> 0.88 1 52059 0.32 47540 0.29 30000 0.18 15000 0.09 41000 0.40 26020 0.25 20000 0.20 14982 0.15 144599 0.88 102002 1 <p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zjzSl0NQ9sc9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_824_z5XPEUA71o9l">INCOME TAX</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was established in the State of Nevada in United States and is subject to Nevada State and US Federal tax laws. The Company has not recognized an income tax benefit for its operating losses based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the periods presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses and other temporary differences, the realization of which could not be considered more likely than not. Further, the benefit from utilization of NOL (“net operating loss”) carry forwards could be subject to limitations due to material ownership changes that could occur in the Company as it continues to raise additional capital. Based on such limitations, the Company has significant NOLs for which realization of tax benefits is uncertain. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and 2022, the Company has accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20231231_zqmAO0UdCFV6" title="Accumulated deficit">348,245</span> and $<span id="xdx_903_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20221231_zNE7iEADS226" title="Accumulated deficit">345,310</span>. In 2023, the Company incurred a net loss of $<span id="xdx_902_eus-gaap--ProfitLoss_iN_pp0p0_di_c20230101__20231231_zpsnN25r0oP6" title="Net loss">2,935</span>, as the management is not yet able to reliably estimate when the Company will generate profits that would enable the Company to make use of such potential future tax benefits. Consequently, a valuation allowance has been set up for the entire amount of the net deferred tax asset. Management continually assesses its future earnings potential and related tax impacts. If circumstances change in the future that will enable Management to accurately forecast future profits, the Company may carryover of such tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -348245 -345310 -2935 <p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zAQVXktKfose" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_zN6s0jr4oYH7">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2024, the Company and one of the shareholders renewed the loan agreement and extended the repayment date to April 11, 2025, subject to an automatic extension for an additional one year. The annual interest rate is <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240405__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zjn3yet8Bqa5" title="Annual interest rate percentage">4</span>% with no collateral.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated subsequent events that have occurred after the date of the balance sheet through April 14, 2024 and determined that no subsequent events require recognition or disclosure to the financial statements other than the above matter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> 0.04 false false false false

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